archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,5.508e-06,1.7184,1.5009,1,1
1,GO BLEB ASSEMBLY,2.7578e-07,1.6202,1.4129,1,1
1,GO MEMBRANE RAFT ASSEMBLY,2.5774e-06,1.4257,1.574,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,1.349e-05,1.3467,1.1412,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,3.17e-07,1.2317,1.0873,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,8.4155e-08,1.1934,1.1896,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,2.4515e-08,1.1682,1.1164,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,2.9957e-08,1.1619,1.1056,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.013e-05,1.1571,1.0862,1,1
1,GO NEUTROPHIL HOMEOSTASIS,2.1831e-07,1.0953,1.0242,1,1
1,GO RESPONSE TO INTERFERON ALPHA,3.3202e-07,1.076,1.1515,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,1.725e-07,1.0692,1.0512,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2971e-07,1.054,1.0019,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,4.6623e-06,1.0476,0.9885,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,9.389e-05,1.0416,0.80787,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.9873e-07,1.0286,1.0401,1,1
1,GO HYALURONAN CATABOLIC PROCESS,6.93e-08,1.0272,1.0615,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,4.4878e-05,1.0145,0.89651,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,2.3975e-07,0.99651,0.87839,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,6.2786e-05,0.99375,0.8563,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.4039e-05,0.9908,0.87926,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,2.2879e-07,0.98973,0.84912,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,4.2876e-06,0.98827,0.87997,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,3.6414e-07,0.9695,0.95482,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,5.0683e-06,0.94575,0.95524,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,3.8423e-08,0.93272,0.93407,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.17e-07,0.93268,0.99762,1,1
1,GO BONE TRABECULA FORMATION,1.4039e-05,0.92917,0.88071,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,2.9301e-06,0.92892,0.84687,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.4994e-06,0.92141,0.86984,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,2.8496e-08,0.92007,0.9877,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.0311e-06,0.91684,0.86337,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00011241,0.91524,0.72381,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.0784e-06,0.90936,0.89304,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,3.9926e-07,0.90577,0.97577,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,8.628e-07,0.90321,0.81079,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,4.6623e-06,0.89158,1.0644,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.3441e-06,0.88821,1.2473,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,7.2756e-08,0.88753,0.92083,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,3.479e-08,0.87035,0.95484,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,3.6414e-07,0.86993,0.83986,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,1.2366e-07,0.8622,0.84804,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,7.2111e-07,0.86061,0.73218,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,4.2424e-08,0.85508,0.86684,1,1
1,GO MEMBRANE RAFT ORGANIZATION,2.4692e-06,0.85217,0.93814,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.0033e-05,0.83667,0.7734,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,5.6999e-08,0.83422,0.84731,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.1702e-06,0.83326,0.72633,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.5813e-07,0.83235,0.72335,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.2879e-07,0.83091,0.83929,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.6322e-07,0.82762,0.77824,1,1
1,GO CD40 SIGNALING PATHWAY,3.8131e-07,0.82693,0.76047,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.1237e-07,0.82175,0.79057,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,6.6003e-08,0.81999,0.79183,1,1
1,GO RESPONSE TO INTERFERON BETA,2.3654e-06,0.81918,0.96086,1,1
1,GO HIPPO SIGNALING,1.0311e-06,0.81736,0.66293,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,6.5896e-07,0.81364,0.88591,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.5201e-05,0.80448,0.81594,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,3.4772e-07,0.80446,0.68239,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,5.0194e-07,0.80137,0.70362,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,3.9926e-07,0.79819,0.77418,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,2.5308e-05,0.79748,0.71523,1,1
1,GO ZYMOGEN INHIBITION,3.3202e-07,0.79652,0.81438,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.5427e-07,0.79611,0.70191,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.725e-07,0.79161,0.77508,1,1
1,GO PLASMINOGEN ACTIVATION,5.2139e-05,0.79105,0.63467,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,3.1904e-06,0.7774,0.68572,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.0207e-07,0.77482,0.71761,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,8.6584e-06,0.77167,0.65882,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,9.7275e-08,0.76737,0.76016,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.8958e-07,0.76567,0.76789,1,1
1,GO ENDODERM FORMATION,4.6826e-08,0.76452,0.83948,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.7578e-07,0.75871,0.87318,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,3.7791e-06,0.7582,0.71576,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,1.104e-05,0.75427,0.68002,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,1.7118e-05,0.75255,0.63701,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00079435,0.74994,0.54448,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00014935,0.74461,0.67938,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.2971e-07,0.74323,0.70837,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.0198e-07,0.74315,0.72966,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,1.1267e-06,0.73634,0.69929,1,1
1,GO EPIBOLY,8.8325e-08,0.73565,0.80908,1,1
1,GO LATERAL MESODERM DEVELOPMENT,4.8612e-06,0.73191,0.6384,1,1
1,GO GAP JUNCTION ASSEMBLY,1.0311e-06,0.73129,0.67255,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,5.986e-08,0.72952,0.70342,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,9.2696e-08,0.72741,0.6954,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,3.6228e-06,0.72536,0.74745,1,1
1,GO CELLULAR RESPONSE TO X RAY,1.9263e-05,0.72155,0.59077,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00038934,0.72057,0.54763,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,5.1671e-08,0.71959,0.70783,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,7.0571e-06,0.71559,0.71371,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,5.2139e-05,0.71338,0.67383,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.4334e-07,0.71211,0.68399,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.6003e-08,0.71003,0.73512,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,2.4346e-05,0.70774,0.63065,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,2.0784e-06,0.70343,0.74778,1,1
1,GO LEUKOCYTE AGGREGATION,0.00011241,0.69722,0.60339,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,6.93e-08,0.69716,0.69103,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.6729e-06,0.69356,0.62259,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.00017186,0.69309,0.56826,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,6.0198e-07,0.69195,0.63481,1,1
1,GO NOTOCHORD DEVELOPMENT,2.5122e-07,0.68927,0.78584,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,1.4039e-05,0.68836,0.6141,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,2.7343e-05,0.68761,0.55695,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,3.8131e-07,0.68664,0.84649,1,1
1,GO SALIVARY GLAND DEVELOPMENT,3.17e-07,0.68638,0.67602,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,5.986e-08,0.68278,0.66825,1,1
1,GO VASCULOGENESIS,2.8496e-08,0.68204,0.65965,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.4334e-07,0.67953,0.73999,1,1
1,GO FIBRINOLYSIS,1.0779e-06,0.67892,0.81607,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.5813e-07,0.67742,0.59491,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.3287e-06,0.67604,0.57416,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.3975e-07,0.67448,0.73294,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,4.1617e-05,0.67352,0.63404,1,1
1,GO BIOLOGICAL PHASE,0.00020448,0.67212,0.61919,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,9.8628e-07,0.67077,0.80045,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,3.4728e-06,0.66881,0.80018,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.2837e-06,0.66835,0.62614,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00021909,0.664,0.50011,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.4728e-06,0.66109,0.51158,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,9.4334e-07,0.6609,0.61441,1,1
1,GO RESPONSE TO INTERLEUKIN 18,0.0073363,0.66078,0.60706,1,1
1,GO T CELL EXTRAVASATION,7.0571e-06,0.66048,0.67233,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.3441e-06,0.65821,0.59943,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,5.9841e-06,0.65686,0.55414,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.3441e-06,0.65443,0.66436,1,1
1,GO REGULATION OF PINOCYTOSIS,4.8379e-05,0.65266,0.63654,1,1
1,GO SKIN MORPHOGENESIS,8.3127e-06,0.65191,0.80368,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,3.1888e-05,0.65072,0.62192,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,5.2837e-06,0.64875,0.6295,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.1267e-06,0.6482,0.70463,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00065623,0.64802,0.50733,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,9.3916e-06,0.64565,0.56948,1,1
1,GO APOPTOTIC CELL CLEARANCE,8.8325e-08,0.64512,0.73573,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,4.2876e-06,0.64479,0.57037,1,1
1,GO MUCUS SECRETION,0.0011199,0.64318,0.51538,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,5.2139e-05,0.64162,0.56673,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.5774e-06,0.64007,0.62719,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,7.889e-07,0.6392,0.60534,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,2.5308e-05,0.63898,0.55847,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.8077e-06,0.63626,0.74231,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.4963e-07,0.62926,0.67969,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,3.8423e-08,0.62907,0.62618,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,3.7791e-06,0.62864,0.55245,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,9.0221e-07,0.62737,0.74372,1,1
1,GO ENDODERM DEVELOPMENT,6.2859e-08,0.62469,0.69376,1,1
1,GO CELLULAR RESPONSE TO IRON ION,1.8084e-07,0.62306,0.63603,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,3.8131e-07,0.62179,0.63472,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.0375e-08,0.62011,0.63901,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.1776e-06,0.61767,0.65141,1,1
1,GO DNA DEAMINATION,5.7413e-06,0.61555,0.62226,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,6.7728e-06,0.61406,0.59624,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,2.3654e-06,0.61151,0.545,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,6.2786e-05,0.60729,0.43524,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.4692e-06,0.60628,0.71537,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.6455e-05,0.60417,0.56309,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,2.1702e-06,0.60305,0.66544,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.1267e-06,0.60224,0.66415,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,5.0194e-07,0.60223,0.62889,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.725e-07,0.60211,0.65678,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.9873e-07,0.60033,0.61925,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,6.7728e-06,0.60027,0.59159,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,2.2879e-07,0.59871,0.51871,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0037331,0.59725,0.37797,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.6729e-06,0.59693,0.67702,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,4.1617e-05,0.59676,0.56317,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.4044e-06,0.59621,0.50964,1,1
1,GO LIVER REGENERATION,2.2167e-08,0.59611,0.62435,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00027832,0.59606,0.41536,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,1.0311e-06,0.59451,0.54487,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,5.508e-06,0.59393,0.69408,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0038387,0.59369,0.68239,1,1
1,GO REGULATION OF FIBRINOLYSIS,2.0033e-05,0.59308,0.60813,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,2.3418e-05,0.59277,0.51755,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00011241,0.59186,0.49079,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,6.2985e-07,0.59159,0.66751,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0073363,0.59057,0.48591,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.0683e-06,0.58951,0.60123,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,3.4728e-06,0.58625,0.51544,1,1
1,GO RESPONSE TO X RAY,2.8496e-08,0.58533,0.6381,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,7.2754e-05,0.58363,0.46339,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.9301e-06,0.58286,0.52773,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.4963e-07,0.58243,0.59464,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,1.906e-06,0.58178,0.49143,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00022676,0.58103,0.49147,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.0604e-05,0.58028,0.54071,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,1.8084e-07,0.57919,0.61678,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.2971e-07,0.57918,0.63349,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.4039e-05,0.57865,0.5865,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,4.7955e-07,0.57823,0.54135,1,1
1,GO RESPONSE TO TYPE I INTERFERON,2.3418e-05,0.57683,0.64307,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,2.6902e-06,0.57606,0.64345,1,1
1,GO AORTIC VALVE DEVELOPMENT,1.4674e-06,0.57598,0.57178,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,3.7791e-06,0.57578,0.67583,1,1
1,GO AMYLOID BETA CLEARANCE,5.2533e-07,0.57467,0.502,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,1.104e-05,0.57423,0.60146,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,2.1663e-05,0.57321,0.53206,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,7.0571e-06,0.57217,0.59984,1,1
1,GO ENTRY INTO HOST,2.2879e-07,0.57198,0.59714,1,1
1,GO HEME METABOLIC PROCESS,2.0784e-06,0.57183,0.51518,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.6015e-06,0.57079,0.49733,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00016023,0.57034,0.45126,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.9418e-06,0.56938,0.5261,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.0604e-05,0.56519,0.46787,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,3.0576e-06,0.56309,0.74151,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7343e-05,0.56139,0.45568,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.4772e-07,0.56103,0.59418,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,1.104e-05,0.5601,0.53101,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.0033e-05,0.55988,0.47954,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,1.2308e-06,0.55959,0.51596,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,7.889e-07,0.55853,0.56302,1,1
1,GO TOLERANCE INDUCTION,0.00011241,0.55805,0.50511,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.019739,0.55727,0.38238,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.0207e-07,0.557,0.58626,1,1
1,GO PIGMENT GRANULE MATURATION,0.00014935,0.55681,0.4344,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,5.0683e-06,0.5539,0.53795,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.00013917,0.5528,0.60879,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,5.2533e-07,0.55218,0.50396,1,1
1,GO TYPE 2 IMMUNE RESPONSE,5.508e-06,0.5506,0.56334,1,1
1,GO CYTOLYSIS,3.6228e-06,0.54962,0.48231,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.0198e-07,0.5484,0.59362,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.4963e-07,0.54697,0.53793,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0007696,0.54679,0.43161,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0025083,0.5456,0.39081,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0001165,0.54443,0.48453,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,3.7791e-06,0.54439,0.47906,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,4.4712e-06,0.54234,0.58473,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.00065623,0.54189,0.43228,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.4044e-06,0.54152,0.51795,1,1
1,GO INTERLEUKIN 1 PRODUCTION,4.1112e-06,0.53987,0.49721,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.4609e-05,0.53898,0.40458,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,9.3916e-06,0.53874,0.49543,1,1
1,GO COLLAGEN CATABOLIC PROCESS,5.4977e-07,0.53677,0.59561,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,1.2454e-05,0.53459,0.55137,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,4.1802e-07,0.53434,0.49367,1,1
1,GO ZYMOGEN ACTIVATION,1.1964e-05,0.53383,0.54373,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.8131e-07,0.5333,0.58501,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,7.889e-07,0.53276,0.58372,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,7.3528e-06,0.53275,0.49209,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0207e-07,0.53268,0.56439,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00013433,0.53213,0.48009,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,9.0179e-06,0.53206,0.65343,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,5.8301e-05,0.5317,0.42431,1,1
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0046564,0.53123,0.35871,1,1
1,GO VAGINA DEVELOPMENT,1.5331e-06,0.53062,0.60296,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,6.2985e-07,0.53034,0.52662,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,7.2111e-07,0.52885,0.50215,1,1
1,GO RESPONSE TO INTERFERON GAMMA,2.0784e-06,0.52776,0.528,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,3.5759e-05,0.52653,0.46011,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.5691e-07,0.52641,0.60119,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00090094,0.52614,0.55853,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,1.4268e-07,0.52534,0.48066,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.2454e-05,0.52479,0.53952,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,6.2859e-08,0.52372,0.53622,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.31e-08,0.52304,0.51984,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.6729e-06,0.52287,0.45135,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.0194e-07,0.52137,0.50984,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,6.5149e-05,0.52076,0.45961,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00041602,0.51955,0.4455,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0019282,0.51884,0.38198,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,5.4977e-07,0.51825,0.46919,1,1
1,GO VIRAL GENOME REPLICATION,6.8936e-07,0.51779,0.47932,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.3202e-07,0.51749,0.47658,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.3287e-06,0.51692,0.53205,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,4.0073e-05,0.51528,0.50871,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.349e-05,0.51489,0.44234,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.1663e-05,0.51455,0.53631,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.4674e-06,0.51362,0.47492,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.725e-07,0.51143,0.54693,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,3.4421e-05,0.51102,0.50668,1,1
1,GO PULMONARY VALVE DEVELOPMENT,8.1192e-05,0.51006,0.51078,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,4.5813e-07,0.50975,0.75055,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.7596e-05,0.50867,0.44217,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.8077e-06,0.50831,0.45265,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,3.0576e-06,0.5083,0.53335,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.6999e-08,0.50793,0.52023,1,1
1,GO T CELL MEDIATED IMMUNITY,1.6729e-06,0.50765,0.49809,1,1
1,GO ENAMEL MINERALIZATION,6.7596e-05,0.5076,0.50329,1,1
1,GO OSTEOBLAST DEVELOPMENT,6.7596e-05,0.50516,0.46095,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0001165,0.50438,0.478,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,3.8583e-05,0.50344,0.39677,1,1
1,GO RESPONSE TO HYPEROXIA,1.0184e-05,0.50157,0.52224,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.2308e-06,0.50143,0.48073,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.9301e-06,0.50099,0.58244,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.0221e-07,0.5007,0.6274,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,7.8282e-05,0.4997,0.50542,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.7955e-07,0.49959,0.51994,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,2.2658e-06,0.49926,0.49037,1,1
1,GO PEPTIDE CROSS LINKING,5.4121e-05,0.49844,0.5217,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,2.9532e-05,0.4983,0.52124,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.5331e-06,0.49778,0.54084,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,9.3916e-06,0.4976,0.43014,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,2.6322e-07,0.49739,0.56731,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00041602,0.49693,0.47921,1,1
1,GO LYMPHANGIOGENESIS,2.5122e-07,0.49659,0.52339,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00030804,0.49644,0.42953,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.001191,0.49603,0.42872,1,1
1,GO STORE OPERATED CALCIUM ENTRY,6.4994e-06,0.49539,0.4176,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.001662,0.49509,0.40113,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0010528,0.49409,0.40842,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,1.8251e-06,0.49401,0.46549,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.013e-05,0.49286,0.36739,1,1
1,GO GLAND MORPHOGENESIS,2.6902e-06,0.49221,0.47366,1,1
1,GO DETECTION OF BIOTIC STIMULUS,2.1702e-06,0.49201,0.50412,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00084609,0.49094,0.46949,1,1
1,GO FOREGUT MORPHOGENESIS,7.0571e-06,0.49031,0.50204,1,1
1,GO FIBROBLAST ACTIVATION,0.00012512,0.48989,0.42295,1,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0029794,0.48779,0.41499,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,9.8628e-07,0.48769,0.52434,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.011326,0.48596,0.40804,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00072223,0.48586,0.37189,1,1
1,GO PINOCYTOSIS,2.7578e-07,0.48579,0.61965,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,5.4272e-08,0.48568,0.50204,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,2.5308e-05,0.48508,0.39866,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00074557,0.48507,0.52123,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,5.2533e-07,0.48502,0.46893,1,1
1,GO PROTEIN OXIDATION,0.00031859,0.48447,0.47647,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,6.4994e-06,0.48286,0.47391,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.1493e-05,0.4825,0.39885,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.2962e-05,0.48197,0.52592,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.6603e-06,0.48118,0.48768,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.5201e-05,0.48084,0.4311,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00055855,0.48059,0.37338,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.007729,0.48008,0.26905,1,1
1,GO RESPONSE TO ANGIOTENSIN,9.4334e-07,0.47974,0.46273,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.7413e-06,0.47935,0.48012,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,2.1702e-06,0.47868,0.48843,1,1
1,GO VIRAL RNA GENOME REPLICATION,5.6999e-08,0.47778,0.47308,1,1
1,GO REGULATION OF TRANSPOSITION,1.5816e-05,0.47764,0.5152,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.1904e-06,0.47736,0.43811,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,3.3132e-05,0.47718,0.45458,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,3.9926e-07,0.4766,0.40141,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00013433,0.47632,0.39817,1,1
1,GO NIK NF KAPPAB SIGNALING,1.1788e-07,0.4751,0.44192,1,1
1,GO CYTOKINE METABOLIC PROCESS,1.7474e-06,0.47403,0.41172,1,1
1,GO BLOOD VESSEL REMODELING,4.8379e-05,0.47379,0.42356,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,5.2533e-07,0.47301,0.51739,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,4.4878e-05,0.47298,0.41503,1,1
1,GO HYALURONAN METABOLIC PROCESS,2.5122e-07,0.47297,0.50941,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.1802e-07,0.47221,0.49903,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.2524e-05,0.47181,0.44653,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.0184e-05,0.47136,0.49741,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,4.1112e-06,0.4713,0.48348,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,3.3287e-06,0.47005,0.50663,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00079435,0.46966,0.45714,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.9301e-06,0.46884,0.53929,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.1663e-05,0.46861,0.41337,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.1964e-05,0.46829,0.43867,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,3.8131e-07,0.46814,0.51002,1,1
1,GO REGULATION OF MYOBLAST FUSION,4.6597e-05,0.46731,0.53485,1,1
1,GO DEFENSE RESPONSE TO VIRUS,5.2837e-06,0.46678,0.43157,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,2.2524e-05,0.46674,0.45194,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.3763e-07,0.46666,0.51311,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.6729e-06,0.4665,0.42559,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,1.6455e-05,0.46564,0.59884,1,1
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.0019282,0.46498,0.59317,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,9.0551e-05,0.46484,0.39138,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,8.628e-07,0.46434,0.47518,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,1.0779e-06,0.46341,0.46979,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0018173,0.46336,0.38856,1,1
1,GO RESPONSE TO INTERLEUKIN 12,3.0264e-07,0.4632,0.44406,1,1
1,GO BONE GROWTH,1.1267e-06,0.4616,0.5596,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,3.7791e-06,0.46152,0.41941,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,6.0198e-07,0.46152,0.47516,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.6826e-08,0.46133,0.4494,1,1
1,GO MACROPHAGE PROLIFERATION,0.00057693,0.46034,0.46996,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00018427,0.46009,0.42487,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0060989,0.45999,0.32449,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,9.3916e-06,0.45962,0.41041,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.2837e-06,0.45935,0.44055,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,7.013e-05,0.45863,0.39536,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00034072,0.45763,0.41108,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,5.0683e-06,0.45696,0.45277,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.7791e-06,0.45695,0.41965,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,9.8628e-07,0.4567,0.40206,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,4.8612e-06,0.45662,0.41288,1,1
1,GO REPLICATIVE SENESCENCE,0.00036427,0.4566,0.45109,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,1.5201e-05,0.45603,0.53236,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013457,0.45586,0.43816,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,7.0571e-06,0.45585,0.45832,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,7.5427e-07,0.45481,0.41386,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.45459,0.41183,1,1
1,GO ANIMAL ORGAN REGENERATION,9.7275e-08,0.45455,0.51689,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.4268e-07,0.45439,0.40297,1,1
1,GO PROTEASOME ASSEMBLY,0.00017186,0.45437,0.31453,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.3132e-05,0.45359,0.69859,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,7.6603e-06,0.45257,0.49676,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.3605e-07,0.4525,0.51194,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.5896e-07,0.45234,0.48177,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.0018173,0.45175,0.36868,1,1
1,GO TRABECULA FORMATION,0.00011241,0.4515,0.48904,1,1
1,GO MRNA TRANSCRIPTION,2.7343e-05,0.45148,0.37433,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.014486,0.45146,0.28393,1,1
1,GO MUSCLE CELL FATE COMMITMENT,3.1888e-05,0.45136,0.45821,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,2.7343e-05,0.45131,0.35745,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00052342,0.45123,0.32221,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.0311e-06,0.45052,0.41222,1,1
1,GO RESPONSE TO SALT STRESS,3.0264e-07,0.45042,0.41909,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.001191,0.45035,0.36474,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,1.3441e-06,0.45007,0.39798,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,3.17e-07,0.44967,0.52049,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,7.5427e-07,0.44963,0.42391,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,3.0264e-07,0.44781,0.42852,1,1
1,GO TONGUE MORPHOGENESIS,0.01282,0.44763,0.31539,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.3132e-05,0.44759,0.40291,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.9926e-07,0.44684,0.4321,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00018427,0.44657,0.4854,1,1
1,GO HAIR FOLLICLE MATURATION,0.00087311,0.44653,0.36396,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.1663e-05,0.44636,0.36603,1,1
1,GO MATURATION OF LSU RRNA,0.00013917,0.4463,0.38091,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00027832,0.44597,0.36682,1,1
1,GO RESPONSE TO PROGESTERONE,0.0060989,0.44549,0.29835,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.4977e-07,0.44516,0.43554,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,2.6902e-06,0.44463,0.51177,1,1
1,GO ETHANOL OXIDATION,0.013798,0.44459,0.38118,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,6.8936e-07,0.44452,0.39721,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.0576e-06,0.44436,0.4461,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.7343e-05,0.44397,0.53568,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,4.1112e-06,0.44386,0.39086,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.8301e-05,0.44368,0.32778,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00013433,0.44332,0.39958,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,6.5896e-07,0.4425,0.41131,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,5.9841e-06,0.44232,0.47999,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00081984,0.44133,0.33266,1,1
1,GO EMBRYO IMPLANTATION,3.0264e-07,0.44132,0.53216,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00065623,0.44109,0.40692,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,1.7474e-06,0.44108,0.54439,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,7.6603e-06,0.43997,0.47511,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,2.1663e-05,0.43992,0.49914,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00090094,0.43989,0.46246,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,9.8628e-07,0.43934,0.45692,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,1.349e-05,0.43912,0.41624,1,1
1,GO REGULATION OF HIPPO SIGNALING,5.4121e-05,0.43903,0.40661,1,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.023205,0.43896,0.27247,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,4.6597e-05,0.4387,0.35116,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00074557,0.43804,0.54122,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,9.0551e-05,0.43779,0.6396,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0017641,0.43741,0.31401,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00057693,0.4374,0.51477,1,1
1,GO VIRAL TRANSLATION,5.2837e-06,0.4367,0.41455,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,3.4421e-05,0.43643,0.41067,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,3.9418e-06,0.43604,0.45408,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00067758,0.43512,0.32015,1,1
1,GO DISTAL TUBULE DEVELOPMENT,0.012203,0.43499,0.34738,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.3127e-06,0.43469,0.41498,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.4977e-07,0.43407,0.45457,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,5.508e-06,0.43402,0.48004,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,2.2524e-05,0.434,0.4691,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,6.2786e-05,0.4337,0.39049,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.7596e-05,0.43294,0.35645,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,2.3418e-05,0.43243,0.31654,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,7.2754e-05,0.43216,0.3845,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00057693,0.43181,0.35482,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,4.4878e-05,0.43171,0.37885,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0050528,0.43133,0.26081,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00084609,0.43072,0.46835,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.43051,0.47308,1,1
1,GO FOCAL ADHESION ASSEMBLY,3.3287e-06,0.4299,0.43249,1,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0039469,0.42942,0.28778,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.1702e-06,0.42879,0.41876,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.5331e-06,0.42869,0.59202,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,9.0551e-05,0.42777,0.38098,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.0034322,0.42732,0.3936,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0011549,0.42653,0.3326,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,6.2367e-06,0.42639,0.38131,1,1
1,GO FIBROBLAST MIGRATION,4.1802e-07,0.42632,0.44796,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.00059588,0.4263,0.49259,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.4963e-07,0.42609,0.45895,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,4.6623e-06,0.42585,0.46272,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,6.2985e-07,0.4255,0.41943,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,1.2862e-06,0.4253,0.43484,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,5.7413e-06,0.42502,0.39932,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.2971e-07,0.42501,0.39221,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,4.4712e-06,0.42487,0.37314,1,1
1,GO I KAPPAB PHOSPHORYLATION,5.0683e-06,0.42378,0.34683,1,1
1,GO RECEPTOR CATABOLIC PROCESS,4.8612e-06,0.42329,0.42185,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,5.753e-07,0.42324,0.39979,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,1.1776e-06,0.42312,0.46262,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,3.8583e-05,0.42129,0.34644,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00047456,0.42118,0.48173,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.4211,0.40813,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,4.4878e-05,0.42104,0.36792,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,4.1617e-05,0.42058,0.38039,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.2308e-06,0.41965,0.3758,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00063551,0.41955,0.30059,1,1
1,GO VIRAL LIFE CYCLE,1.6452e-07,0.41928,0.43742,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,6.2985e-07,0.41881,0.36738,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,2.2658e-06,0.4188,0.40225,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00034072,0.41814,0.35916,1,1
1,GO TOOTH MINERALIZATION,0.00031859,0.41799,0.35106,1,1
1,GO IMMATURE T CELL PROLIFERATION,6.4994e-06,0.41788,0.47812,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,3.7791e-06,0.41779,0.44856,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,3.9418e-06,0.41743,0.36297,1,1
1,GO MULTI ORGANISM LOCALIZATION,6.6003e-08,0.41721,0.41753,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,8.7323e-05,0.41665,0.42495,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.2454e-05,0.41629,0.42609,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00016595,0.41575,0.34953,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00029782,0.41551,0.33804,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.001986,0.41542,0.33184,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00013433,0.41503,0.39286,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,2.0833e-05,0.41442,0.39404,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,2.7343e-05,0.41398,0.4873,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,4.4712e-06,0.41343,0.40083,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,2.0829e-07,0.4132,0.41919,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,1.349e-05,0.4132,0.35796,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,9.2696e-08,0.41314,0.40922,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00074557,0.41258,0.35594,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0057817,0.41251,0.32307,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.0023671,0.4121,0.41985,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.4712e-06,0.41181,0.41574,1,1
1,GO LENS FIBER CELL DEVELOPMENT,7.8282e-05,0.41124,0.46027,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.5201e-05,0.41118,0.49195,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00095906,0.41106,0.31698,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0014299,0.41106,0.31566,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.2505e-07,0.41099,0.41056,1,1
1,GO PLATELET AGGREGATION,6.8936e-07,0.41073,0.39543,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00012074,0.41069,0.39557,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00025131,0.41067,0.40932,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0013872,0.4106,0.37924,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.7474e-06,0.41033,0.41669,1,1
1,GO COPPER ION HOMEOSTASIS,5.7413e-06,0.40959,0.49461,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00055855,0.40881,0.32476,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00031859,0.40821,0.38782,1,1
1,GO REGULATION OF MRNA BINDING,2.9532e-05,0.40814,0.35834,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,7.3528e-06,0.40805,0.43756,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,2.1663e-05,0.40762,0.31474,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,6.7728e-06,0.40742,0.46673,1,1
1,GO INTERACTION WITH SYMBIONT,6.4994e-06,0.40735,0.35046,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,1.5201e-05,0.40725,0.60288,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0039469,0.40721,0.31257,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,3.8583e-05,0.40714,0.40231,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0045306,0.4063,0.42698,1,1
1,GO RIBOSOME ASSEMBLY,0.00095906,0.40605,0.30983,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.8251e-06,0.40562,0.42348,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0038387,0.40561,0.29002,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.2837e-06,0.4053,0.48023,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,6.8936e-07,0.40499,0.37879,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0064317,0.40495,0.45903,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.00013917,0.40493,0.41342,1,1
1,GO POSITIVE REGULATION OF CELL SIZE,0.03245,0.40476,0.24325,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.019283,0.40455,0.25412,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,2.2524e-05,0.40431,0.35948,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00013917,0.40385,0.41031,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.3916e-06,0.40363,0.36413,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00038934,0.40356,0.3555,1,1
1,GO INTERLEUKIN 8 PRODUCTION,4.6623e-06,0.40344,0.40128,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,4.6597e-05,0.40231,0.48349,1,1
1,GO CELL SUBSTRATE ADHESION,3.3202e-07,0.40222,0.43433,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.8379e-05,0.40197,0.42985,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00038934,0.40041,0.48014,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00087311,0.40024,0.30491,1,1
1,GO REGULATION OF STEROL TRANSPORT,3.3287e-06,0.40018,0.3528,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,9.7801e-06,0.3998,0.47496,1,1
1,GO INTERFERON BETA PRODUCTION,2.4346e-05,0.39934,0.33089,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,5.0226e-05,0.39932,0.40259,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,4.7955e-07,0.39927,0.38815,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.00026003,0.399,0.37255,1,1
1,GO GENITALIA MORPHOGENESIS,0.0014299,0.39898,0.34403,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00014418,0.39898,0.36353,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,7.8282e-05,0.39853,0.40436,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00057693,0.3984,0.32299,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,5.2533e-07,0.39777,0.42665,1,1
1,GO SPROUTING ANGIOGENESIS,1.0311e-06,0.39741,0.39064,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.1904e-06,0.39685,0.35255,1,1
1,GO NEURAL CREST CELL MIGRATION,0.0025083,0.39675,0.27672,1,1
1,GO PRIMARY MIRNA PROCESSING,3.7145e-05,0.39624,0.39607,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,3.4728e-06,0.39609,0.39301,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.018398,0.39607,0.35906,1,1
1,GO TYPE I INTERFERON PRODUCTION,7.0571e-06,0.39558,0.34487,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00049035,0.39556,0.32527,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.7474e-06,0.39547,0.498,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,5.7413e-06,0.39516,0.44722,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00023468,0.39484,0.5331,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0019282,0.39441,0.33315,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0036303,0.39434,0.48562,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,8.3127e-06,0.39367,0.44573,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00049035,0.39326,0.33356,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.015574,0.39287,0.2673,1,1
1,GO CHONDROCYTE DEVELOPMENT,2.6307e-05,0.3927,0.42333,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,8.7323e-05,0.39213,0.36006,1,1
1,GO MYOBLAST DIFFERENTIATION,1.2308e-06,0.39197,0.37714,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.015574,0.39159,0.23633,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00027832,0.39137,0.33663,1,1
1,GO OSTEOCLAST DEVELOPMENT,1.4674e-06,0.39084,0.4321,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.0571e-06,0.39081,0.37292,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,2.0033e-05,0.39063,0.44451,1,1
1,GO CARNITINE METABOLIC PROCESS,9.389e-05,0.39055,0.37277,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.3528e-06,0.39052,0.42323,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,1.2962e-05,0.39002,0.36923,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.013798,0.39,0.35536,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00022676,0.38999,0.41384,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1702e-06,0.38909,0.37049,1,1
1,GO URETER DEVELOPMENT,0.00041602,0.38905,0.36045,1,1
1,GO INTERACTION WITH HOST,4.3763e-07,0.38851,0.43804,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,1.3441e-06,0.38821,0.42304,1,1
1,GO ERBB2 SIGNALING PATHWAY,3.4728e-06,0.38782,0.35095,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0028957,0.38744,0.36176,1,1
1,GO T CELL APOPTOTIC PROCESS,9.8628e-07,0.38743,0.37698,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00040247,0.38656,0.30366,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.2859e-08,0.38616,0.39678,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0007696,0.3861,0.3116,1,1
1,GO RESPONSE TO ESTROGEN,2.8891e-07,0.38605,0.40701,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.0033e-05,0.38539,0.34552,1,1
1,GO REGULATION OF GASTRULATION,4.5813e-07,0.38483,0.39684,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00040247,0.38479,0.40096,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,3.6228e-06,0.3847,0.35572,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00012074,0.38339,0.31385,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0026572,0.38332,0.32862,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0021062,0.38304,0.28445,1,1
1,GO PHAGOCYTOSIS RECOGNITION,0.00016595,0.38198,0.52221,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,7.9801e-06,0.38186,0.34631,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00027832,0.3813,0.37827,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0016129,0.38098,0.44887,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.1493e-05,0.38043,0.33234,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00030804,0.37929,0.31592,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.011326,0.37908,0.24689,1,1
1,GO MEMBRANE INVAGINATION,1.1267e-06,0.37863,0.37241,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.1267e-06,0.3785,0.47687,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00087311,0.37847,0.40253,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,6.7728e-06,0.37795,0.3289,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,9.7801e-06,0.37792,0.48888,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,8.3127e-06,0.3776,0.31717,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.9301e-06,0.37758,0.44774,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,8.628e-07,0.37732,0.38043,1,1
1,GO MUSCLE FILAMENT SLIDING,2.1702e-06,0.37727,0.38353,1,1
1,GO REGULATION OF PHAGOCYTOSIS,3.0264e-07,0.37716,0.40933,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,1.1776e-06,0.37663,0.41177,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.00017186,0.37643,0.33811,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0001547,0.37627,0.3262,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.6729e-06,0.37625,0.35319,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,8.1192e-05,0.37601,0.28929,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.00026903,0.37583,0.35501,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.7955e-07,0.37582,0.52909,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00026003,0.37515,0.31233,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.009256,0.37506,0.29688,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.00057693,0.37462,0.34686,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.00049035,0.37432,0.47491,1,1
1,GO T CELL CYTOKINE PRODUCTION,3.0576e-06,0.37391,0.43388,1,1
1,GO REGULATION OF LIPASE ACTIVITY,7.6603e-06,0.37269,0.29335,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,8.7323e-05,0.37205,0.29455,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.6015e-06,0.37192,0.40919,1,1
1,GO REGULATION OF PROTEIN IMPORT,8.6584e-06,0.37155,0.3762,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,1.104e-05,0.37147,0.34969,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.00011241,0.37114,0.2928,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.0039469,0.37088,0.43334,1,1
1,GO MEMBRANE DISASSEMBLY,0.00017186,0.37042,0.30777,1,1
1,GO INTERLEUKIN 17 PRODUCTION,4.6623e-06,0.37025,0.45312,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0022332,0.36963,0.44343,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,2.1663e-05,0.36911,0.30242,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,5.2139e-05,0.36901,0.29275,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0013457,0.3688,0.25294,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0020453,0.36879,0.28683,1,1
1,GO CHEMOKINE PRODUCTION,0.00084609,0.36857,0.28433,1,1
1,GO RIG I SIGNALING PATHWAY,8.4205e-05,0.36825,0.35611,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.0017641,0.3679,0.3187,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00095906,0.36769,0.27998,1,1
1,GO CHONDROCYTE DIFFERENTIATION,2.3654e-06,0.36766,0.34635,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,9.389e-05,0.36731,0.30709,1,1
1,GO KERATINOCYTE MIGRATION,2.6307e-05,0.3672,0.36761,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.00034072,0.3671,0.36236,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.001872,0.36695,0.29009,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00095906,0.36639,0.28986,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,7.9801e-06,0.36626,0.3458,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00036427,0.36623,0.29937,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.0073e-05,0.36599,0.32294,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,9.0551e-05,0.3658,0.2936,1,1
1,GO GLIAL CELL ACTIVATION,0.00036427,0.36566,0.33333,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0083534,0.36563,0.38078,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0032441,0.36536,0.30037,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00042998,0.36517,0.28183,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0012662,0.36504,0.33149,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.1192e-05,0.36502,0.44186,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.0689e-05,0.36479,0.31308,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00044439,0.36451,0.30988,1,1
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.012203,0.36361,0.32982,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.6729e-06,0.36359,0.36797,1,1
1,GO TRANSLATIONAL INITIATION,0.00030804,0.36348,0.29944,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.9301e-06,0.36298,0.40298,1,1
1,GO MESODERM MORPHOGENESIS,2.0829e-07,0.36274,0.38813,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,6.2786e-05,0.36267,0.30401,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.9841e-06,0.36256,0.33475,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00045924,0.36245,0.36964,1,1
1,GO LYMPH VESSEL DEVELOPMENT,9.0551e-05,0.3623,0.41288,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00021909,0.36224,0.3815,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00050664,0.36221,0.305,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0015653,0.36207,0.27075,1,1
1,GO PROSTANOID METABOLIC PROCESS,4.3218e-05,0.36201,0.38651,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,3.7145e-05,0.36163,0.34897,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.013798,0.36073,0.34667,1,1
1,GO MUSCLE CELL MIGRATION,0.0032441,0.36066,0.26953,1,1
1,GO VASCULATURE DEVELOPMENT,1.0311e-06,0.36033,0.33505,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,3.8131e-07,0.36015,0.34958,1,1
1,GO RESPONSE TO CORTICOSTEROID,8.4205e-05,0.36013,0.2709,1,1
1,GO GASTRULATION,1.4268e-07,0.35998,0.39661,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00019079,0.35981,0.31965,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.1888e-05,0.3595,0.33992,1,1
1,GO RETINAL METABOLIC PROCESS,0.010245,0.35945,0.31067,1,1
1,GO RESPONSE TO VIRUS,3.0576e-06,0.3591,0.37023,1,1
1,GO MATURATION OF 5 8S RRNA,0.00067758,0.35875,0.26412,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.0001165,0.35868,0.29248,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.0033e-05,0.35847,0.2988,1,1
1,GO FOREBRAIN MORPHOGENESIS,0.036164,0.35829,0.18538,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,2.1663e-05,0.35821,0.28555,1,1
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.010506,0.35819,0.24596,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.2962e-05,0.35757,0.39017,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00065623,0.35754,0.31708,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,7.9801e-06,0.35743,0.37553,1,1
1,GO HYPOTONIC RESPONSE,0.00022676,0.35712,0.32167,1,1
1,GO WOUND HEALING,3.3287e-06,0.35685,0.34761,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.00040247,0.35657,0.31584,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,7.547e-05,0.35638,0.40028,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,1.7118e-05,0.35633,0.33618,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00030804,0.35629,0.30948,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0047853,0.3562,0.29745,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,2.3654e-06,0.35555,0.38151,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.6452e-07,0.35527,0.39832,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,3.7791e-06,0.35527,0.37698,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.0311e-06,0.35515,0.37907,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.00074557,0.35474,0.33669,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,1.0604e-05,0.35434,0.39998,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,3.8583e-05,0.35427,0.33478,1,1
1,GO ENDOTHELIAL CELL MIGRATION,2.8077e-06,0.35421,0.36021,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.7118e-05,0.35415,0.34044,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00013433,0.35402,0.2949,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,8.6584e-06,0.35398,0.35815,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,9.0179e-06,0.35377,0.37693,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.4712e-06,0.35336,0.37131,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,9.2696e-08,0.35322,0.37305,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,5.7413e-06,0.35291,0.33919,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.5774e-06,0.35283,0.34003,1,1
1,GO CHONDROCYTE PROLIFERATION,0.00067758,0.35273,0.47315,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.9418e-06,0.35213,0.41541,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0013872,0.35078,0.24248,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,3.7145e-05,0.35072,0.33176,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00010845,0.35045,0.33658,1,1
1,GO B CELL MEDIATED IMMUNITY,9.0179e-06,0.35039,0.32256,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.9904e-06,0.35015,0.34875,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.033166,0.34999,0.29114,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,4.3218e-05,0.34992,0.28461,1,1
1,GO ERAD PATHWAY,1.5816e-05,0.34991,0.2649,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.8418e-05,0.34969,0.27193,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00037661,0.34967,0.3816,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.00034072,0.34936,0.41664,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,7.2754e-05,0.34888,0.4205,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,2.9532e-05,0.34883,0.37954,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2139e-05,0.34844,0.38134,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,6.4994e-06,0.34652,0.35534,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00055855,0.34579,0.314,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,2.4692e-06,0.34515,0.38039,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0049174,0.34434,0.24962,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0006154,0.34418,0.3643,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0024367,0.34378,0.32105,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.001191,0.34376,0.31282,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.5201e-05,0.34369,0.30267,1,1
1,GO TISSUE MIGRATION,5.9841e-06,0.34364,0.33071,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0067808,0.3431,0.28886,1,1
1,GO VIRAL GENE EXPRESSION,5.0226e-05,0.34305,0.33472,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,7.5427e-07,0.34289,0.33847,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.8077e-06,0.34281,0.38271,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00013917,0.34245,0.25611,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00031859,0.34226,0.36283,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00012074,0.34205,0.45551,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,2.0033e-05,0.34183,0.34739,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,2.6307e-05,0.34159,0.31082,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00010092,0.34126,0.33201,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,5.0226e-05,0.3411,0.37569,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,4.4878e-05,0.34108,0.35422,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.8077e-06,0.34067,0.34491,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,6.5896e-07,0.34036,0.43025,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00037661,0.34028,0.42126,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0021689,0.33988,0.36928,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,4.6597e-05,0.33981,0.31344,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,5.2139e-05,0.3398,0.3566,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00044439,0.3396,0.34908,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.0033e-05,0.33957,0.40821,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,6.4994e-06,0.33933,0.33087,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00026903,0.33911,0.3873,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00087311,0.33898,0.3122,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0022992,0.33887,0.32333,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00030804,0.33869,0.31819,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0006154,0.33851,0.45396,1,1
1,GO NATURAL KILLER CELL ACTIVATION,1.0311e-06,0.33817,0.34937,1,1
1,GO DECIDUALIZATION,0.0012662,0.33798,0.41675,1,1
1,GO L GLUTAMATE IMPORT,0.0039469,0.33789,0.28867,1,1
1,GO CARTILAGE DEVELOPMENT,4.2876e-06,0.33751,0.31029,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,5.508e-06,0.33746,0.29246,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,3.1904e-06,0.33729,0.39959,1,1
1,GO PROTEIN HYDROXYLATION,0.007729,0.33717,0.36629,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00028792,0.33692,0.26,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00038934,0.33691,0.31374,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00023468,0.33684,0.33748,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.8958e-07,0.33631,0.3641,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.00047456,0.33612,0.27297,1,1
1,GO PROSTATIC BUD FORMATION,0.0006154,0.33585,0.48138,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.7343e-05,0.33554,0.36556,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,7.0571e-06,0.3351,0.31242,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,8.4205e-05,0.3345,0.24353,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,7.3528e-06,0.33443,0.4164,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00013433,0.33435,0.32518,1,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.023205,0.3342,0.1934,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,3.0689e-05,0.33416,0.28992,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,3.4421e-05,0.3341,0.27906,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.00067758,0.33395,0.21679,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,5.2837e-06,0.33393,0.3391,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.349e-05,0.33372,0.46564,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,5.2837e-06,0.33369,0.33207,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,5.2533e-07,0.33348,0.4048,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00016023,0.33311,0.43196,1,1
1,GO CELL MATRIX ADHESION,3.3287e-06,0.33299,0.36709,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,7.013e-05,0.33296,0.35892,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,9.389e-05,0.33279,0.37146,1,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.0083534,0.3324,0.25428,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,3.8131e-07,0.33206,0.34353,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00032948,0.33181,0.33723,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,1.906e-06,0.33124,0.32594,1,1
1,GO GLOMERULUS DEVELOPMENT,2.7343e-05,0.33113,0.41455,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,5.0683e-06,0.33076,0.32029,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00084609,0.33076,0.24147,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00084609,0.33051,0.29838,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00010845,0.33042,0.262,1,1
1,GO RESPONSE TO WOUNDING,2.3654e-06,0.33042,0.30397,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00021167,0.33034,0.3116,1,1
1,GO RESPONSE TO MANGANESE ION,1.5201e-05,0.3302,0.31716,1,1
1,GO PROTEIN TARGETING TO VACUOLE,7.8282e-05,0.33016,0.26638,1,1
1,GO TISSUE REGENERATION,1.7806e-05,0.32996,0.3383,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.3654e-06,0.32971,0.31148,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,8.1192e-05,0.32953,0.29167,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,3.4728e-06,0.3294,0.40405,1,1
1,GO NADPH REGENERATION,0.00036427,0.32921,0.30185,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,3.3132e-05,0.32891,0.30439,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,6.2367e-06,0.32887,0.33631,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0028957,0.32879,0.31063,1,1
1,GO AMYLOID FIBRIL FORMATION,0.022165,0.32847,0.26309,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0017123,0.32836,0.36234,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00079435,0.32824,0.25527,1,1
1,GO REGENERATION,1.2971e-07,0.32782,0.33217,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0017641,0.32774,0.22786,1,1
1,GO MACROPHAGE MIGRATION,1.1267e-06,0.3277,0.38329,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0025817,0.32766,0.33896,1,1
1,GO REGULATION OF HEART GROWTH,6.7728e-06,0.32763,0.29731,1,1
1,GO MACROPHAGE DIFFERENTIATION,8.6584e-06,0.32739,0.37734,1,1
1,GO MUSCLE CELL PROLIFERATION,6.2985e-07,0.32726,0.3483,1,1
1,GO PIGMENT ACCUMULATION,0.00028792,0.32724,0.30868,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.00025131,0.32704,0.2921,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00018427,0.327,0.32984,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,1.4044e-06,0.32652,0.35994,1,1
1,GO PEPTIDE CATABOLIC PROCESS,7.547e-05,0.32645,0.26176,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,9.0551e-05,0.3263,0.29501,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00035231,0.3263,0.36867,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00019079,0.32555,0.36693,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00038934,0.32549,0.35457,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,6.4994e-06,0.32525,0.32283,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00019079,0.32491,0.29078,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.3528e-06,0.32487,0.29303,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0025817,0.32434,0.26089,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,8.2505e-07,0.32407,0.29046,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,9.0221e-07,0.324,0.3143,1,1
1,GO MATURATION OF SSU RRNA,0.0006154,0.32345,0.29832,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00010845,0.3227,0.28532,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00022676,0.32251,0.30849,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.017549,0.32249,0.19299,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.6307e-05,0.32243,0.40398,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00035231,0.32241,0.29484,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00016595,0.32237,0.31355,1,1
1,GO RESPONSE TO INTERLEUKIN 1,1.0311e-06,0.32236,0.36946,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.2876e-06,0.32235,0.30915,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.6623e-06,0.32205,0.35115,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,5.9841e-06,0.322,0.35441,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.0014299,0.32189,0.27618,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.5331e-06,0.32185,0.33129,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,0.00013433,0.32172,0.22954,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0025817,0.32141,0.23581,1,1
1,GO NECROTIC CELL DEATH,4.0073e-05,0.32109,0.40332,1,1
1,GO CYTOKINETIC PROCESS,2.6902e-06,0.32024,0.32384,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,8.1192e-05,0.31984,0.27394,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0039469,0.31971,0.36279,1,1
1,GO SYNCYTIUM FORMATION,1.0184e-05,0.31957,0.3487,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00016595,0.31928,0.26441,1,1
1,GO ASTROCYTE ACTIVATION,9.0551e-05,0.31904,0.35246,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,4.3763e-07,0.31874,0.3538,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.9904e-06,0.31858,0.35186,1,1
1,GO HISTONE PHOSPHORYLATION,3.9926e-07,0.31819,0.31884,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00025131,0.31814,0.34164,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,2.5308e-05,0.31805,0.39551,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00036427,0.31799,0.32963,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.5427e-07,0.31778,0.3424,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4609e-05,0.31755,0.3962,1,1
1,GO VIRAL RELEASE FROM HOST CELL,7.2754e-05,0.31754,0.2805,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.00090094,0.31733,0.27638,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0015653,0.3172,0.23568,1,1
1,GO SNRNA PROCESSING,0.001986,0.31672,0.5482,1,1
1,GO REGULATION OF CELL KILLING,0.00095906,0.3167,0.23408,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,3.5759e-05,0.31668,0.30788,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,7.889e-07,0.31659,0.35953,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.8379e-05,0.31656,0.34451,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0001165,0.31639,0.2824,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00044439,0.31617,0.30669,1,1
1,GO REGULATION OF ORGAN GROWTH,2.0829e-07,0.31608,0.34289,1,1
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0079323,0.31575,0.30824,1,1
1,GO RENAL FILTRATION,0.0050528,0.31496,0.37967,1,1
1,GO IRON ION HOMEOSTASIS,4.6623e-06,0.3149,0.27564,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.2756e-08,0.3146,0.32672,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.0689e-05,0.31442,0.26702,1,1
1,GO INNATE IMMUNE RESPONSE,8.6584e-06,0.31441,0.28882,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0062634,0.31427,0.45453,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0097392,0.31416,0.23587,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.012508,0.31412,0.27244,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0001547,0.31363,0.28863,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00095906,0.31356,0.40301,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,7.8282e-05,0.31341,0.30256,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00019753,0.31318,0.30409,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00031859,0.31284,0.29268,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00018427,0.31264,0.35992,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0010206,0.31251,0.23892,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00052342,0.31232,0.29881,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.0001547,0.31231,0.39588,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.0033e-05,0.31221,0.26598,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,4.0073e-05,0.31209,0.35194,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00010845,0.31172,0.28948,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.001191,0.31156,0.20843,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,3.3132e-05,0.31143,0.38887,1,1
1,GO VESICLE CARGO LOADING,0.00012512,0.31075,0.28125,1,1
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.033894,0.31059,0.3728,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,6.0504e-05,0.31036,0.30161,1,1
1,GO OSTEOBLAST DIFFERENTIATION,1.6015e-06,0.31013,0.32627,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00011241,0.31,0.24847,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00024286,0.30971,0.34122,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,5.0226e-05,0.30967,0.28641,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.6603e-06,0.30918,0.30546,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.104e-05,0.30911,0.28582,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,7.9801e-06,0.30905,0.41325,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,6.5149e-05,0.30894,0.41687,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00026903,0.30892,0.2929,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,1.7806e-05,0.30885,0.37349,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.7474e-06,0.30865,0.35557,1,1
1,GO MACROPHAGE CHEMOTAXIS,1.9263e-05,0.30858,0.35615,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,2.7578e-07,0.30854,0.33426,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00065623,0.30823,0.2854,1,1
1,GO RESPONSE TO PROTOZOAN,0.00017186,0.30772,0.31899,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,2.9301e-06,0.30765,0.28173,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.00065623,0.30728,0.41601,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00072223,0.30639,0.2643,1,1
1,GO NEURAL TUBE PATTERNING,0.00092958,0.30636,0.25352,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0017123,0.3054,0.32425,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,8.7323e-05,0.30525,0.25046,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,7.3528e-06,0.30464,0.2858,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00025131,0.30439,0.2987,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00018427,0.304,0.22811,1,1
1,GO MESENCHYME MORPHOGENESIS,0.0011549,0.30372,0.33791,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.3441e-06,0.30344,0.23737,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,3.5759e-05,0.30279,0.30688,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0014738,0.30263,0.29383,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,2.1702e-06,0.30251,0.44319,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.0054795,0.30223,0.22642,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.7118e-05,0.3022,0.27805,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,9.389e-05,0.30201,0.29465,1,1
1,GO PIGMENT METABOLIC PROCESS,1.6455e-05,0.30198,0.26703,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00049035,0.30195,0.28375,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00016595,0.30194,0.31737,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0087944,0.30191,0.35138,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,1.6015e-06,0.30179,0.28198,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.1702e-06,0.30171,0.37943,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00025131,0.30164,0.27413,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00012964,0.3015,0.28746,1,1
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.015953,0.30136,0.41823,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.020205,0.30131,0.22145,1,1
1,GO SELECTIVE AUTOPHAGY,1.6729e-06,0.30121,0.29974,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,4.3218e-05,0.30117,0.29474,1,1
1,GO PLASMA MEMBRANE TUBULATION,6.4994e-06,0.30096,0.34669,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,7.9801e-06,0.30055,0.32719,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.349e-05,0.30038,0.27366,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.906e-06,0.30032,0.33949,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0010859,0.30023,0.26164,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0075304,0.29989,0.22155,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.03245,0.2998,0.27523,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,1.1493e-05,0.29941,0.31055,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010845,0.29918,0.28576,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,2.0033e-05,0.29899,0.23336,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0017123,0.29871,0.30857,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.7413e-06,0.29853,0.26885,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,7.8282e-05,0.29845,0.38103,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0021689,0.29829,0.23479,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.024288,0.29828,0.31289,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0013457,0.29826,0.25989,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00011241,0.29798,0.20307,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,2.7343e-05,0.29795,0.31879,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,7.0571e-06,0.29783,0.29025,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0023671,0.29761,0.30454,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,6.5149e-05,0.29726,0.28649,1,1
1,GO PODOSOME ASSEMBLY,7.2754e-05,0.2969,0.37578,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,5.7413e-06,0.2969,0.36236,1,1
1,GO PROSTATE GLAND DEVELOPMENT,0.00010462,0.2967,0.45796,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00057693,0.29649,0.29969,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00019753,0.29605,0.30434,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.2308e-06,0.296,0.28361,1,1
1,GO TRABECULA MORPHOGENESIS,0.00013917,0.29589,0.31048,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,1.7474e-06,0.29555,0.30055,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,1.5816e-05,0.29552,0.35078,1,1
1,GO TRANSPOSITION,0.001662,0.29552,0.28455,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.5759e-05,0.29543,0.27013,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.014841,0.29542,0.23032,1,1
1,GO RESPONSE TO CYTOKINE,4.2876e-06,0.29539,0.31178,1,1
1,GO RESPONSE TO RETINOIC ACID,2.5308e-05,0.29505,0.2842,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00047456,0.29502,0.2337,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.8251e-06,0.29489,0.25889,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0014299,0.29486,0.27412,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,2.1702e-06,0.2947,0.31701,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00017796,0.29444,0.35979,1,1
1,GO TRNA CATABOLIC PROCESS,0.050569,0.29439,0.24047,1,1
1,GO TONGUE DEVELOPMENT,0.00055855,0.29437,0.37263,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00098941,0.29414,0.25104,1,1
1,GO CYTOKINE PRODUCTION,9.0179e-06,0.2941,0.27399,1,1
1,GO REGULATION OF CELL AGING,1.9873e-07,0.29407,0.33221,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.001191,0.29401,0.22511,1,1
1,GO SPERM EGG RECOGNITION,1.349e-05,0.29394,0.25495,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.0073e-05,0.29373,0.24818,1,1
1,GO POSITIVE CHEMOTAXIS,0.0012662,0.29362,0.25041,1,1
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.047551,0.29351,0.34456,1,1
1,GO SNRNA METABOLIC PROCESS,0.00059588,0.29348,0.43984,1,1
1,GO TRACHEA MORPHOGENESIS,0.00026003,0.29325,0.2967,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,3.3132e-05,0.29324,0.31984,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00024286,0.29295,0.33106,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0037331,0.29266,0.25563,1,1
1,GO RESPONSE TO DSRNA,3.4728e-06,0.29261,0.35998,1,1
1,GO COAGULATION,3.7791e-06,0.29223,0.3057,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00040247,0.29219,0.24676,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,7.9801e-06,0.29206,0.29555,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0041716,0.29199,0.22628,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00022676,0.29186,0.29323,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,6.5149e-05,0.29172,0.25076,1,1
1,GO GONADOTROPIN SECRETION,0.019739,0.29148,0.23541,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0047853,0.29144,0.36004,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.027188,0.29121,0.30367,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.8077e-06,0.29105,0.31887,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.018836,0.29093,0.24037,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,1.9904e-06,0.2906,0.23951,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,1.2862e-06,0.29037,0.30295,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.00035231,0.29032,0.27157,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00023468,0.29,0.25329,1,1
1,GO NCRNA PROCESSING,0.00012964,0.28872,0.24901,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00021167,0.2886,0.26168,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00025131,0.28853,0.26949,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,8.4205e-05,0.28779,0.31816,1,1
1,GO MYOBLAST FUSION,6.5149e-05,0.28771,0.35071,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,2.4346e-05,0.28766,0.27792,1,1
1,GO T CELL CHEMOTAXIS,6.5149e-05,0.28754,0.24611,1,1
1,GO REGULATION OF RNA BINDING,1.104e-05,0.28722,0.28958,1,1
1,GO RESPONSE TO BACTERIUM,1.8521e-05,0.2872,0.26653,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,3.0576e-06,0.28709,0.26919,1,1
1,GO SYMBIOTIC PROCESS,1.5691e-07,0.28705,0.28733,1,1
1,GO LIPID IMPORT INTO CELL,0.0067808,0.28695,0.23656,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.0264e-07,0.28687,0.27271,1,1
1,GO REGULATION OF WOUND HEALING,0.00012964,0.28669,0.3103,1,1
1,GO STEROL TRANSPORT,0.0001547,0.28642,0.22613,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,7.547e-05,0.28628,0.3471,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.7323e-05,0.28627,0.28864,1,1
1,GO ARTERY DEVELOPMENT,0.00042998,0.28608,0.30981,1,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.023741,0.28599,0.18652,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0016129,0.28595,0.27698,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.012203,0.28592,0.23012,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00014935,0.28584,0.25273,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,3.1888e-05,0.28583,0.2813,1,1
1,GO CELL CELL RECOGNITION,1.2308e-06,0.28569,0.28905,1,1
1,GO ASTROCYTE DEVELOPMENT,2.2524e-05,0.28566,0.34615,1,1
1,GO BONE MORPHOGENESIS,4.0073e-05,0.2853,0.30585,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.014841,0.2853,0.19944,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.00027832,0.28499,0.27219,1,1
1,GO PLACENTA DEVELOPMENT,9.7346e-05,0.28417,0.24456,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,2.5308e-05,0.28405,0.29741,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.00067758,0.28405,0.20614,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,2.6902e-06,0.28401,0.26802,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.28384,0.34917,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,8.3127e-06,0.2838,0.27605,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.4039e-05,0.28378,0.25396,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0059384,0.28353,0.20022,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,3.9418e-06,0.28344,0.23832,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00044439,0.28341,0.24429,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00020448,0.28297,0.3166,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,1.7118e-05,0.28291,0.28086,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00045924,0.28272,0.22747,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.0013872,0.28271,0.27102,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,2.0784e-06,0.28244,0.26693,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,6.7728e-06,0.28234,0.29194,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00020448,0.28227,0.40919,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,1.6455e-05,0.28227,0.29371,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.2754e-05,0.28222,0.23035,1,1
1,GO RNA 5 END PROCESSING,0.001191,0.28201,0.24118,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.0073363,0.2819,0.20986,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0045306,0.2815,0.4372,1,1
1,GO HISTONE H4 DEACETYLATION,0.0029794,0.28093,0.27769,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00067758,0.28063,0.33651,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.28061,0.367,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.042857,0.28057,0.1818,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.7346e-05,0.28031,0.21748,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00059588,0.28015,0.24508,1,1
1,GO REGULATION OF GENE SILENCING,1.906e-06,0.28012,0.25829,1,1
1,GO RESPONSE TO IONIZING RADIATION,1.5331e-06,0.2792,0.29396,1,1
1,GO CHOLESTEROL EFFLUX,4.6597e-05,0.27905,0.27208,1,1
1,GO TISSUE REMODELING,0.00020448,0.27882,0.26781,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.019739,0.27863,0.22413,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.7145e-05,0.27862,0.31563,1,1
1,GO NUCLEOSIDE SALVAGE,0.0019282,0.27852,0.40917,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.7596e-05,0.27852,0.45626,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.0576e-06,0.27834,0.30938,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1.0184e-05,0.27826,0.22138,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,7.547e-05,0.27737,0.2725,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0028141,0.27715,0.1955,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.018836,0.27707,0.22399,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.024288,0.27702,0.20516,1,1
1,GO MYOBLAST PROLIFERATION,0.05161,0.27701,0.15435,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.4346e-05,0.27695,0.28518,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.023741,0.27687,0.22191,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00081984,0.2768,0.20867,1,1
1,GO MESENCHYME DEVELOPMENT,1.7118e-05,0.27658,0.25865,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.013139,0.27636,0.20499,1,1
1,GO RESPONSE TO OXYGEN RADICAL,7.547e-05,0.27635,0.21509,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.01282,0.27612,0.24158,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.8521e-05,0.27595,0.2436,1,1
1,GO ERK1 AND ERK2 CASCADE,4.1112e-06,0.27594,0.2625,1,1
1,GO RRNA METABOLIC PROCESS,0.00054072,0.27593,0.24076,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.00084609,0.27574,0.28123,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00036427,0.27553,0.29987,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.7343e-05,0.27534,0.27607,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00019079,0.27517,0.25607,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,9.7801e-06,0.27511,0.23816,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,6.2786e-05,0.27492,0.2892,1,1
1,GO CELLULAR RESPONSE TO LIPID,4.1617e-05,0.27488,0.21772,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.01282,0.27483,0.46088,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,8.6584e-06,0.27461,0.26384,1,1
1,GO T CELL MIGRATION,0.00014935,0.27459,0.27706,1,1
1,GO CELL REDOX HOMEOSTASIS,4.8379e-05,0.27437,0.27323,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.024288,0.27378,0.22604,1,1
1,GO ACUTE PHASE RESPONSE,0.0034322,0.27373,0.27708,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,2.6902e-06,0.2732,0.24281,1,1
1,GO FACE DEVELOPMENT,3.7145e-05,0.27319,0.29234,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,4.3218e-05,0.27309,0.33784,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.023205,0.27304,0.32487,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1267e-06,0.27301,0.25721,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00059588,0.27266,0.3078,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,2.4346e-05,0.27192,0.26024,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00013433,0.27188,0.21454,1,1
1,GO MESODERM DEVELOPMENT,4.1112e-06,0.27184,0.2408,1,1
1,GO DNA LIGATION,0.00011241,0.27181,0.30211,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0013054,0.27174,0.27647,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00017186,0.27149,0.22086,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0001165,0.27146,0.21707,1,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0032441,0.27135,0.26312,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,3.4421e-05,0.27126,0.36892,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0083534,0.27115,0.23253,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,6.8936e-07,0.27113,0.27984,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.0604e-05,0.27041,0.3078,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00028792,0.27038,0.27467,1,1
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.027803,0.27019,0.21006,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00012964,0.27019,0.23496,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0012662,0.27018,0.30552,1,1
1,GO DETECTION OF OTHER ORGANISM,0.0012662,0.27011,0.32779,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0011549,0.27009,0.28314,1,1
1,GO TUBE MORPHOGENESIS,1.349e-05,0.26996,0.24183,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00018427,0.26994,0.28228,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.00074557,0.26975,0.21137,1,1
1,GO RIBOSOME BIOGENESIS,0.00041602,0.26974,0.2562,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00013917,0.26973,0.29802,1,1
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0032441,0.26933,0.35257,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.001228,0.26924,0.25561,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0013054,0.26909,0.30565,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00027832,0.26873,0.29176,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0034322,0.26864,0.25376,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0011199,0.26858,0.23295,1,1
1,GO PHAGOCYTOSIS,6.8936e-07,0.26827,0.33898,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.0833e-05,0.26815,0.26917,1,1
1,GO NCRNA 3 END PROCESSING,0.018398,0.26797,0.34733,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0032441,0.26796,0.28997,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,7.6603e-06,0.26748,0.26385,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,3.4772e-07,0.26747,0.27359,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0031536,0.26747,0.24447,1,1
1,GO SEQUESTERING OF METAL ION,0.001191,0.26745,0.24946,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.007729,0.2673,0.19503,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.3441e-06,0.26716,0.27067,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00038934,0.2671,0.2179,1,1
1,GO RESPONSE TO REDOX STATE,0.012203,0.2669,0.22639,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016339,0.26674,0.2591,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00079435,0.26622,0.22936,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,2.4346e-05,0.2662,0.28044,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0071468,0.26593,0.33779,1,1
1,GO MIDGUT DEVELOPMENT,0.043763,0.26564,0.20965,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.4878e-05,0.26542,0.22717,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0016129,0.2653,0.35709,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0026572,0.26523,0.30048,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,3.17e-07,0.26522,0.27484,1,1
1,GO RNA CATABOLIC PROCESS,2.0784e-06,0.26513,0.25257,1,1
1,GO NCRNA METABOLIC PROCESS,0.00026903,0.26492,0.21954,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00067758,0.26473,0.28537,1,1
1,GO REGULATION OF PROTEOLYSIS,1.4609e-05,0.26473,0.20941,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.00027832,0.2647,0.20119,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0042883,0.26457,0.23402,1,1
1,GO CELL AGING,4.8612e-06,0.26455,0.22253,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.00098941,0.26451,0.43728,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0027346,0.2644,0.22926,1,1
1,GO VIRION ASSEMBLY,6.0504e-05,0.26433,0.21113,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0066042,0.26425,0.20845,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.1702e-06,0.2642,0.26294,1,1
1,GO TOXIN TRANSPORT,0.0029794,0.26416,0.17846,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00050664,0.26416,0.28707,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.027188,0.26392,0.18094,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,9.389e-05,0.26377,0.26546,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.015203,0.26359,0.20967,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00040247,0.26345,0.24733,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00055855,0.26343,0.23979,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,9.7801e-06,0.26321,0.38129,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0057817,0.26317,0.26312,1,1
1,GO PROTEIN KINASE B SIGNALING,4.4712e-06,0.26305,0.23763,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.001228,0.26304,0.18421,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,2.0833e-05,0.26289,0.21133,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,8.6584e-06,0.26241,0.24509,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,3.3132e-05,0.2621,0.25039,1,1
1,GO HEART VALVE DEVELOPMENT,0.00016023,0.26197,0.31117,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.00011241,0.26154,0.23751,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,6.7728e-06,0.26154,0.28503,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00026003,0.26143,0.24139,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0018173,0.26131,0.34176,1,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.018398,0.26096,0.14652,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.00041602,0.2609,0.23322,1,1
1,GO AUTOPHAGOSOME MATURATION,8.4205e-05,0.26078,0.25791,1,1
1,GO FATTY ACID BETA OXIDATION,0.00028792,0.26068,0.24757,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,9.7801e-06,0.26068,0.22634,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,2.2658e-06,0.26056,0.33255,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0051916,0.26052,0.2117,1,1
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0015653,0.26043,0.25278,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.0042883,0.2604,0.21414,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.8301e-05,0.25998,0.23987,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,7.547e-05,0.25962,0.20759,1,1
1,GO RESPONSE TO TESTOSTERONE,2.1663e-05,0.25954,0.28266,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0059384,0.25944,0.22938,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0021062,0.25933,0.24494,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00028792,0.2593,0.27413,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.00045924,0.25927,0.23846,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,6.4994e-06,0.25923,0.3464,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,4.8612e-06,0.25921,0.26233,1,1
1,GO ETHANOL METABOLIC PROCESS,0.0059384,0.25921,0.279,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.0001165,0.25908,0.23883,1,1
1,GO RNA DESTABILIZATION,3.0689e-05,0.25884,0.2522,1,1
1,GO T CELL PROLIFERATION,0.00032948,0.25878,0.21627,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00027832,0.25858,0.24164,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,2.0033e-05,0.25824,0.22355,1,1
1,GO IMMUNE EFFECTOR PROCESS,7.0571e-06,0.25819,0.28504,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,6.0504e-05,0.25806,0.26873,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.3654e-06,0.25792,0.31376,1,1
1,GO RESPONSE TO VITAMIN A,0.014138,0.25784,0.19917,1,1
1,GO PROTEIN FOLDING,8.4205e-05,0.25772,0.2204,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.9301e-06,0.2576,0.28521,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.0031536,0.25748,0.25602,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.7343e-05,0.25738,0.31123,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0001547,0.25732,0.2487,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00049035,0.25727,0.25089,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.5816e-05,0.25722,0.2565,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.2754e-05,0.25674,0.33627,1,1
1,GO TRNA 5 END PROCESSING,0.00029782,0.25637,0.27623,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00074557,0.25617,0.31142,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00017796,0.25562,0.22705,1,1
1,GO STRESS FIBER ASSEMBLY,0.0007696,0.25553,0.23735,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00095906,0.25546,0.1819,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.01282,0.25533,0.18868,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,1.2308e-06,0.25531,0.24738,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00010092,0.25529,0.27071,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.036948,0.25513,0.28711,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.2547,0.29806,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00029782,0.25459,0.19909,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,1.104e-05,0.2544,0.25618,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,3.0689e-05,0.25431,0.2312,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.02068,0.25355,0.19067,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,5.508e-06,0.25329,0.27255,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,7.9801e-06,0.25303,0.254,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,6.0198e-07,0.25298,0.24698,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,7.013e-05,0.25279,0.24207,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,6.2786e-05,0.25276,0.28574,1,1
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.01282,0.25264,0.27943,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00026003,0.25262,0.20319,1,1
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.014841,0.25259,0.22491,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.0689e-05,0.25242,0.21137,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,0.00010092,0.25227,0.26807,1,1
1,GO LYMPHOCYTE MIGRATION,9.0551e-05,0.25196,0.22897,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00063551,0.25158,0.26698,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,2.4692e-06,0.25132,0.2362,1,1
1,GO INFLAMMATORY RESPONSE,6.7596e-05,0.25125,0.24954,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.00018427,0.25096,0.25556,1,1
1,GO FIBROBLAST APOPTOTIC PROCESS,0.017137,0.25051,0.23408,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00047456,0.25035,0.24009,1,1
1,GO OSTEOCLAST DIFFERENTIATION,1.9904e-06,0.25017,0.24218,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.0028957,0.25013,0.21101,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0019282,0.24999,0.30159,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,5.8301e-05,0.2499,0.29269,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,2.0833e-05,0.24952,0.21807,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0029794,0.24942,0.21488,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.5816e-05,0.24918,0.29605,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0028957,0.24892,0.2482,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.010245,0.24891,0.28982,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0024367,0.24844,0.32417,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00017186,0.24818,0.21648,1,1
1,GO RRNA TRANSCRIPTION,0.0019282,0.24808,0.19882,1,1
1,GO NUCLEUS LOCALIZATION,0.0073363,0.24791,0.16321,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,2.8418e-05,0.24744,0.21394,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,9.389e-05,0.24708,0.23038,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,0.0028957,0.24704,0.33249,1,1
1,GO GTP METABOLIC PROCESS,0.00052342,0.24681,0.28293,1,1
1,GO T CELL ACTIVATION,3.7145e-05,0.24678,0.2242,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,1.6455e-05,0.24651,0.25956,1,1
1,GO AMELOGENESIS,0.009256,0.24648,0.24992,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,4.8612e-06,0.24637,0.24519,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00016023,0.24627,0.20578,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.00057693,0.24626,0.17812,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.036948,0.24609,0.12711,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,7.6603e-06,0.24599,0.29026,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,8.4205e-05,0.24585,0.22292,1,1
1,GO P38MAPK CASCADE,2.4346e-05,0.24581,0.33779,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.023205,0.24469,0.17117,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00013433,0.24461,0.22382,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0042883,0.24436,0.3828,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.1493e-05,0.24432,0.24978,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,7.3528e-06,0.24408,0.21467,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00042998,0.24347,0.22118,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.00013433,0.24342,0.29105,1,1
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.046579,0.24318,0.16755,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0013872,0.24315,0.21731,1,1
1,GO AORTA DEVELOPMENT,0.0033369,0.24311,0.29162,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0042883,0.24301,0.34396,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00021167,0.24275,0.20022,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,3.1888e-05,0.24259,0.21215,1,1
1,GO REGULATION OF IMMUNE RESPONSE,1.0184e-05,0.24247,0.2257,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,3.6228e-06,0.24234,0.24713,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0006154,0.24227,0.22492,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.00014935,0.24204,0.26179,1,1
1,GO RRNA MODIFICATION,0.012203,0.24195,0.1653,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.349e-05,0.24185,0.28526,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00055855,0.24174,0.19226,1,1
1,GO REGULATION OF MITOPHAGY,0.019739,0.24166,0.19067,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0069616,0.24149,0.15923,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00054072,0.24144,0.1851,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.4039e-05,0.24117,0.2362,1,1
1,GO NADP METABOLIC PROCESS,0.037747,0.24105,0.16528,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,2.4346e-05,0.24064,0.21189,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00049035,0.24034,0.27216,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.4044e-06,0.24034,0.22714,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00022676,0.24023,0.2237,1,1
1,GO PEPTIDE METABOLIC PROCESS,8.6584e-06,0.24018,0.20283,1,1
1,GO OSSIFICATION,5.0226e-05,0.24013,0.23337,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00057693,0.24008,0.22153,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.0015653,0.24005,0.22822,1,1
1,GO PLATELET ACTIVATION,6.7596e-05,0.23998,0.24849,1,1
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0025817,0.23997,0.23458,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00012074,0.23988,0.21572,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.4421e-05,0.23948,0.36188,1,1
1,GO REGULATION OF CELL ADHESION,0.00045924,0.23935,0.20896,1,1
1,GO DEFENSE RESPONSE,2.8418e-05,0.2391,0.23251,1,1
1,GO MITOTIC CELL CYCLE ARREST,0.0099891,0.23909,0.19715,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0034322,0.23905,0.18963,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0028141,0.23891,0.20424,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.014138,0.23889,0.25244,1,1
1,GO MEMBRANE BIOGENESIS,0.011047,0.23859,0.21032,1,1
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0021062,0.23848,0.35418,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0007696,0.23846,0.19006,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.2524e-05,0.23845,0.3011,1,1
1,GO EPITHELIAL CELL PROLIFERATION,0.00026903,0.23821,0.21377,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.0017641,0.23782,0.28637,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00032948,0.2378,0.18826,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0017123,0.23778,0.25366,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00025131,0.23778,0.33391,1,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0019282,0.23758,0.20325,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0062634,0.23754,0.2021,1,1
1,GO ANIMAL ORGAN FORMATION,0.00095906,0.23742,0.21853,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,1.2454e-05,0.23739,0.21833,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00041602,0.23711,0.2014,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.8521e-05,0.23703,0.27174,1,1
1,GO MYOBLAST MIGRATION,0.011047,0.23699,0.38271,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00063551,0.23651,0.23134,1,1
1,GO HEAD MORPHOGENESIS,0.00072223,0.23645,0.26753,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.00072223,0.23614,0.22916,1,1
1,GO MYOTUBE DIFFERENTIATION,0.0066042,0.23595,0.16044,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00054072,0.23585,0.25146,1,1
1,GO ORGAN GROWTH,5.0226e-05,0.23549,0.24024,1,1
1,GO DNA DEALKYLATION,0.0011199,0.23537,0.224,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0020453,0.23516,0.21539,1,1
1,GO HYPEROSMOTIC RESPONSE,0.00092958,0.23488,0.24565,1,1
1,GO HISTONE H2B UBIQUITINATION,0.007729,0.23483,0.1696,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00013433,0.23444,0.20871,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,5.8301e-05,0.23317,0.20343,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,9.8628e-07,0.2331,0.27221,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,8.1192e-05,0.23293,0.26472,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00036427,0.23282,0.23798,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0007696,0.23266,0.27671,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,1.1964e-05,0.23235,0.24826,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.547e-05,0.23229,0.24429,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.014486,0.23228,0.2219,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0011549,0.23221,0.18435,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,9.3916e-06,0.23214,0.21486,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0059384,0.23172,0.17069,1,1
1,GO MYELOID CELL HOMEOSTASIS,2.9301e-06,0.23169,0.23265,1,1
1,GO CELLULAR EXTRAVASATION,9.7346e-05,0.23119,0.22768,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,0.0019282,0.23117,0.18135,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00034072,0.23093,0.26455,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00012512,0.23091,0.19516,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,3.1888e-05,0.23062,0.23412,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00029782,0.23044,0.20567,1,1
1,GO TRNA METHYLATION,0.0012662,0.23037,0.18249,1,1
1,GO REGULATION OF PROTON TRANSPORT,0.0024367,0.23037,0.21071,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0013054,0.23001,0.23649,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,1.6729e-06,0.22991,0.2337,1,1
1,GO REGULATION OF HEMOPOIESIS,4.1112e-06,0.22985,0.22174,1,1
1,GO STEROL IMPORT,0.00029782,0.22965,0.4251,1,1
1,GO RNA 3 END PROCESSING,0.00069957,0.22924,0.17783,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,2.3654e-06,0.22913,0.20771,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0085714,0.22912,0.15997,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0019282,0.22889,0.2447,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,7.2754e-05,0.22864,0.25798,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,1.4044e-06,0.22854,0.23009,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0013457,0.22842,0.19926,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.001986,0.22801,0.19141,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.0030654,0.22757,0.19869,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0030654,0.22732,0.19223,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00019753,0.22728,0.23402,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,3.7145e-05,0.22703,0.26137,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,2.1663e-05,0.22691,0.22672,1,1
1,GO AGING,2.1663e-05,0.22677,0.19722,1,1
1,GO POSITIVE REGULATION OF CELL KILLING,0.014138,0.22677,0.16809,1,1
1,GO MITOPHAGY,0.0010206,0.22669,0.22377,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,2.1663e-05,0.22657,0.24154,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00041602,0.22647,0.22662,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,2.4346e-05,0.22606,0.22339,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00012964,0.226,0.24294,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00014418,0.22585,0.21157,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00014418,0.22555,0.35716,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,2.9532e-05,0.2255,0.23577,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,7.5427e-07,0.2252,0.20175,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00035231,0.22519,0.27492,1,1
1,GO REGULATION OF BODY FLUID LEVELS,8.7323e-05,0.22516,0.20614,1,1
1,GO KINETOCHORE ASSEMBLY,0.033894,0.22504,0.17756,1,1
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0021689,0.22479,0.29095,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.7596e-05,0.22465,0.18459,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0014299,0.22433,0.17241,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,2.3418e-05,0.22415,0.21293,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0026572,0.22404,0.19728,1,1
1,GO RESPONSE TO GONADOTROPIN,0.0032441,0.2238,0.28977,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00042998,0.22367,0.22375,1,1
1,GO PERICARDIUM DEVELOPMENT,0.0013054,0.2236,0.2806,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.22333,0.28046,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0069616,0.2233,0.20609,1,1
1,GO CELL KILLING,0.0023671,0.22321,0.16413,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0056288,0.22304,0.22693,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.00090094,0.22304,0.19288,1,1
1,GO PLATELET MORPHOGENESIS,0.00041602,0.22279,0.22896,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0017123,0.22265,0.21737,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0007696,0.22254,0.23043,1,1
1,GO LEUKOCYTE HOMEOSTASIS,9.389e-05,0.22209,0.20622,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,4.1112e-06,0.22209,0.24222,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00019753,0.22208,0.32803,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.011326,0.22193,0.1673,1,1
1,GO HINDLIMB MORPHOGENESIS,0.02068,0.22184,0.22142,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0025083,0.22171,0.2781,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,2.4692e-06,0.22127,0.21364,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0045306,0.22116,0.19011,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00012074,0.22115,0.22921,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,2.6307e-05,0.22078,0.19256,1,1
1,GO REGULATION OF URINE VOLUME,9.389e-05,0.22054,0.25475,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.001662,0.22028,0.17466,1,1
1,GO REPLACEMENT OSSIFICATION,0.0014299,0.22015,0.32086,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6597e-05,0.21995,0.21261,1,1
1,GO OVULATION,0.031059,0.21987,0.22934,1,1
1,GO BODY FLUID SECRETION,0.00036427,0.21983,0.20859,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00031859,0.21961,0.23222,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00038934,0.21958,0.20983,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,1.4609e-05,0.21957,0.2041,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.001986,0.21939,0.19961,1,1
1,GO TISSUE MORPHOGENESIS,3.0689e-05,0.21928,0.197,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0050528,0.21909,0.19272,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.5816e-05,0.21904,0.2348,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,1.5201e-05,0.21884,0.22275,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.011904,0.2188,0.17683,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00024286,0.21859,0.20796,1,1
1,GO REGULATION OF VASCULOGENESIS,0.024288,0.2178,0.27745,1,1
1,GO INTERFERON GAMMA PRODUCTION,5.2139e-05,0.21747,0.26436,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.004408,0.21699,0.16796,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0017123,0.2169,0.18389,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0014299,0.21687,0.21787,1,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.042857,0.21642,0.16515,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,2.8418e-05,0.21603,0.20201,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00026903,0.216,0.19705,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,1.0604e-05,0.216,0.18088,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.001228,0.21583,0.18594,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.0010528,0.21566,0.22342,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0097392,0.21555,0.24567,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0062634,0.21546,0.20174,1,1
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00098941,0.21528,0.23103,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,7.0571e-06,0.21526,0.19502,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.4674e-06,0.21471,0.20647,1,1
1,GO REGULATION OF CELL ACTIVATION,5.4121e-05,0.21463,0.20738,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00027832,0.21444,0.22214,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0038387,0.2141,0.15056,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0011199,0.21397,0.24272,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00092958,0.21394,0.23137,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0032441,0.21379,0.21339,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0033369,0.21359,0.13852,1,1
1,GO BONE DEVELOPMENT,3.5759e-05,0.21353,0.24032,1,1
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.022165,0.21345,0.2021,1,1
1,GO SPINDLE LOCALIZATION,3.3287e-06,0.21337,0.2116,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,0.00012512,0.21324,0.20425,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.00084609,0.21322,0.20908,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0017641,0.21315,0.19176,1,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.042857,0.21291,0.12547,1,1
1,GO TRNA MODIFICATION,0.0036303,0.21222,0.14837,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,0.0021062,0.21206,0.21644,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.052669,0.2118,0.10649,1,1
1,GO AMINE CATABOLIC PROCESS,0.0010528,0.21166,0.31193,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0079323,0.21153,0.26754,1,1
1,GO RNA MODIFICATION,0.00069957,0.21144,0.16051,1,1
1,GO CELL ACTIVATION,1.4039e-05,0.21138,0.23614,1,1
1,GO REGULATION OF DEFENSE RESPONSE,8.4205e-05,0.21122,0.20466,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.2658e-06,0.21113,0.24401,1,1
1,GO RESPONSE TO LIPID,0.00032948,0.21105,0.17802,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0015189,0.21091,0.18545,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.4346e-05,0.21087,0.23069,1,1
1,GO MITOTIC CYTOKINESIS,0.00014418,0.21071,0.22298,1,1
1,GO LYMPHOCYTE ACTIVATION,2.8418e-05,0.21024,0.20422,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.7806e-05,0.21022,0.21866,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,2.6307e-05,0.20992,0.18093,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0083534,0.20978,0.17206,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.00025131,0.20959,0.19766,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00013917,0.20958,0.19798,1,1
1,GO RRNA METHYLATION,0.018398,0.20936,0.13963,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0040578,0.20936,0.18476,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0067808,0.20905,0.18836,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.00017796,0.20885,0.19896,1,1
1,GO TRNA PROCESSING,0.0025083,0.20879,0.14846,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.019739,0.20847,0.24045,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0024367,0.20847,0.16859,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,6.7728e-06,0.20827,0.2102,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.001228,0.20827,0.19278,1,1
1,GO MYELOID CELL DIFFERENTIATION,4.2876e-06,0.20806,0.19327,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,4.4712e-06,0.20749,0.23372,1,1
1,GO CAMP METABOLIC PROCESS,0.02843,0.20744,0.21666,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,1.104e-05,0.20742,0.25151,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0020453,0.20702,0.17657,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,5.0226e-05,0.20697,0.27355,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00038934,0.20654,0.18097,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.7118e-05,0.20651,0.22746,1,1
1,GO LEUKOCYTE MIGRATION,0.0016129,0.20628,0.19458,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.012508,0.20567,0.16538,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00353,0.20564,0.17078,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00013917,0.20545,0.19083,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00042998,0.2054,0.22312,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0037331,0.2054,0.22591,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.0028957,0.20534,0.22461,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,8.3127e-06,0.20499,0.2006,1,1
1,GO RUFFLE ORGANIZATION,0.001986,0.20481,0.1557,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.0013054,0.20481,0.20942,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00041602,0.2047,0.1791,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0011549,0.20466,0.19094,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00034072,0.20436,0.16897,1,1
1,GO RESPONSE TO KETONE,0.0038387,0.20427,0.15619,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.8251e-06,0.20376,0.23503,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0007696,0.20366,0.19658,1,1
1,GO MIDBODY ABSCISSION,0.0094949,0.2034,0.20782,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.001986,0.2032,0.28738,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,1.9263e-05,0.20319,0.21673,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.5149e-05,0.20293,0.15689,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00037661,0.20272,0.17302,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.20259,0.25004,1,1
1,GO REGULATION OF LIPID STORAGE,0.00069957,0.2024,0.23966,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0060989,0.20239,0.23577,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.009256,0.20209,0.19572,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0007696,0.20208,0.18926,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.00026903,0.20205,0.17786,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0017641,0.20204,0.18437,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00013917,0.20189,0.1684,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.6623e-06,0.20184,0.19624,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001228,0.20164,0.16341,1,1
1,GO SECRETION BY TISSUE,0.029068,0.20161,0.14299,1,1
1,GO HEART GROWTH,0.00057693,0.20136,0.1967,1,1
1,GO TRNA METABOLIC PROCESS,0.0030654,0.20095,0.14574,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.0311e-06,0.20085,0.1923,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.010245,0.2008,0.22092,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.906e-06,0.20027,0.18125,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0022992,0.20026,0.22245,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.011326,0.20021,0.16208,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00032948,0.20009,0.19356,1,1
1,GO BODY MORPHOGENESIS,0.0033369,0.19999,0.18658,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,9.7346e-05,0.19988,0.17125,1,1
1,GO PROTEIN PROCESSING,0.00023468,0.19977,0.20209,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00069957,0.19966,0.20027,1,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.035393,0.19912,0.1502,1,1
1,GO CARNITINE SHUTTLE,0.042857,0.19902,0.15634,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00065623,0.19887,0.16878,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,5.2533e-07,0.19884,0.16616,1,1
1,GO NUCLEAR EXPORT,8.3127e-06,0.19868,0.20204,1,1
1,GO TUBE DEVELOPMENT,0.00010462,0.19846,0.19742,1,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.02268,0.19825,0.20528,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.013139,0.19799,0.13373,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0026572,0.19748,0.20278,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.013798,0.1974,0.15479,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,6.2786e-05,0.19708,0.18961,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.033894,0.19694,0.091015,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.010245,0.19672,0.19274,1,1
1,GO NEURAL TUBE FORMATION,0.001986,0.19646,0.20077,1,1
1,GO HEART TRABECULA MORPHOGENESIS,0.0053338,0.19631,0.20348,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,9.7801e-06,0.19627,0.22044,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.0026572,0.19597,0.22768,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,3.1888e-05,0.1959,0.17572,1,1
1,GO VESICLE TARGETING,0.00049035,0.19585,0.19756,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.011326,0.1958,0.20103,1,1
1,GO STEM CELL DIFFERENTIATION,2.2524e-05,0.19562,0.20305,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.031748,0.19555,0.15749,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.00014418,0.19521,0.16457,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,6.7728e-06,0.19489,0.18352,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,4.4878e-05,0.19428,0.2027,1,1
1,GO TRANSLATIONAL ELONGATION,0.007729,0.19408,0.16328,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.010773,0.19402,0.12874,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,1.5816e-05,0.19354,0.19428,1,1
1,GO ALDITOL METABOLIC PROCESS,0.0013872,0.19338,0.20366,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.027803,0.19335,0.16387,1,1
1,GO TRANSLATIONAL TERMINATION,0.0029794,0.19295,0.19824,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.00019753,0.19255,0.17619,1,1
1,GO RESPONSE TO GAMMA RADIATION,6.7596e-05,0.19175,0.23926,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00034072,0.19172,0.29373,1,1
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.044685,0.19165,0.16492,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.0033e-05,0.19162,0.19654,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,9.0551e-05,0.1916,0.23249,1,1
1,GO RESPONSE TO UV,2.9532e-05,0.19128,0.19393,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.017137,0.19034,0.14352,1,1
1,GO PROTEIN TARGETING,0.00034072,0.19024,0.16372,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.389e-05,0.19012,0.16057,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,6.7596e-05,0.19004,0.18236,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00025131,0.19004,0.19606,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00035231,0.19003,0.16092,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00074557,0.19001,0.18505,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,4.4878e-05,0.18989,0.1941,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.001228,0.18987,0.16965,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00010092,0.18966,0.19574,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00067758,0.18957,0.16348,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0006154,0.18945,0.14596,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.013139,0.1894,0.17167,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.004408,0.18937,0.14175,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,6.0504e-05,0.18895,0.20022,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00024286,0.1889,0.20944,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.00067758,0.18864,0.15066,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0029794,0.18839,0.13876,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,1.1964e-05,0.18834,0.16972,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0025083,0.18806,0.18791,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.00041602,0.18757,0.19532,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00098941,0.18753,0.1846,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00019079,0.18744,0.17768,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,3.6414e-07,0.18718,0.1792,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.0033e-05,0.18716,0.15696,1,1
1,GO RESPONSE TO GROWTH FACTOR,8.7323e-05,0.18714,0.178,1,1
1,GO HISTONE DEACETYLATION,0.00052342,0.18712,0.1312,1,1
1,GO ORGANELLE INHERITANCE,0.0013054,0.18635,0.17319,1,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.031748,0.18628,0.1327,1,1
1,GO CELLULAR RESPONSE TO UV,0.00025131,0.18588,0.18047,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,3.1904e-06,0.18517,0.1544,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,6.5149e-05,0.18497,0.18282,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0054795,0.18468,0.26426,1,1
1,GO BIOLOGICAL ADHESION,0.0054795,0.18456,0.13772,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,5.2139e-05,0.18445,0.15923,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.00054072,0.18442,0.16693,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.023205,0.18388,0.16966,1,1
1,GO RNA METHYLATION,0.0024367,0.18327,0.15141,1,1
1,GO REGULATION OF AMYLOID BETA FORMATION,0.026586,0.18289,0.16963,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0073363,0.18289,0.15852,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,7.2754e-05,0.18279,0.17373,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.00092958,0.18265,0.1753,1,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.024846,0.18262,0.13464,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.001986,0.18255,0.16681,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,3.6228e-06,0.18255,0.184,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0039469,0.18224,0.12844,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.011326,0.18222,0.1246,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,4.0073e-05,0.18161,0.1616,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.001986,0.18153,0.16156,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00021167,0.18152,0.16634,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0013872,0.18143,0.14652,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.029719,0.1806,0.21274,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.007729,0.18033,0.20721,1,1
1,GO RESPONSE TO INTERLEUKIN 6,0.046579,0.18024,0.11719,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00055855,0.18021,0.17218,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.0049174,0.18001,0.16127,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.031059,0.17981,0.12261,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.3763e-07,0.17974,0.17823,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00027832,0.17948,0.15484,1,1
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.036164,0.17914,0.1784,1,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.0081404,0.17905,0.11172,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0040578,0.17899,0.15288,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.00041602,0.1787,0.16371,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.00069957,0.17842,0.17965,1,1
1,GO RESPONSE TO IRON ION,0.02068,0.17827,0.14099,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.00017796,0.17811,0.1754,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00020448,0.17808,0.15762,1,1
1,GO XENOBIOTIC TRANSPORT,0.0022332,0.17807,0.23296,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,9.0179e-06,0.17749,0.1777,1,1
1,GO EPITHELIAL CELL DEVELOPMENT,0.0046564,0.17726,0.15774,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.00030804,0.17717,0.17856,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.0017641,0.17712,0.18556,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00090094,0.17681,0.20695,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.00024286,0.17648,0.16499,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00016023,0.17599,0.16591,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0067808,0.17584,0.13437,1,1
1,GO TRNA TRANSPORT,0.0097392,0.17573,0.14978,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00023468,0.17564,0.19278,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,3.4728e-06,0.17557,0.16743,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.00013917,0.17476,0.2001,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0047853,0.17469,0.16813,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0036303,0.17454,0.14473,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.0053338,0.17437,0.13567,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00087311,0.17435,0.16124,1,1
1,GO GOLGI VESICLE TRANSPORT,2.3418e-05,0.17426,0.16258,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.0011549,0.17419,0.1829,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0028957,0.17392,0.14811,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0021062,0.17384,0.1709,1,1
1,GO CENTRIOLE ASSEMBLY,0.007729,0.17344,0.12327,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0040578,0.17324,0.12996,1,1
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0019282,0.17314,0.29718,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00049035,0.17309,0.17282,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.6902e-06,0.17273,0.16172,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.013139,0.17266,0.17177,1,1
1,GO REGULATION OF MAPK CASCADE,8.4205e-05,0.17259,0.16851,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0013872,0.17233,0.18664,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0018173,0.17231,0.16897,1,1
1,GO RESPONSE TO CHEMOKINE,0.016339,0.17226,0.18439,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.021165,0.1722,0.13754,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0075304,0.17211,0.17531,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,1.906e-06,0.17186,0.16152,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0021062,0.17184,0.15173,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00069957,0.17181,0.17894,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.04854,0.1717,0.19297,1,1
1,GO LYSOSOMAL TRANSPORT,0.00057693,0.17139,0.16816,1,1
1,GO TRANSLESION SYNTHESIS,0.00034072,0.17119,0.17023,1,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.030383,0.17116,0.13323,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0033369,0.17095,0.16982,1,1
1,GO REGULATION OF RESPONSE TO STRESS,2.6307e-05,0.17084,0.16534,1,1
1,GO COENZYME A METABOLIC PROCESS,0.013139,0.17074,0.15407,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.8379e-05,0.17043,0.18236,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.02268,0.17033,0.13997,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0017641,0.17018,0.14282,1,1
1,GO REGULATION OF NUCLEAR DIVISION,2.7343e-05,0.17003,0.14911,1,1
1,GO BLASTOCYST GROWTH,0.0025083,0.16955,0.24007,1,1
1,GO REGULATION OF CATABOLIC PROCESS,7.889e-07,0.1695,0.1623,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0001547,0.16919,0.13964,1,1
1,GO REGULATION OF CELL SHAPE,0.0030654,0.16902,0.18732,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.041093,0.16883,0.10593,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.001228,0.16866,0.24956,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0053338,0.16863,0.19901,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0038387,0.16858,0.19841,1,1
1,GO MUSCLE ORGAN MORPHOGENESIS,0.047551,0.16848,0.13367,1,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0075304,0.16841,0.12716,1,1
1,GO VACUOLAR TRANSPORT,0.0012662,0.1682,0.14035,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0039469,0.16818,0.14856,1,1
1,GO IMPORT INTO NUCLEUS,0.00028792,0.16798,0.13799,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.0016129,0.16756,0.18402,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,3.7791e-06,0.16748,0.15617,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.00353,0.16744,0.17834,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.026586,0.16734,0.1768,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0011199,0.16726,0.13087,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00026003,0.16683,0.18679,1,1
1,GO RESPONSE TO BMP,0.021165,0.16642,0.13928,1,1
1,GO PROTEIN DENEDDYLATION,0.0094949,0.16628,0.16,1,1
1,GO AMYLOID BETA METABOLIC PROCESS,0.016339,0.16626,0.15872,1,1
1,GO REGULATION OF B CELL ACTIVATION,0.011326,0.16617,0.12793,1,1
1,GO LAMELLIPODIUM ORGANIZATION,0.00052342,0.1659,0.21976,1,1
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.041093,0.16577,0.13426,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0019282,0.16567,0.1888,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,6.5149e-05,0.16563,0.14963,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0021689,0.16556,0.13085,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,9.7346e-05,0.16554,0.13758,1,1
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.0083534,0.16545,0.13942,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.011612,0.16518,0.17322,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00020448,0.16514,0.20909,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00034072,0.16511,0.20207,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.004408,0.16504,0.17076,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.00055855,0.16459,0.14039,1,1
1,GO LAMELLIPODIUM ASSEMBLY,0.00067758,0.16451,0.21238,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.2876e-06,0.16447,0.16909,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018427,0.16445,0.18211,1,1
1,GO REGULATION OF MYELINATION,0.011612,0.16445,0.14145,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.011326,0.16437,0.17336,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0026572,0.16378,0.12129,1,1
1,GO RESPONSE TO PH,0.025994,0.16335,0.17198,1,1
1,GO RESPONSE TO ANTIBIOTIC,0.0016129,0.16316,0.19236,1,1
1,GO RNA DECAPPING,0.00041602,0.16313,0.19151,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00016595,0.16287,0.15988,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.4994e-06,0.16278,0.14523,1,1
1,GO HEART MORPHOGENESIS,0.0034322,0.16235,0.16245,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.02843,0.16233,0.11369,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.00081984,0.16213,0.15755,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00041602,0.16211,0.20325,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00074557,0.16209,0.15972,1,1
1,GO VACUOLE ORGANIZATION,0.00030804,0.16206,0.14107,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0025083,0.16198,0.148,1,1
1,GO RRNA 3 END PROCESSING,0.0036303,0.16195,0.1766,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.007729,0.16176,0.16112,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,8.1192e-05,0.16169,0.18276,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0047853,0.16141,0.18005,1,1
1,GO RECEPTOR RECYCLING,0.016339,0.16122,0.11988,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.030383,0.16117,0.13923,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0020453,0.16108,0.12252,1,1
1,GO PROTEIN POLYUBIQUITINATION,2.2524e-05,0.161,0.1564,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.02268,0.161,0.14363,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.017549,0.16073,0.14857,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.0027346,0.16042,0.19923,1,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0051916,0.16023,0.098224,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.013139,0.16022,0.13386,1,1
1,GO MAMMARY GLAND DEVELOPMENT,0.0060989,0.16021,0.16434,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0014738,0.16001,0.20788,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,4.1617e-05,0.15981,0.16332,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.009256,0.15957,0.14197,1,1
1,GO PROTEOLYSIS,1.7806e-05,0.15947,0.14516,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0081404,0.15933,0.19789,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,4.8379e-05,0.15925,0.19057,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.013465,0.15898,0.17564,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0087944,0.15839,0.16827,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0031536,0.15826,0.13885,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00036427,0.15794,0.20364,1,1
1,GO POSTREPLICATION REPAIR,0.00026903,0.15789,0.14927,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.010245,0.15752,0.15917,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00353,0.15736,0.14973,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.012508,0.15712,0.23929,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0010528,0.15697,0.14163,1,1
1,GO PROTEIN IMPORT,0.0001165,0.15671,0.15442,1,1
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0054795,0.15665,0.19456,1,1
1,GO MAINTENANCE OF LOCATION,9.0551e-05,0.156,0.16337,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0006154,0.1558,0.15242,1,1
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.049546,0.15579,0.16194,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0069616,0.15512,0.14122,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.00098941,0.15497,0.15627,1,1
1,GO PROTEIN CATABOLIC PROCESS,3.1904e-06,0.15492,0.14536,1,1
1,GO RESPONSE TO HEAT,0.00034072,0.15478,0.17555,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.00028792,0.15417,0.16766,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.00041602,0.15401,0.18536,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,0.0039469,0.15345,0.19305,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,3.5759e-05,0.15332,0.18274,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,1.2962e-05,0.15305,0.18414,1,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.001872,0.15302,0.28042,1,1
1,GO CELL MOTILITY,0.0040578,0.15291,0.12094,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.00059588,0.1528,0.14423,1,1
1,GO AMYLOID BETA FORMATION,0.024846,0.15269,0.15724,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0064317,0.15266,0.10873,1,1
1,GO TELOMERE ORGANIZATION,0.0011549,0.15251,0.12291,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,3.5759e-05,0.1523,0.13415,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,7.3528e-06,0.15189,0.15562,1,1
1,GO REGULATION OF CELL DEATH,7.547e-05,0.15169,0.14259,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.030383,0.15166,0.10566,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.001228,0.15159,0.11503,1,1
1,GO B CELL ACTIVATION,0.001228,0.15151,0.14117,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00031859,0.15137,0.13575,1,1
1,GO REGULATION OF BINDING,0.00018427,0.15112,0.14291,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00019753,0.15091,0.1491,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.0833e-05,0.15067,0.16434,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.010773,0.15056,0.1985,1,1
1,GO LACTATION,0.0083534,0.15046,0.1752,1,1
1,GO REGULATION OF ERAD PATHWAY,0.00057693,0.1504,0.14562,1,1
1,GO RESPONSE TO LEPTIN,0.02166,0.15038,0.18643,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0012662,0.15034,0.16853,1,1
1,GO GOLGI VESICLE BUDDING,0.0026572,0.14979,0.1623,1,1
1,GO RESPONSE TO VITAMIN,0.036948,0.14949,0.16878,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.050569,0.14938,0.10615,1,1
1,GO HEART DEVELOPMENT,0.00026003,0.14936,0.16167,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0099891,0.14936,0.12219,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0019282,0.14929,0.20351,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0042883,0.14927,0.12862,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00052342,0.14921,0.13892,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00057693,0.14897,0.13662,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,2.7343e-05,0.14888,0.15111,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00014935,0.14842,0.19145,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.00081984,0.14805,0.18477,1,1
1,GO REGULATION OF PROTEIN BINDING,0.00024286,0.14769,0.15781,1,1
1,GO DNA BIOSYNTHETIC PROCESS,1.4674e-06,0.14764,0.16582,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0023671,0.1476,0.11515,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00017186,0.14706,0.12228,1,1
1,GO TUBE FORMATION,0.0071468,0.147,0.15003,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0053338,0.14694,0.14833,1,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.020205,0.14691,0.12296,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0040578,0.14631,0.18715,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.00055855,0.14608,0.13845,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.02843,0.14584,0.09765,1,1
1,GO CHROMOSOME LOCALIZATION,0.022165,0.14565,0.11807,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.00012074,0.14545,0.12204,1,1
1,GO MITOTIC RECOMBINATION,0.018836,0.14529,0.16391,1,1
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0069616,0.1451,0.17432,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.011047,0.14478,0.21527,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0013457,0.14472,0.13601,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0045306,0.14472,0.16678,1,1
1,GO NUCLEAR TRANSPORT,5.4121e-05,0.14458,0.14747,1,1
1,GO REGULATION OF CELL DIVISION,0.0075304,0.14453,0.10529,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00010092,0.14448,0.14527,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.00026003,0.14447,0.14938,1,1
1,GO REGULATION OF DNA BINDING,0.018836,0.14437,0.089188,1,1
1,GO RNA LOCALIZATION,0.00035231,0.14429,0.17298,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.00021167,0.14391,0.12443,1,1
1,GO VACUOLAR ACIDIFICATION,0.0060989,0.14387,0.15795,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.010773,0.14368,0.15257,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.011612,0.14339,0.14595,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.00023468,0.14318,0.12769,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.031059,0.14317,0.14727,1,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.012508,0.14311,0.23337,1,1
1,GO RNA PROCESSING,0.00030804,0.14295,0.14859,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0039469,0.14253,0.10982,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00035231,0.14245,0.18739,1,1
1,GO COPII COATED VESICLE BUDDING,0.0051916,0.14234,0.16085,1,1
1,GO EPITHELIAL TUBE FORMATION,0.023741,0.14213,0.13709,1,1
1,GO RNA CAPPING,0.001662,0.14165,0.14068,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.013798,0.14134,0.11431,1,1
1,GO PROTEIN NEDDYLATION,0.0046564,0.14116,0.16595,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.027803,0.14074,0.16823,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.00090094,0.1406,0.12916,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,6.2786e-05,0.14057,0.13341,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00011241,0.14043,0.13928,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0014738,0.13975,0.12927,1,1
1,GO CYTOKINESIS,0.00084609,0.13949,0.12969,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00029782,0.13896,0.16921,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.0085714,0.13892,0.14136,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.6307e-05,0.13892,0.15048,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00018427,0.13874,0.16295,1,1
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0064317,0.13807,0.12252,1,1
1,GO ENDOSOME ORGANIZATION,0.00047456,0.13765,0.15976,1,1
1,GO SPINDLE ORGANIZATION,0.00059588,0.13731,0.13477,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0075304,0.13726,0.12022,1,1
1,GO APOPTOTIC PROCESS,7.547e-05,0.13719,0.13407,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00012964,0.13711,0.14077,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.0059384,0.13709,0.11533,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.0032441,0.13703,0.17041,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0066042,0.13702,0.18703,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00041602,0.13666,0.12392,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00023468,0.13645,0.16829,1,1
1,GO NUCLEUS ORGANIZATION,0.0031536,0.13624,0.11874,1,1
1,GO GENE SILENCING,9.389e-05,0.13576,0.13397,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.01282,0.13522,0.1106,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00021167,0.13508,0.13112,1,1
1,GO FAT CELL DIFFERENTIATION,0.0034322,0.13495,0.1279,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0039469,0.13485,0.10686,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0085714,0.13419,0.092766,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00021909,0.13395,0.15154,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0071468,0.13392,0.19536,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.015953,0.13331,0.19639,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00031859,0.13267,0.14978,1,1
1,GO OXALATE TRANSPORT,0.044685,0.13224,0.096043,1,1
1,GO VIRAL BUDDING,0.0046564,0.13218,0.13868,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.004408,0.13215,0.14936,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0013872,0.13127,0.13589,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00055855,0.13116,0.13708,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.0051916,0.13114,0.11846,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00067758,0.13107,0.17764,1,1
1,GO CHROMOSOME CONDENSATION,0.0027346,0.13093,0.13786,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.00353,0.1305,0.12038,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0016129,0.12993,0.13255,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0097392,0.1297,0.096545,1,1
1,GO CELL DIVISION,0.00027832,0.12918,0.12456,1,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.013139,0.1291,0.11961,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.0010206,0.12904,0.13878,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00036427,0.12876,0.13773,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.0073e-05,0.1286,0.14635,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.00014935,0.12824,0.13755,1,1
1,GO MRNA METABOLIC PROCESS,7.547e-05,0.12795,0.14857,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0024367,0.12782,0.11782,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0014299,0.12768,0.19351,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0017641,0.12762,0.11201,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.023741,0.12753,0.10933,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00063551,0.12744,0.12114,1,1
1,GO REGULATION OF DNA REPAIR,0.0075304,0.1273,0.097303,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00024286,0.12654,0.11295,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00038934,0.12649,0.14089,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.0019282,0.12643,0.11157,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.0019282,0.12626,0.13215,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00059588,0.12616,0.10988,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00081984,0.12615,0.11659,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.03939,0.1261,0.16067,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.0571e-06,0.12604,0.12122,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00050664,0.12601,0.12139,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00017186,0.12559,0.21519,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.004408,0.12541,0.11332,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.011326,0.12507,0.097991,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00069957,0.12468,0.12999,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.004408,0.12466,0.1094,1,1
1,GO MEMBRANE ORGANIZATION,0.0027346,0.12443,0.10151,1,1
1,GO MITOTIC CELL CYCLE,0.00016023,0.1243,0.12277,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,3.3132e-05,0.12394,0.12685,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00353,0.12356,0.1176,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00049035,0.12336,0.12878,1,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.02068,0.12309,0.15501,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.016339,0.12303,0.098804,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00065623,0.12286,0.14005,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.0030654,0.12269,0.1348,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.009256,0.12254,0.089169,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00023468,0.12208,0.10341,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.033166,0.12171,0.099949,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,4.8379e-05,0.12119,0.13265,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00045924,0.12117,0.1705,1,1
1,GO CELLULAR SENESCENCE,0.0027346,0.12096,0.12477,1,1
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.007729,0.12057,0.16699,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.02843,0.12043,0.088165,1,1
1,GO ENDOCYTOSIS,0.00095906,0.11991,0.13217,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0018173,0.11989,0.1627,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.00012964,0.11974,0.11378,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00353,0.1197,0.11694,1,1
1,GO FLUID TRANSPORT,0.0046564,0.11895,0.15022,1,1
1,GO REGULATION OF DNA REPLICATION,0.0013054,0.11843,0.11621,1,1
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.027803,0.11822,0.096605,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.6174e-05,0.11802,0.13885,1,1
1,GO CHROMOSOME SEPARATION,0.0071468,0.11668,0.13798,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.018836,0.11649,0.090456,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0013872,0.1163,0.11478,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00017796,0.11605,0.13622,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.001986,0.11582,0.12664,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0047853,0.11574,0.12475,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.018836,0.11523,0.094847,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.0011199,0.11502,0.13863,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00084609,0.11494,0.1192,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0024367,0.11489,0.12106,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.010506,0.11482,0.11863,1,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.015574,0.11446,0.080023,1,1
1,GO REGULATION OF AUTOPHAGY,5.8301e-05,0.11411,0.13587,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0013457,0.11376,0.11618,1,1
1,GO ORGANELLE FISSION,0.0014738,0.11369,0.098494,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.0053338,0.11364,0.086034,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.031059,0.11323,0.12129,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.00072223,0.11293,0.11902,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0001547,0.11267,0.11329,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.00050664,0.11239,0.12939,1,1
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.023205,0.11234,0.081032,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0026572,0.11233,0.10475,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00038934,0.11221,0.11171,1,1
1,GO MACROAUTOPHAGY,5.6174e-05,0.11204,0.13267,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0047853,0.11169,0.09179,1,1
1,GO FEMALE GAMETE GENERATION,0.0025083,0.11153,0.099842,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0024367,0.11144,0.11354,1,1
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02166,0.1111,0.10296,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00067758,0.11092,0.12495,1,1
1,GO METAPHASE PLATE CONGRESSION,0.015203,0.11086,0.11512,1,1
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.011047,0.11076,0.12479,1,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.017969,0.10967,0.090435,1,1
1,GO MRNA TRANSPORT,0.00072223,0.10949,0.1556,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,1.8521e-05,0.10925,0.12536,1,1
1,GO ORGANELLE DISASSEMBLY,0.00074557,0.10897,0.11714,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0006154,0.10845,0.10094,1,1
1,GO CYTOSKELETON ORGANIZATION,0.02843,0.10832,0.073862,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00054072,0.1082,0.1135,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,2.2524e-05,0.10751,0.11314,1,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.01282,0.10742,0.098388,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0067808,0.10647,0.1066,1,1
1,GO SULFATE TRANSPORT,0.0031536,0.10612,0.11352,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.0036303,0.10576,0.1797,1,1
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.030383,0.10568,0.073984,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0062634,0.10564,0.16601,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0006154,0.10542,0.1258,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.001662,0.10406,0.12773,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.0083534,0.10385,0.097964,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0083534,0.1038,0.12848,1,1
1,GO CELL CYCLE PROCESS,0.00030804,0.10353,0.10072,1,1
1,GO MRNA CLEAVAGE,0.010245,0.10301,0.095414,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.027188,0.10203,0.075965,1,1
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.016339,0.10138,0.086063,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.0051916,0.10135,0.11124,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.030383,0.10104,0.086549,1,1
1,GO REGULATION OF CELL CYCLE,0.00042998,0.10084,0.088985,1,1
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.029719,0.10063,0.087048,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00014418,0.099937,0.13449,1,1
1,GO PROTEIN TETRAMERIZATION,0.0083534,0.099286,0.10184,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.004408,0.098904,0.19827,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0028957,0.098743,0.095974,1,1
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.042857,0.098423,0.11141,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.013139,0.098032,0.095114,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0062634,0.096813,0.18237,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.036948,0.09675,0.091883,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0006154,0.095805,0.076897,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0027346,0.095001,0.088013,1,1
1,GO MACROMOLECULE DEACYLATION,0.018398,0.094987,0.074363,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0064317,0.094858,0.12223,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.00045924,0.094263,0.087248,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0018173,0.093935,0.10508,1,1
1,GO MRNA 3 END PROCESSING,0.022165,0.093093,0.098174,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.011612,0.092858,0.080535,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0030654,0.092091,0.12969,1,1
1,GO MULTI ORGANISM PROCESS,0.0047853,0.092018,0.068931,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.018398,0.091715,0.088866,1,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.016734,0.09145,0.11259,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0066042,0.091401,0.14546,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0017641,0.090791,0.11587,1,1
1,GO CELL CYCLE,0.00050664,0.09073,0.08412,1,1
1,GO NEGATIVE REGULATION OF GROWTH,0.025994,0.090637,0.079313,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.05161,0.090494,0.08378,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.017969,0.090262,0.08705,1,1
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0051916,0.089693,0.093786,1,1
1,GO IRON ION TRANSPORT,0.0081404,0.08938,0.094071,1,1
1,GO REGULATION OF CYTOKINESIS,0.037747,0.089267,0.074076,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.01282,0.088978,0.08993,1,1
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.029719,0.088833,0.068501,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.0085714,0.08844,0.11339,1,1
1,GO RESPONSE TO ACID CHEMICAL,0.046579,0.088233,0.11721,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00035231,0.087704,0.092213,1,1
1,GO MUSCLE CELL DIFFERENTIATION,0.03245,0.087516,0.10749,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.014138,0.087492,0.10299,1,1
1,GO SPINDLE ASSEMBLY,0.0049174,0.086935,0.097064,1,1
1,GO DNA METABOLIC PROCESS,0.00034072,0.086822,0.094615,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0033369,0.086683,0.12624,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00031859,0.085656,0.088966,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0037331,0.085483,0.098986,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.019739,0.085254,0.077934,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00044439,0.084405,0.10058,1,1
1,GO POSITIVE REGULATION OF SIGNALING,0.011326,0.084129,0.076112,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00034072,0.083888,0.10582,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0046564,0.083293,0.065301,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00025131,0.083088,0.093344,1,1
1,GO DNA GEOMETRIC CHANGE,0.025414,0.08162,0.11952,1,1
1,GO RESPONSE TO RADIATION,0.007729,0.081098,0.069949,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.037747,0.079624,0.056011,1,1
1,GO CELL CYCLE CHECKPOINT,0.0047853,0.079292,0.088715,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.042857,0.079178,0.075305,1,1
1,GO JNK CASCADE,0.03939,0.075757,0.066911,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0028957,0.075382,0.13985,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.041093,0.074211,0.082131,1,1
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.038561,0.073357,0.086039,1,1
1,GO DNA CATABOLIC PROCESS,0.012203,0.073105,0.069313,1,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.04854,0.072454,0.080875,1,1
1,GO CHROMOSOME SEGREGATION,0.022165,0.071793,0.087507,1,1
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0066042,0.071599,0.094573,1,1
1,GO T CELL LINEAGE COMMITMENT,0.043763,0.071521,0.10918,1,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0099891,0.071049,0.066936,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.023741,0.070728,0.11404,1,1
1,GO EMBRYO DEVELOPMENT,0.015953,0.070658,0.088129,1,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.030383,0.07063,0.078195,1,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.011326,0.068697,0.055381,1,1
1,GO SNRNA TRANSCRIPTION,0.0067808,0.065664,0.093449,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.050569,0.065535,0.070285,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.035393,0.065358,0.059211,1,1
1,GO GLAND DEVELOPMENT,0.037747,0.064331,0.096809,1,1
1,GO DNA REPAIR,0.0071468,0.06391,0.07903,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.01282,0.063461,0.09106,1,1
1,GO INTRACELLULAR TRANSPORT,0.0038387,0.063372,0.067539,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.03245,0.061943,0.046634,1,1
1,GO MITOCHONDRION ORGANIZATION,0.010245,0.061687,0.066657,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.014486,0.06149,0.052455,1,1
1,GO REPRODUCTION,0.029719,0.06079,0.055817,1,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.019739,0.060453,0.060427,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0046564,0.058212,0.1191,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0017641,0.055678,0.069428,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.050569,0.055151,0.053682,1,1
1,GO DNA REPLICATION,0.047551,0.049182,0.062098,1,1
1,GO DNA RECOMBINATION,0.049546,0.043564,0.081338,1,1
1,GO ORGANELLE ASSEMBLY,0.013798,0.040663,0.062271,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,2.3975e-07,1.2188,0.98077,1,1
2,GO ETHANOL OXIDATION,6.8936e-07,1.0574,0.91957,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00025131,0.96721,0.71972,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.6414e-07,0.82551,0.76751,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00049035,0.82084,0.6559,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.7791e-06,0.80051,0.61412,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.4963e-07,0.77703,0.7163,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00012074,0.75668,0.61402,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0001547,0.7414,0.61311,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00067758,0.73434,0.48717,1,1
2,GO RESPONSE TO INTERLEUKIN 18,8.4205e-05,0.71907,0.69033,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,9.7801e-06,0.70935,0.70201,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00021909,0.69788,0.51912,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.2876e-06,0.68144,0.51662,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.8131e-07,0.68021,0.52836,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.3202e-07,0.67989,0.64115,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,2.0833e-05,0.67581,0.59002,1,1
2,GO BIOLOGICAL PHASE,5.8301e-05,0.67252,0.64455,1,1
2,GO MUCUS SECRETION,0.00041602,0.66447,0.62258,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,0.00014418,0.66081,0.48671,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00012512,0.65356,0.55602,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0032441,0.64671,0.46843,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00079435,0.63924,0.56895,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0067808,0.63783,0.41816,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00026903,0.62238,0.47929,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,7.9801e-06,0.61743,0.54446,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00079435,0.6163,0.43915,1,1
2,GO MYOBLAST MIGRATION,0.012203,0.61214,0.48969,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.9904e-06,0.61141,0.58141,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0006154,0.60615,0.39289,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,2.8077e-06,0.59842,0.53565,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,7.013e-05,0.59822,0.57271,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.4421e-05,0.59241,0.56255,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.001662,0.5892,0.41026,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0014738,0.58398,0.48389,1,1
2,GO PROSTATE GLAND GROWTH,2.6902e-06,0.58277,0.66094,1,1
2,GO PROSTANOID METABOLIC PROCESS,1.2454e-05,0.57692,0.50387,1,1
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0036303,0.57617,0.5243,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00072223,0.5746,0.41042,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.8612e-06,0.5727,0.41492,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,8.3127e-06,0.57002,0.51339,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00054072,0.56861,0.49296,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.0226e-05,0.56849,0.50487,1,1
2,GO HAIR FOLLICLE MATURATION,5.0226e-05,0.56535,0.46299,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,7.547e-05,0.56443,0.52748,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,6.0504e-05,0.5639,0.50941,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00029782,0.55977,0.55728,1,1
2,GO ETHER METABOLIC PROCESS,2.2658e-06,0.55969,0.52151,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.00057693,0.54504,0.45648,1,1
2,GO LYSINE METABOLIC PROCESS,0.00027832,0.54427,0.50937,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.5331e-06,0.53953,0.52941,1,1
2,GO OTIC VESICLE DEVELOPMENT,0.00035231,0.53863,0.44538,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,5.2533e-07,0.5381,0.50383,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.1493e-05,0.53748,0.58244,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00035231,0.53501,0.54111,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.0085714,0.53404,0.37151,1,1
2,GO RETINAL METABOLIC PROCESS,0.011612,0.52399,0.33519,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.5201e-05,0.52013,0.45297,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,8.1192e-05,0.50824,0.40378,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00040247,0.50678,0.4586,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0023671,0.50474,0.3476,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00045924,0.50334,0.43411,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.0184e-05,0.50221,0.42961,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00012964,0.50121,0.46953,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,2.8418e-05,0.50099,0.40463,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,0.00013433,0.49905,0.45815,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.0034322,0.49763,0.40906,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.0073363,0.49416,0.4227,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00037661,0.49345,0.43814,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010206,0.48643,0.35473,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00034072,0.48059,0.47727,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4692e-06,0.47901,0.43059,1,1
2,GO ACTIN FILAMENT SEVERING,0.03939,0.47803,0.31778,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.00011241,0.47764,0.43602,1,1
2,GO OXYGEN TRANSPORT,0.0097392,0.47714,0.44234,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,6.7728e-06,0.47699,0.47013,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,5.2139e-05,0.4752,0.43857,1,1
2,GO ETHANOL METABOLIC PROCESS,3.9418e-06,0.47423,0.53454,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0094949,0.47382,0.31455,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.7806e-05,0.47187,0.42891,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.043763,0.47024,0.31162,1,1
2,GO MUSCLE ATROPHY,0.0056288,0.46832,0.35363,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00074557,0.46758,0.36777,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.8077e-06,0.46665,0.46345,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.017969,0.46374,0.33599,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.052669,0.46175,0.2215,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0039469,0.46115,0.3362,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00010092,0.45356,0.32321,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.0683e-06,0.45162,0.44542,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0025083,0.45013,0.35679,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.2139e-05,0.44985,0.38143,1,1
2,GO NEPHRON TUBULE FORMATION,0.0051916,0.44818,0.29165,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,1.8521e-05,0.44531,0.36481,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.2139e-05,0.44416,0.39268,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,3.4421e-05,0.44402,0.44861,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00038934,0.4434,0.31054,1,1
2,GO OTIC VESICLE MORPHOGENESIS,0.00065623,0.43886,0.40518,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0012662,0.43534,0.28381,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00065623,0.43487,0.32608,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0037331,0.43454,0.36136,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.021165,0.4339,0.38552,1,1
2,GO DENDRITIC CELL MIGRATION,0.00023468,0.43328,0.35887,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0013054,0.43308,0.34556,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0014738,0.43185,0.41882,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.43045,0.34009,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0099891,0.41912,0.31179,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.03245,0.41769,0.28844,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00081984,0.41675,0.40011,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,8.7323e-05,0.41199,0.35263,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,7.6603e-06,0.41126,0.34496,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00095906,0.40983,0.34481,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00067758,0.40915,0.3631,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.013798,0.40864,0.36164,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0013872,0.40716,0.36921,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.036948,0.40538,0.21569,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00059588,0.40313,0.31314,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0021689,0.40206,0.36819,1,1
2,GO PIGMENT GRANULE MATURATION,0.0064317,0.40113,0.28935,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.39563,0.37481,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0007696,0.39535,0.36431,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.4609e-05,0.39275,0.36363,1,1
2,GO NEURAL CREST FORMATION,0.001986,0.39274,0.31258,1,1
2,GO PORE COMPLEX ASSEMBLY,1.5331e-06,0.39017,0.3861,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.0056288,0.38851,0.34701,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0021062,0.38673,0.39568,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00024286,0.38641,0.33182,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0071468,0.3838,0.34373,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,3.6228e-06,0.38376,0.3767,1,1
2,GO GAS TRANSPORT,0.0027346,0.38344,0.3948,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00047456,0.38307,0.29409,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00034072,0.38284,0.29717,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0085714,0.38202,0.30739,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.010506,0.38191,0.27894,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.01282,0.38181,0.34354,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.00013917,0.37995,0.34824,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.2139e-05,0.3795,0.44891,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0060989,0.37871,0.24295,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.0059384,0.37771,0.34512,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0022992,0.3771,0.31748,1,1
2,GO LIMB BUD FORMATION,0.004408,0.37637,0.45708,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.6228e-06,0.37556,0.3522,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,7.9801e-06,0.37499,0.34095,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00081984,0.37398,0.26276,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00020448,0.3725,0.44521,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,1.6015e-06,0.37228,0.38208,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.001986,0.37038,0.27804,1,1
2,GO VESICLE CARGO LOADING,7.6603e-06,0.36955,0.32422,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.00079435,0.36948,0.30425,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00017186,0.36863,0.3066,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,8.1192e-05,0.36734,0.34248,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00095906,0.36619,0.34868,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,3.4421e-05,0.36571,0.30276,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.00050664,0.36557,0.26279,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.042857,0.36536,0.1533,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.015574,0.36517,0.32126,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0015189,0.36464,0.39153,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0025083,0.3632,0.3316,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0007696,0.36136,0.28495,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.00013433,0.36053,0.30139,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,2.5308e-05,0.35899,0.36324,1,1
2,GO ERYTHROCYTE MATURATION,0.0032441,0.35683,0.33047,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,0.3557,0.30435,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,5.4121e-05,0.35549,0.35851,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0011199,0.35417,0.25943,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.0040578,0.35337,0.21368,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,4.4878e-05,0.35275,0.36296,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.00079435,0.35091,0.3868,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0013872,0.35069,0.28011,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00037661,0.34998,0.27938,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.7791e-06,0.3499,0.32381,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,6.5149e-05,0.34977,0.29849,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,4.8379e-05,0.34956,0.49294,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0011199,0.34881,0.38049,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0001165,0.34839,0.33558,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,8.7323e-05,0.34835,0.24901,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0015653,0.34824,0.25943,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00017796,0.34744,0.30255,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.016734,0.34708,0.26331,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0010859,0.34597,0.28162,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.017969,0.34567,0.21733,1,1
2,GO PRE MIRNA PROCESSING,0.0024367,0.34144,0.21951,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.015953,0.34087,0.33089,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.0001165,0.33992,0.29113,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0022992,0.33906,0.28396,1,1
2,GO REGULATION OF DNA METHYLATION,0.00049035,0.3388,0.242,1,1
2,GO NEUROBLAST DIVISION,0.00072223,0.33846,0.37127,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00057693,0.33599,0.28252,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.0024367,0.33597,0.23208,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.038561,0.3359,0.18055,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0019282,0.33542,0.26919,1,1
2,GO NOTOCHORD DEVELOPMENT,0.00017186,0.3353,0.50849,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.021165,0.33524,0.21581,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.027803,0.3351,0.19838,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.00011241,0.33447,0.3165,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0033369,0.3344,0.33026,1,1
2,GO RNA DECAPPING,1.1493e-05,0.33388,0.25129,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00035231,0.3336,0.25115,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,1.6455e-05,0.33295,0.37286,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.001662,0.33102,0.3149,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.00074557,0.33092,0.25496,1,1
2,GO TONGUE MORPHOGENESIS,0.019283,0.33071,0.29047,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.001228,0.33066,0.33854,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,2.5308e-05,0.33032,0.35008,1,1
2,GO RETINOL METABOLIC PROCESS,8.1192e-05,0.33001,0.34236,1,1
2,GO FIBROBLAST ACTIVATION,0.00032948,0.32998,0.33966,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0018173,0.32972,0.32863,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.001662,0.32941,0.2276,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.0087944,0.32827,0.20394,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00084609,0.32825,0.27999,1,1
2,GO MICROVILLUS ASSEMBLY,0.010506,0.32748,0.307,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0062634,0.3265,0.22607,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0067808,0.32616,0.21725,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.017969,0.32523,0.24907,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,9.7801e-06,0.32178,0.32829,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.0011199,0.32154,0.29743,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0010528,0.32145,0.2392,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0036303,0.32106,0.27455,1,1
2,GO FOREGUT MORPHOGENESIS,0.001228,0.32032,0.36484,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0073363,0.3201,0.28901,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00013917,0.31908,0.42465,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00022676,0.31757,0.28225,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.4692e-06,0.31751,0.26071,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,4.3218e-05,0.31731,0.30741,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.024288,0.31666,0.21477,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0012662,0.31647,0.25098,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,6.2985e-07,0.31647,0.29308,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0013054,0.31594,0.27754,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011241,0.31574,0.2736,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0034322,0.31543,0.26202,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00021909,0.31514,0.27835,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.012203,0.31502,0.22058,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.6902e-06,0.31497,0.33393,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0081404,0.31474,0.29061,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00050664,0.3143,0.2573,1,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.02268,0.31397,0.26268,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.011326,0.31389,0.23893,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00027832,0.31301,0.28947,1,1
2,GO CARNITINE SHUTTLE,4.4878e-05,0.31298,0.32458,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0069616,0.31284,0.29225,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0022992,0.31212,0.25508,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.001228,0.31164,0.26226,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,3.6228e-06,0.3115,0.30406,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0604e-05,0.31107,0.26557,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0040578,0.31092,0.30449,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.6455e-05,0.3096,0.24778,1,1
2,GO AMP METABOLIC PROCESS,0.0083534,0.30824,0.24605,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.015953,0.30823,0.22793,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0013872,0.30794,0.20978,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0025817,0.30789,0.24625,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00017186,0.3076,0.27318,1,1
2,GO OVULATION,7.547e-05,0.30732,0.34627,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00055855,0.30703,0.26567,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0028957,0.30673,0.22582,1,1
2,GO DNA LIGATION,0.0013872,0.30662,0.22916,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00059588,0.30575,0.26266,1,1
2,GO MONONUCLEAR CELL MIGRATION,5.4121e-05,0.3057,0.27806,1,1
2,GO INTERLEUKIN 2 PRODUCTION,5.8301e-05,0.30565,0.2589,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.30557,0.27088,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.014138,0.305,0.3023,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0010528,0.30438,0.22548,1,1
2,GO CHONDROCYTE PROLIFERATION,0.0016129,0.30433,0.37661,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0087944,0.30363,0.18653,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0090226,0.30346,0.27204,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0010859,0.30308,0.29313,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0010528,0.30198,0.25207,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00016595,0.29938,0.32981,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00072223,0.29931,0.23673,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00010092,0.29871,0.25627,1,1
2,GO RESPONSE TO GONADOTROPIN,0.0030654,0.29827,0.2272,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00040247,0.29755,0.24907,1,1
2,GO RESPONSE TO TUMOR CELL,0.001228,0.29688,0.2561,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00012512,0.29589,0.29569,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0001165,0.29584,0.32224,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0028141,0.29582,0.18248,1,1
2,GO NUCLEAR PORE ORGANIZATION,5.9841e-06,0.29577,0.36087,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0010859,0.29556,0.20829,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.29527,0.28158,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00010092,0.29466,0.24138,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0012662,0.29446,0.24354,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,7.2111e-07,0.29425,0.2659,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0046564,0.2937,0.26234,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0010206,0.29304,0.23921,1,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0097392,0.29273,0.26839,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,7.013e-05,0.29107,0.24873,1,1
2,GO HISTONE H4 DEACETYLATION,4.4878e-05,0.29103,0.3279,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001547,0.29001,0.29361,1,1
2,GO PODOSOME ASSEMBLY,0.0022332,0.28995,0.25805,1,1
2,GO REGULATION OF GTP BINDING,0.050569,0.28956,0.18015,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0034322,0.28871,0.23378,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0038387,0.28853,0.27612,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0010859,0.28853,0.22523,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00022676,0.28845,0.29004,1,1
2,GO MRNA MODIFICATION,0.001191,0.28832,0.21786,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00017796,0.28826,0.26875,1,1
2,GO GASTRIC ACID SECRETION,0.0024367,0.28823,0.22976,1,1
2,GO RIG I SIGNALING PATHWAY,9.389e-05,0.2881,0.25117,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.044685,0.28763,0.17223,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.023741,0.28738,0.34516,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00027832,0.28729,0.27398,1,1
2,GO PEPTIDE CROSS LINKING,0.0021689,0.28685,0.26412,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.020205,0.28525,0.3749,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0060989,0.28503,0.23448,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00018427,0.28472,0.21719,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.001872,0.28431,0.27043,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.1888e-05,0.28428,0.28014,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00012074,0.28381,0.26318,1,1
2,GO BLASTODERM SEGMENTATION,0.027803,0.28377,0.28331,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0054795,0.28375,0.24407,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.037747,0.28284,0.2367,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0001547,0.28128,0.25224,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00016023,0.28011,0.24105,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00050664,0.27965,0.2655,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.001228,0.27896,0.4369,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00031859,0.27855,0.2719,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00054072,0.27659,0.25955,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.0033e-05,0.27471,0.25233,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,4.3218e-05,0.27462,0.37623,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0059384,0.27414,0.33267,1,1
2,GO REGULATION OF CELL KILLING,0.0036303,0.27402,0.19491,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00029782,0.27323,0.27101,1,1
2,GO HIPPO SIGNALING,0.0017123,0.27315,0.33362,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.029719,0.27292,0.33387,1,1
2,GO CHROMATIN DISASSEMBLY,0.0033369,0.27261,0.19177,1,1
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0038387,0.27242,0.24319,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015189,0.27208,0.20134,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.27153,0.26824,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.04854,0.2695,0.16692,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013457,0.26947,0.21333,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.0032441,0.26892,0.23371,1,1
2,GO MIRNA METABOLIC PROCESS,2.7343e-05,0.26846,0.21557,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,7.013e-05,0.2683,0.23074,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,8.1192e-05,0.26805,0.24199,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0017641,0.26734,0.28463,1,1
2,GO GTP METABOLIC PROCESS,0.0021689,0.26711,0.27004,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.00047456,0.26689,0.19917,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.018398,0.26687,0.20717,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00031859,0.26667,0.23997,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00049035,0.2655,0.24123,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.009256,0.26545,0.19744,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.046579,0.26516,0.14257,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0017123,0.26478,0.19242,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0064317,0.26433,0.24907,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0019282,0.26382,0.2562,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0019282,0.26309,0.20352,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.026586,0.263,0.21919,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0020453,0.26282,0.18821,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0057817,0.26253,0.26756,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.017549,0.26251,0.14963,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0083534,0.26208,0.22252,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.004408,0.26155,0.19522,1,1
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0040578,0.26074,0.30895,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00092958,0.26067,0.25007,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0013054,0.26006,0.18805,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.017969,0.25969,0.15241,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00017186,0.25959,0.22385,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00035231,0.25894,0.24524,1,1
2,GO T CELL CHEMOTAXIS,0.00018427,0.25766,0.2468,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0024367,0.25744,0.20189,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.029719,0.25735,0.17793,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.25722,0.18507,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0011549,0.25712,0.20929,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00069957,0.2569,0.2449,1,1
2,GO MATURATION OF SSU RRNA,0.00084609,0.25673,0.29059,1,1
2,GO AMINE CATABOLIC PROCESS,0.0036303,0.25667,0.29734,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.04854,0.25663,0.21703,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.00081984,0.25639,0.41676,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0014738,0.25496,0.20245,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.7118e-05,0.2542,0.27672,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0021689,0.2539,0.28436,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0034322,0.25361,0.27097,1,1
2,GO HYPEROSMOTIC RESPONSE,0.0015653,0.25339,0.25632,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0013457,0.25295,0.22878,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,4.8379e-05,0.25284,0.22507,1,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0062634,0.25197,0.248,1,1
2,GO HISTONE H3 K9 ACETYLATION,7.2754e-05,0.25194,0.23856,1,1
2,GO NUCLEAR MIGRATION,0.015203,0.25191,0.17003,1,1
2,GO LAMELLIPODIUM ORGANIZATION,0.00014418,0.25118,0.24104,1,1
2,GO TRNA METHYLATION,0.00032948,0.25004,0.22206,1,1
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.017549,0.24908,0.15923,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.00063551,0.24882,0.23474,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0049174,0.2486,0.2264,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00065623,0.24712,0.21993,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.050569,0.247,0.2102,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0034322,0.2458,0.24629,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0027346,0.24537,0.16134,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0006154,0.24507,0.18006,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.038561,0.24479,0.19904,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001191,0.2446,0.23915,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,4.1617e-05,0.24431,0.21518,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.05161,0.24393,0.10771,1,1
2,GO PIGMENT ACCUMULATION,0.0018173,0.24311,0.23967,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.014138,0.24257,0.14992,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0037331,0.24227,0.3657,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0020453,0.2422,0.17979,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.046579,0.24218,0.16041,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0033369,0.24189,0.25778,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001986,0.24169,0.24642,1,1
2,GO SECRETION BY TISSUE,0.00084609,0.24153,0.26552,1,1
2,GO RESPONSE TO X RAY,0.00021167,0.24149,0.32623,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0013054,0.24067,0.22835,1,1
2,GO RESPIRATORY BURST,0.0071468,0.24015,0.208,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.2401,0.23034,1,1
2,GO LIPID OXIDATION,0.0021062,0.23939,0.17205,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00041602,0.23939,0.21465,1,1
2,GO BONE GROWTH,0.029068,0.23881,0.1969,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.0037331,0.23853,0.16552,1,1
2,GO RNA DESTABILIZATION,0.0024367,0.2384,0.17203,1,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.024846,0.2383,0.23175,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00065623,0.23789,0.20556,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0025817,0.23788,0.2218,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0031536,0.23774,0.16335,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00092958,0.23742,0.22919,1,1
2,GO LAMELLIPODIUM ASSEMBLY,0.00072223,0.23741,0.19308,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0033369,0.23721,0.1863,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.0037331,0.23681,0.25739,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0013457,0.23666,0.23242,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031859,0.23639,0.23097,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0069616,0.23437,0.19769,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0042883,0.23412,0.21176,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0069616,0.23371,0.21872,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.014841,0.23354,0.15149,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0057817,0.23337,0.23912,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0033369,0.23332,0.25122,1,1
2,GO PLATELET MORPHOGENESIS,0.00035231,0.23317,0.22927,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0045306,0.23289,0.16763,1,1
2,GO APOPTOTIC CELL CLEARANCE,0.0016129,0.23281,0.16276,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0014738,0.23278,0.1853,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.017969,0.232,0.23813,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00087311,0.23158,0.14143,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0021062,0.23137,0.2324,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.001986,0.23108,0.20533,1,1
2,GO BLASTOCYST FORMATION,0.00018427,0.23087,0.21374,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0006154,0.23059,0.22253,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.23008,0.16171,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,4.4878e-05,0.22963,0.18907,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0022332,0.22962,0.29499,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.0021062,0.22959,0.2365,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00012074,0.22931,0.24113,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0073363,0.22907,0.20161,1,1
2,GO GOLGI LOCALIZATION,0.013798,0.22894,0.17862,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00014418,0.22856,0.19017,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0010528,0.22811,0.15312,1,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.029068,0.22789,0.2342,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,6.7728e-06,0.2271,0.20914,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00028792,0.22699,0.22064,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00054072,0.22693,0.18568,1,1
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.036164,0.22639,0.15966,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0051916,0.22589,0.25335,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0028957,0.22506,0.15516,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0059384,0.22408,0.14845,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0025817,0.22397,0.23425,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00353,0.22311,0.19444,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.001986,0.22295,0.22217,1,1
2,GO NUCLEUS LOCALIZATION,0.0022992,0.22255,0.17072,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.1888e-05,0.22099,0.21191,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0021062,0.22023,0.22781,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.026586,0.21991,0.22807,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0073363,0.21941,0.17182,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0014299,0.21924,0.20608,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0013872,0.21916,0.1558,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001165,0.21882,0.18182,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,6.2786e-05,0.21847,0.19701,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,7.547e-05,0.21796,0.18325,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.00057693,0.2177,0.19629,1,1
2,GO STEM CELL DIVISION,0.0024367,0.21697,0.2289,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.017137,0.21665,0.1399,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00054072,0.21655,0.15534,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0013457,0.21629,0.18669,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0042883,0.21627,0.18511,1,1
2,GO T CELL APOPTOTIC PROCESS,0.00042998,0.21578,0.23293,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00047456,0.21534,0.22068,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0054795,0.21529,0.23026,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.00028792,0.21523,0.20008,1,1
2,GO REGULATION OF GENE SILENCING,5.0683e-06,0.21484,0.20369,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0020453,0.2146,0.23118,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017969,0.21442,0.17791,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.0013457,0.21402,0.19559,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0014299,0.21348,0.16489,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00035231,0.2133,0.22123,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.015953,0.21288,0.16625,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0087944,0.2128,0.19349,1,1
2,GO B CELL HOMEOSTASIS,0.05161,0.21235,0.1073,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0017641,0.21185,0.19463,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00038934,0.21182,0.21758,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0062634,0.21164,0.15797,1,1
2,GO B CELL APOPTOTIC PROCESS,0.012203,0.21164,0.14712,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00059588,0.21126,0.22841,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00011241,0.21104,0.18282,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0028957,0.21095,0.16386,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00035231,0.21028,0.20847,1,1
2,GO RRNA TRANSCRIPTION,0.00045924,0.21026,0.2361,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0025817,0.2102,0.1538,1,1
2,GO LEUKOCYTE PROLIFERATION,0.00081984,0.20964,0.16127,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,5.0226e-05,0.2095,0.19498,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00024286,0.20924,0.16592,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00012074,0.20924,0.19773,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.011047,0.20914,0.15851,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.010506,0.20862,0.17098,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0059384,0.20828,0.15751,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.20759,0.20384,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00013433,0.20735,0.26378,1,1
2,GO RNA POLYADENYLATION,0.00090094,0.20729,0.15255,1,1
2,GO CYTOPLASM ORGANIZATION,0.014138,0.20701,0.22853,1,1
2,GO RNA STABILIZATION,0.0010859,0.20696,0.15655,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.017549,0.20675,0.17263,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.045624,0.20643,0.17967,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0040578,0.20642,0.15938,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00041602,0.20632,0.23578,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.043763,0.20628,0.15932,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0050528,0.20625,0.15868,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.025994,0.20513,0.18979,1,1
2,GO ASYMMETRIC CELL DIVISION,0.017549,0.20512,0.17735,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00098941,0.20481,0.21861,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0013872,0.20411,0.18274,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,9.7801e-06,0.20398,0.25326,1,1
2,GO CORNIFICATION,0.0054795,0.20373,0.26068,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00063551,0.20371,0.1765,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.00079435,0.2034,0.26889,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0030654,0.20338,0.21657,1,1
2,GO HISTONE DEUBIQUITINATION,7.547e-05,0.2029,0.18267,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00353,0.20256,0.21796,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00021167,0.20213,0.2128,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0010859,0.20199,0.18167,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0099891,0.20159,0.14887,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.0038387,0.20083,0.15725,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.031748,0.20068,0.16199,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.02166,0.20016,0.1438,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.0038387,0.2001,0.20733,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,9.0551e-05,0.20004,0.17681,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00029782,0.19988,0.18905,1,1
2,GO INTERACTION WITH SYMBIONT,0.00013917,0.19985,0.21832,1,1
2,GO TRACHEA DEVELOPMENT,0.036164,0.19939,0.18053,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0039469,0.19936,0.23072,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.010506,0.19913,0.15499,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,9.0551e-05,0.19886,0.19566,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00013917,0.19847,0.1919,1,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0085714,0.19833,0.20911,1,1
2,GO RNA METHYLATION,0.00092958,0.19798,0.16294,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0094949,0.19781,0.19501,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017186,0.1976,0.2146,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0028957,0.19753,0.16624,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0014299,0.19602,0.1642,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0049174,0.196,0.18078,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.0075304,0.19591,0.12552,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.0047853,0.1957,0.14912,1,1
2,GO LEFT RIGHT PATTERN FORMATION,0.0085714,0.19557,0.23464,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0031536,0.19524,0.19626,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.016339,0.19508,0.18222,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,5.2139e-05,0.19463,0.21572,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0011549,0.19456,0.20914,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.019283,0.19425,0.13959,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013054,0.19389,0.16848,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.016734,0.19333,0.15527,1,1
2,GO GENITALIA MORPHOGENESIS,0.033894,0.19304,0.18236,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.0054795,0.19231,0.21851,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0029794,0.19218,0.16155,1,1
2,GO AXIS ELONGATION,0.0057817,0.19211,0.29493,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0019282,0.19199,0.16639,1,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.030383,0.19172,0.21302,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00021909,0.19153,0.23874,1,1
2,GO NEGATIVE T CELL SELECTION,0.0097392,0.19146,0.10581,1,1
2,GO TRNA TRANSPORT,1.2962e-05,0.19136,0.24443,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.0022992,0.19126,0.18958,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00017186,0.19105,0.1935,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0015653,0.191,0.15022,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.02166,0.19062,0.1709,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.1964e-05,0.19023,0.1697,1,1
2,GO TRNA METABOLIC PROCESS,0.00024286,0.19017,0.18626,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0064317,0.19007,0.16536,1,1
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.036948,0.18975,0.13877,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.004408,0.18971,0.13579,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.013798,0.18928,0.1723,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.0046564,0.18915,0.16219,1,1
2,GO T CELL PROLIFERATION,0.0013054,0.1891,0.16658,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00026903,0.18909,0.24946,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.8251e-06,0.18902,0.20438,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00057693,0.18899,0.15748,1,1
2,GO THYMUS DEVELOPMENT,0.0037331,0.18875,0.16836,1,1
2,GO TOXIN TRANSPORT,0.0057817,0.1885,0.1456,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0051916,0.18804,0.21643,1,1
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.052669,0.18756,0.18764,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.001662,0.18718,0.18496,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.104e-05,0.18701,0.20664,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0071468,0.18672,0.17147,1,1
2,GO RNA INTERFERENCE,0.0079323,0.18581,0.17857,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0012662,0.18571,0.18463,1,1
2,GO PIGMENT GRANULE ORGANIZATION,8.7323e-05,0.18527,0.22708,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0069616,0.18433,0.11737,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.0006154,0.18295,0.19425,1,1
2,GO TERPENOID METABOLIC PROCESS,0.014138,0.18173,0.16093,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.035393,0.18155,0.17467,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.03245,0.18005,0.25633,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,7.547e-05,0.17989,0.2359,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.011047,0.17951,0.15129,1,1
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.023741,0.17946,0.15152,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.016734,0.17875,0.21327,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001228,0.17842,0.16056,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030383,0.17838,0.13751,1,1
2,GO FATTY ACID TRANSPORT,0.00047456,0.17825,0.15179,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.052669,0.17825,0.12082,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0024367,0.17744,0.16598,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.023205,0.17733,0.16175,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.041093,0.17726,0.15127,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00095906,0.17713,0.16939,1,1
2,GO LIPID MODIFICATION,0.0021689,0.17696,0.12455,1,1
2,GO NATURAL KILLER CELL PROLIFERATION,0.024288,0.17676,0.2034,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00017796,0.17655,0.1617,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.0604e-05,0.17621,0.15951,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00044439,0.17616,0.15531,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00081984,0.17614,0.17901,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0039469,0.17582,0.12905,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00026003,0.17577,0.17065,1,1
2,GO TRANSLATIONAL ELONGATION,0.0083534,0.17542,0.1696,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00023468,0.17535,0.20304,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0057817,0.17464,0.21213,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.019739,0.17461,0.12015,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0094949,0.17437,0.15959,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0042883,0.17424,0.14521,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0011549,0.17327,0.20141,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0042883,0.17306,0.17563,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021689,0.17303,0.13629,1,1
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.017549,0.17208,0.16465,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00050664,0.17196,0.17433,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0015653,0.1718,0.17091,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.049546,0.17176,0.11927,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.001662,0.17143,0.14687,1,1
2,GO MYOBLAST DIFFERENTIATION,0.009256,0.17078,0.18835,1,1
2,GO HISTONE H2B UBIQUITINATION,0.007729,0.17077,0.14854,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.015574,0.17074,0.15454,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.00042998,0.1698,0.17626,1,1
2,GO STEROL METABOLIC PROCESS,0.011612,0.16977,0.11677,1,1
2,GO METANEPHROS DEVELOPMENT,0.043763,0.16974,0.14965,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0025083,0.16922,0.21776,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.01282,0.16889,0.11203,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.0046564,0.16874,0.16218,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00038934,0.1686,0.16018,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.014841,0.16833,0.16284,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0027346,0.16813,0.18006,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00074557,0.16787,0.13555,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.03939,0.16748,0.16595,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.041967,0.16729,0.11507,1,1
2,GO MRNA METHYLATION,0.043763,0.16696,0.13958,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.025414,0.16674,0.14619,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0053338,0.16558,0.16805,1,1
2,GO KERATINOCYTE PROLIFERATION,0.049546,0.16557,0.26095,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0001165,0.16544,0.16381,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.018836,0.16524,0.13202,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0022332,0.16519,0.13686,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0085714,0.16502,0.17276,1,1
2,GO LIPID HOMEOSTASIS,0.0066042,0.16454,0.13305,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.030383,0.16397,0.099348,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.0024367,0.1636,0.14178,1,1
2,GO PHOTOPERIODISM,0.037747,0.163,0.10871,1,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.044685,0.16235,0.15542,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0036303,0.16221,0.11467,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00092958,0.16212,0.13204,1,1
2,GO MRNA TRANSCRIPTION,0.0054795,0.1621,0.15992,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0011199,0.16207,0.18441,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00045924,0.16152,0.1328,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.017969,0.1614,0.10898,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.014138,0.16136,0.10153,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.010506,0.16111,0.10097,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.05161,0.16072,0.13974,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0051916,0.16065,0.11368,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.013139,0.16041,0.17544,1,1
2,GO ERBB SIGNALING PATHWAY,0.0025083,0.16019,0.13469,1,1
2,GO T CELL DIFFERENTIATION,0.0038387,0.15926,0.13341,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.046579,0.15901,0.17462,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.035393,0.15896,0.12123,1,1
2,GO REGULATION OF CELL CELL ADHESION,0.014138,0.1585,0.12078,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0017641,0.15845,0.25468,1,1
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.022165,0.15811,0.16841,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0020453,0.15803,0.2254,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0099891,0.15693,0.16133,1,1
2,GO REGULATION OF CELL ACTIVATION,0.0036303,0.15647,0.1229,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0071468,0.15591,0.12945,1,1
2,GO P BODY ASSEMBLY,0.0021062,0.15574,0.13824,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.00016023,0.15532,0.16415,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0037331,0.1552,0.11424,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.018836,0.15387,0.12064,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0007696,0.15353,0.18701,1,1
2,GO REGULATION OF HAIR CYCLE,0.015203,0.15329,0.21629,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00016023,0.15322,0.17951,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0012662,0.15321,0.26055,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00055855,0.15295,0.14861,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00019753,0.15285,0.13176,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.038561,0.15277,0.2914,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00054072,0.15264,0.1465,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0023671,0.15244,0.16936,1,1
2,GO DIGESTION,0.010245,0.15226,0.12736,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,8.1192e-05,0.15147,0.14497,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.2454e-05,0.15134,0.17892,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0099891,0.15133,0.228,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00025131,0.15068,0.1261,1,1
2,GO T CELL ACTIVATION,0.0071468,0.15054,0.12592,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00026903,0.15027,0.16241,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0029794,0.15024,0.15125,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00029782,0.15017,0.14509,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0011549,0.14967,0.1426,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028957,0.14932,0.15495,1,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.029719,0.14929,0.20822,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0025083,0.1487,0.13906,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.016734,0.14825,0.22555,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0069616,0.14791,0.18175,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.00055855,0.14791,0.14492,1,1
2,GO B CELL DIFFERENTIATION,0.0083534,0.14779,0.11728,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.015203,0.14779,0.12728,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00065623,0.14779,0.13653,1,1
2,GO GOLGI VESICLE BUDDING,0.001191,0.1476,0.12614,1,1
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.009256,0.14702,0.13791,1,1
2,GO REGULATION OF T CELL ACTIVATION,0.0067808,0.14699,0.12821,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,0.00353,0.1469,0.14386,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0071468,0.14637,0.11556,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,0.0022992,0.14556,0.12527,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0013872,0.14542,0.16642,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.041967,0.14542,0.10338,1,1
2,GO IMPORT INTO NUCLEUS,0.02166,0.14532,0.11211,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.013465,0.1451,0.10265,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0039469,0.1451,0.16692,1,1
2,GO GMP METABOLIC PROCESS,0.029068,0.14505,0.14564,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0097392,0.14404,0.10802,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0027346,0.14395,0.22552,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0073363,0.1434,0.12064,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.013139,0.14308,0.11518,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.023741,0.14298,0.20433,1,1
2,GO GOLGI RIBBON FORMATION,0.018398,0.14271,0.13842,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.050569,0.14237,0.11908,1,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.01282,0.14237,0.09459,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00065623,0.14228,0.12581,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.016339,0.14159,0.09467,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14128,0.12944,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.012508,0.14123,0.11833,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.021165,0.14081,0.13514,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00034072,0.14024,0.1391,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.010245,0.14011,0.14857,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0017641,0.13993,0.1523,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.015574,0.13976,0.11239,1,1
2,GO POLYOL METABOLIC PROCESS,0.00022676,0.13931,0.16091,1,1
2,GO TISSUE HOMEOSTASIS,0.010506,0.13892,0.095562,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.8282e-05,0.13869,0.13004,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0024367,0.13867,0.13598,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.8301e-05,0.13846,0.13368,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0090226,0.13832,0.11569,1,1
2,GO MALE SEX DIFFERENTIATION,0.050569,0.13817,0.12307,1,1
2,GO RESPONSE TO IRON ION,0.050569,0.13805,0.14981,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,3.1888e-05,0.13781,0.14227,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0034322,0.13759,0.1665,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00028792,0.13758,0.17884,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.018398,0.13753,0.087825,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.013465,0.13733,0.1162,1,1
2,GO COPII COATED VESICLE BUDDING,0.0010859,0.13715,0.12497,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.014486,0.13686,0.14357,1,1
2,GO RESPONSE TO ACTIVITY,0.02843,0.13685,0.096477,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.00025131,0.13617,0.13029,1,1
2,GO BASE EXCISION REPAIR,0.0038387,0.13528,0.12574,1,1
2,GO NUCLEAR EXPORT,9.7346e-05,0.13523,0.16091,1,1
2,GO FEVER GENERATION,0.050569,0.13509,0.1561,1,1
2,GO ALPHA BETA T CELL ACTIVATION,0.001986,0.13488,0.16073,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.01282,0.13487,0.12132,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.027188,0.13476,0.15834,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00029782,0.13335,0.15018,1,1
2,GO TELOMERE ORGANIZATION,0.00038934,0.13287,0.13776,1,1
2,GO LIPID METABOLIC PROCESS,0.0011199,0.13283,0.11064,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0025817,0.13282,0.11717,1,1
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.050569,0.13238,0.13667,1,1
2,GO DNA GEOMETRIC CHANGE,0.00014418,0.13213,0.15335,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00049035,0.13205,0.12337,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.04854,0.13121,0.097599,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.2754e-05,0.13118,0.13638,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00052342,0.13042,0.15987,1,1
2,GO MRNA CLEAVAGE,2.2524e-05,0.12849,0.1658,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.011612,0.12821,0.09855,1,1
2,GO MRNA 3 END PROCESSING,0.00045924,0.12808,0.14323,1,1
2,GO REGULATION OF CELL ADHESION,0.035393,0.12796,0.10496,1,1
2,GO HISTONE PHOSPHORYLATION,0.0090226,0.12784,0.10778,1,1
2,GO OXIDATIVE DEMETHYLATION,0.020205,0.12765,0.092979,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0015189,0.12696,0.098636,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0022332,0.12681,0.13721,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.042857,0.1268,0.083463,1,1
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.046579,0.12674,0.081802,1,1
2,GO STEROL IMPORT,0.01282,0.12604,0.17471,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,9.7346e-05,0.12488,0.11788,1,1
2,GO HISTONE H3 DEACETYLATION,0.019283,0.12442,0.11692,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.0015189,0.12418,0.16255,1,1
2,GO RNA PROCESSING,0.00016595,0.12406,0.15172,1,1
2,GO GENE SILENCING,1.4609e-05,0.12385,0.13436,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.041967,0.12359,0.091026,1,1
2,GO SPROUTING ANGIOGENESIS,0.014138,0.12281,0.14236,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.015574,0.1223,0.1206,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0026572,0.12217,0.14542,1,1
2,GO MRNA METABOLIC PROCESS,0.00017796,0.12179,0.13519,1,1
2,GO PROTEIN SUMOYLATION,0.00012074,0.12162,0.12794,1,1
2,GO STRESS GRANULE ASSEMBLY,0.012203,0.12125,0.11656,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.016339,0.1207,0.11852,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0069616,0.1204,0.10391,1,1
2,GO RESPONSE TO MUSCLE ACTIVITY,0.024288,0.12038,0.18032,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00021909,0.12029,0.1183,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0053338,0.12013,0.14305,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0099891,0.11889,0.15156,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0028957,0.11847,0.10615,1,1
2,GO PROTEIN NEDDYLATION,0.029719,0.1179,0.10556,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00022676,0.11771,0.13518,1,1
2,GO FOCAL ADHESION ASSEMBLY,0.044685,0.11749,0.15245,1,1
2,GO ACTIN NUCLEATION,0.018836,0.11733,0.11748,1,1
2,GO REGULATION OF ORGAN GROWTH,0.044685,0.11715,0.1211,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.0094949,0.11703,0.1006,1,1
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0037331,0.11662,0.091428,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00084609,0.11653,0.15272,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0033369,0.11639,0.10396,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.00035231,0.11606,0.10502,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.017137,0.11562,0.16704,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00042998,0.11559,0.13664,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0022992,0.11526,0.12147,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.02268,0.11509,0.16863,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.02268,0.11326,0.098049,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.015203,0.11295,0.095117,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.046579,0.11292,0.15119,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.0099891,0.11272,0.098411,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00047456,0.11254,0.13846,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.033166,0.11249,0.11698,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.013139,0.11244,0.092192,1,1
2,GO REGULATION OF MRNA 3 END PROCESSING,0.015203,0.11232,0.11,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.027803,0.11186,0.085733,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.033894,0.11167,0.081114,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0018173,0.11141,0.12801,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.02843,0.11116,0.10349,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.011047,0.11097,0.083466,1,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.031748,0.11092,0.13206,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,0.013798,0.1109,0.1266,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.0001165,0.11068,0.16892,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.012508,0.11064,0.11214,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.010506,0.11016,0.10935,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0067808,0.11001,0.12022,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00020448,0.10956,0.14177,1,1
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.020205,0.10936,0.088882,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.00084609,0.10883,0.11147,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0087944,0.10781,0.10084,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.013139,0.1067,0.087767,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.031748,0.10467,0.10111,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.036164,0.10462,0.10478,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.012203,0.10453,0.11572,1,1
2,GO MRNA TRANSPORT,0.00098941,0.10385,0.13743,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00024286,0.1037,0.11292,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.0079323,0.10355,0.24638,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.004408,0.10246,0.096349,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.011326,0.10223,0.12461,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,6.2786e-05,0.10215,0.13018,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0014738,0.10198,0.11941,1,1
2,GO MRNA PROCESSING,0.00098941,0.10175,0.10927,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0022332,0.10162,0.13468,1,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.036164,0.10158,0.11777,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.02068,0.1014,0.0759,1,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.02843,0.10107,0.10756,1,1
2,GO RNA LOCALIZATION,0.00018427,0.098195,0.15138,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0046564,0.098112,0.12286,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0025817,0.097503,0.12772,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.014138,0.096221,0.11691,1,1
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.05161,0.094905,0.10417,1,1
2,GO DNA METHYLATION,0.009256,0.09471,0.090647,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.007729,0.094352,0.098635,1,1
2,GO STEM CELL DIFFERENTIATION,0.010506,0.094058,0.12132,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0059384,0.093334,0.12289,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.05161,0.091497,0.07557,1,1
2,GO DNA CONFORMATION CHANGE,0.0094949,0.090581,0.083715,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.033166,0.09009,0.05905,1,1
2,GO RESPONSE TO UV,0.0054795,0.089115,0.12713,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.029068,0.088773,0.086824,1,1
2,GO RNA SPLICING,0.0020453,0.088566,0.107,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0001165,0.088133,0.11976,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00074557,0.0881,0.11853,1,1
2,GO GLUCOSE METABOLIC PROCESS,0.025414,0.087595,0.056385,1,1
2,GO NUCLEOTIDE EXCISION REPAIR,0.007729,0.087517,0.074423,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.024288,0.087296,0.15212,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.017549,0.08723,0.086512,1,1
2,GO CHROMATIN REMODELING,0.0028141,0.08717,0.097614,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.024288,0.086722,0.099406,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0027346,0.085276,0.13248,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.013465,0.084988,0.07816,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.011904,0.083078,0.08958,1,1
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.05161,0.081166,0.12635,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.031059,0.080511,0.077587,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00092958,0.080457,0.097065,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.015203,0.080293,0.083498,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.018398,0.080161,0.17197,1,1
2,GO HISTONE H3 ACETYLATION,0.0027346,0.079136,0.091673,1,1
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.033166,0.078754,0.15685,1,1
2,GO CELLULAR RESPONSE TO UV,0.0069616,0.078364,0.11375,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.024288,0.077301,0.066165,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.0094949,0.077022,0.090903,1,1
2,GO EPITHELIAL TUBE FORMATION,0.052669,0.076783,0.11943,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.024288,0.07674,0.09339,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.02166,0.073512,0.070546,1,1
2,GO MACROAUTOPHAGY,0.017137,0.0718,0.058488,1,1
2,GO RESPONSE TO RADIATION,0.026586,0.070833,0.063464,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.015203,0.068177,0.080644,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0051916,0.068134,0.076837,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.025994,0.067604,0.060824,1,1
2,GO REGULATION OF GTPASE ACTIVITY,0.046579,0.066185,0.065842,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.023741,0.065549,0.083447,1,1
2,GO DNA METABOLIC PROCESS,0.004408,0.0637,0.06765,1,1
2,GO CELLULAR RESPONSE TO RADIATION,0.052669,0.062614,0.086433,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.017137,0.062306,0.080172,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.043763,0.062204,0.059861,1,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.011326,0.06093,0.084026,1,1
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.042857,0.060125,0.1171,1,1
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.01282,0.059742,0.066338,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.025414,0.059455,0.10878,1,1
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.044685,0.059404,0.068066,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.02268,0.058892,0.11355,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0056288,0.058792,0.05732,1,1
2,GO DNA REPAIR,0.010506,0.056856,0.066843,1,1
2,GO TUBE FORMATION,0.052669,0.051947,0.11581,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.04854,0.051571,0.065494,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.014486,0.048574,0.065694,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
3,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
3,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
3,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
3,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
3,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
3,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
3,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
3,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
3,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
3,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
3,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
3,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
3,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
3,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
3,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
3,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
3,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
3,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
3,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
3,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
3,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
3,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
3,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
3,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
3,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
3,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,1
3,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
3,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
3,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
3,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
3,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
3,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
3,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
3,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
3,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
3,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
3,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
3,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
3,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
3,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,1,1
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
3,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
3,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,1
3,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
3,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
3,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
3,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
3,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
3,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
3,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
3,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
3,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
3,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
3,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0053338,0.25352,0.22196,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
3,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
3,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
3,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
3,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
3,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
3,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
3,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
3,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
3,GO SYNAPTIC VESICLE DOCKING,0.023741,0.22255,0.26474,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
3,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
3,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
3,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
3,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
3,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
3,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,1,1
3,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
3,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
3,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
3,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
3,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
3,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
3,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,1,1
3,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
3,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.05161,0.1833,0.11631,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
3,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
3,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,1,1
3,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
3,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
3,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
3,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.041967,0.16632,0.17031,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
3,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
3,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,1
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.046579,0.15659,0.12563,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
3,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
3,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,1
3,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,1,1
3,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.0046564,0.14683,0.19829,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,1
3,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
3,GO PROTEIN DENEDDYLATION,0.033166,0.14066,0.13452,1,1
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
3,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
3,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
3,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
3,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
3,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
3,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
3,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,1,1
3,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,1
3,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
3,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
3,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
3,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
3,GO MATING,0.033166,0.12237,0.091484,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.014486,0.11788,0.11892,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
3,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,1,1
3,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.001986,0.11376,0.13349,1,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
3,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,1,1
3,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
3,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
3,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
3,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,1
3,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
3,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
3,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
3,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,1,1
3,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
3,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,1,1
3,GO METHYLATION,0.033166,0.032322,0.058393,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,4.4878e-05,1.6643,1.332,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,4.8379e-05,1.3282,1.0595,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,1.1267e-06,1.2926,1.2044,1,1
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.3127e-06,0.90295,0.78564,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00034072,0.88801,0.71686,1,1
4,GO CYTIDINE TO URIDINE EDITING,4.8379e-05,0.87532,0.73085,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.5201e-05,0.84588,0.64061,1,1
4,GO TOLERANCE INDUCTION,7.9801e-06,0.79848,0.74312,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.104e-05,0.77816,0.76592,1,1
4,GO MUCUS SECRETION,9.7346e-05,0.76818,0.64826,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00023468,0.76582,0.57149,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,7.6603e-06,0.73848,0.63264,1,1
4,GO HISTAMINE SECRETION,1.4268e-07,0.73013,0.79058,1,1
4,GO LIPID DROPLET FORMATION,5.753e-07,0.7282,0.75666,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,1.9263e-05,0.70915,0.63959,1,1
4,GO EOSINOPHIL CHEMOTAXIS,2.6307e-05,0.70833,0.53276,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0071468,0.67171,0.41655,1,1
4,GO RESPONSE TO TYPE I INTERFERON,3.6228e-06,0.66205,0.65334,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,9.7346e-05,0.66063,0.54153,1,1
4,GO HISTAMINE TRANSPORT,2.0829e-07,0.65361,0.73368,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,3.1888e-05,0.65203,0.53229,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,6.5149e-05,0.65046,0.55737,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.00031859,0.64318,0.4998,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.1237e-07,0.64091,0.62291,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.00010462,0.63721,0.76857,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,1.0184e-05,0.63619,0.50321,1,1
4,GO EOSINOPHIL MIGRATION,3.7145e-05,0.635,0.50896,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,7.0571e-06,0.62672,0.53568,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.00016595,0.6267,0.48896,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,2.2524e-05,0.62499,0.60278,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00017186,0.62185,0.65265,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,2.7343e-05,0.61712,0.59127,1,1
4,GO GERMINAL CENTER FORMATION,0.00027832,0.616,0.46725,1,1
4,GO MATURE B CELL DIFFERENTIATION,3.3132e-05,0.61012,0.44719,1,1
4,GO RENAL ABSORPTION,3.1888e-05,0.60893,0.64507,1,1
4,GO INTESTINAL ABSORPTION,1.1788e-07,0.60799,0.67836,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00069957,0.6077,0.50629,1,1
4,GO SEROTONIN METABOLIC PROCESS,2.9532e-05,0.60488,0.5984,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00022676,0.6045,0.43797,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,5.6174e-05,0.60097,0.58407,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,5.7413e-06,0.60091,0.58009,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,4.4712e-06,0.60002,0.57652,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.7323e-05,0.59818,0.53808,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,3.6228e-06,0.5977,0.59854,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,8.2505e-07,0.59359,0.53704,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,8.628e-07,0.58873,0.50778,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.8251e-06,0.58576,0.60975,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,9.7346e-05,0.58478,0.6094,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,4.4878e-05,0.58169,0.49069,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,2.2658e-06,0.5764,0.57014,1,1
4,GO DETECTION OF OTHER ORGANISM,1.3441e-06,0.57504,0.63087,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.2308e-06,0.57367,0.56723,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00017796,0.57125,0.54992,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.0021062,0.56936,0.71037,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.0006154,0.56841,0.54981,1,1
4,GO ADHESION OF SYMBIONT TO HOST,0.00011241,0.56592,0.4787,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.00028792,0.5566,0.46402,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0069616,0.55442,0.47978,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,6.7596e-05,0.5529,0.4816,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,9.389e-05,0.54781,0.41477,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00027832,0.54408,0.51357,1,1
4,GO O GLYCAN PROCESSING,5.2533e-07,0.54305,0.53197,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.5308e-05,0.5404,0.52384,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,9.389e-05,0.53894,0.43567,1,1
4,GO TOXIN METABOLIC PROCESS,2.6902e-06,0.53844,0.52177,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,9.0551e-05,0.53727,0.55072,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.0683e-06,0.53547,0.53702,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00059588,0.53497,0.46489,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,8.1192e-05,0.53324,0.4905,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.2505e-07,0.53172,0.56869,1,1
4,GO KETONE CATABOLIC PROCESS,0.00010845,0.53151,0.47726,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,4.6597e-05,0.53059,0.59294,1,1
4,GO REGULATION OF PLATELET AGGREGATION,2.6307e-05,0.52876,0.48719,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,2.5308e-05,0.52772,0.65785,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,2.4346e-05,0.52345,0.50699,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.0010528,0.522,0.41546,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00012074,0.52109,0.4012,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00021909,0.52039,0.53155,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.4609e-05,0.51654,0.50493,1,1
4,GO RESPONSE TO EPINEPHRINE,0.001872,0.51035,0.36955,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.3132e-05,0.50847,0.47338,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.9801e-06,0.50785,0.51149,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,2.1702e-06,0.50771,0.50508,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.0006154,0.50765,0.48962,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,3.8583e-05,0.50746,0.48154,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0071468,0.50743,0.34224,1,1
4,GO RESPONSE TO COLD,7.2111e-07,0.49689,0.45466,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0017641,0.49544,0.37839,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00035231,0.4949,0.52959,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.6414e-07,0.49426,0.4666,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,4.0073e-05,0.49381,0.4622,1,1
4,GO ACTIN FILAMENT SEVERING,0.00037661,0.49226,0.41909,1,1
4,GO LIPID DIGESTION,7.2754e-05,0.49113,0.56795,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0099891,0.48947,0.49794,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00025131,0.48639,0.48821,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.0042883,0.48491,0.43396,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00010845,0.48408,0.39343,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0001547,0.48394,0.43593,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,3.7791e-06,0.48333,0.4757,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.00054072,0.47659,0.38235,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00010462,0.4749,0.36314,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00092958,0.47287,0.44188,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00026903,0.4726,0.38044,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,3.3287e-06,0.47244,0.43617,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,1.2962e-05,0.4714,0.47278,1,1
4,GO INTESTINAL LIPID ABSORPTION,1.4609e-05,0.47058,0.63648,1,1
4,GO REGULATION OF PLATELET ACTIVATION,2.3654e-06,0.47025,0.45004,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0010528,0.47018,0.45749,1,1
4,GO RESPONSE TO DIETARY EXCESS,2.0033e-05,0.46774,0.46041,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00092958,0.46637,0.38416,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,6.4994e-06,0.46518,0.51347,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,9.0551e-05,0.46206,0.51686,1,1
4,GO REGULATION OF ANOIKIS,3.7145e-05,0.46161,0.51446,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,2.2879e-07,0.46157,0.47008,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,3.8583e-05,0.46138,0.41166,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,2.5308e-05,0.46117,0.41346,1,1
4,GO RESPONSE TO REDOX STATE,2.7343e-05,0.4565,0.3938,1,1
4,GO REGULATION OF BONE REMODELING,2.4692e-06,0.4563,0.44936,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,8.3127e-06,0.45616,0.41357,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,6.7596e-05,0.45412,0.52354,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,2.9532e-05,0.45388,0.49085,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00027832,0.45333,0.36988,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.1888e-05,0.45244,0.4227,1,1
4,GO REGULATION OF ACROSOME REACTION,0.00017186,0.45083,0.44396,1,1
4,GO ZYMOGEN ACTIVATION,0.00011241,0.45031,0.40312,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00049035,0.44912,0.38427,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00028792,0.44804,0.3903,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00012512,0.44732,0.47018,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,7.2754e-05,0.4452,0.41305,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,3.7791e-06,0.44519,0.45953,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,5.7413e-06,0.4441,0.44202,1,1
4,GO BONE RESORPTION,1.0779e-06,0.44246,0.446,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00017186,0.4421,0.39286,1,1
4,GO QUINONE METABOLIC PROCESS,0.00013917,0.44188,0.57815,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,6.5149e-05,0.44017,0.35063,1,1
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.024288,0.43999,0.29724,1,1
4,GO MICROVILLUS ORGANIZATION,0.00079435,0.43977,0.36368,1,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,6.2786e-05,0.43938,0.45411,1,1
4,GO RESPONSE TO STEROL DEPLETION,9.3916e-06,0.43925,0.48569,1,1
4,GO INSEMINATION,0.00017796,0.43903,0.41333,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.001662,0.43885,0.34849,1,1
4,GO REGULATION OF TISSUE REMODELING,4.1112e-06,0.43875,0.39577,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,2.6307e-05,0.43866,0.45893,1,1
4,GO SIGNAL PEPTIDE PROCESSING,1.104e-05,0.43827,0.4406,1,1
4,GO LIVER MORPHOGENESIS,5.4121e-05,0.43779,0.40583,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.00014935,0.43775,0.38817,1,1
4,GO GALACTOSE METABOLIC PROCESS,0.0021689,0.4369,0.4482,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,4.6597e-05,0.43678,0.3998,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,9.0179e-06,0.43613,0.41297,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00027832,0.43498,0.47586,1,1
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.0018173,0.43323,0.45409,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00017796,0.43283,0.35134,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00026003,0.43277,0.3777,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,7.547e-05,0.43262,0.41844,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0010528,0.43096,0.38488,1,1
4,GO IMMUNOGLOBULIN SECRETION,3.0689e-05,0.4306,0.3953,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.2524e-05,0.43023,0.40444,1,1
4,GO REGULATION OF NEURON MATURATION,0.00020448,0.4297,0.35391,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,9.0551e-05,0.4289,0.37972,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,2.3654e-06,0.42794,0.42583,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,1.2454e-05,0.42576,0.36945,1,1
4,GO PARTURITION,0.010506,0.42557,0.28295,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00098941,0.42506,0.40545,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.014841,0.42466,0.34184,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.0604e-05,0.42452,0.33737,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,2.2524e-05,0.42364,0.3802,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,7.8282e-05,0.42207,0.3327,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0024367,0.42138,0.38398,1,1
4,GO PLASMINOGEN ACTIVATION,0.0026572,0.42061,0.3948,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,2.4692e-06,0.42049,0.47411,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,2.5308e-05,0.41947,0.40552,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.8077e-06,0.41896,0.46553,1,1
4,GO B CELL APOPTOTIC PROCESS,5.0194e-07,0.41876,0.46959,1,1
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.012508,0.41843,0.33148,1,1
4,GO L PHENYLALANINE METABOLIC PROCESS,0.00047456,0.41786,0.58192,1,1
4,GO CELLULAR DEFENSE RESPONSE,8.6584e-06,0.41768,0.4027,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,1.9263e-05,0.41707,0.35887,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0010859,0.41676,0.32843,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,1.1267e-06,0.4166,0.36804,1,1
4,GO T CELL MEDIATED IMMUNITY,0.00013433,0.41651,0.32212,1,1
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.0031536,0.41607,0.42588,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00055855,0.413,0.32944,1,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.001191,0.41176,0.29286,1,1
4,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.023205,0.41161,0.25807,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,3.4421e-05,0.4112,0.38532,1,1
4,GO PROTEIN DEMANNOSYLATION,2.6307e-05,0.41112,0.41011,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,8.1192e-05,0.41045,0.40464,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,2.8418e-05,0.41013,0.41948,1,1
4,GO VITAMIN D METABOLIC PROCESS,1.1493e-05,0.41001,0.40106,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00044439,0.4099,0.38547,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0013872,0.40875,0.37207,1,1
4,GO FOAM CELL DIFFERENTIATION,1.7118e-05,0.40809,0.33499,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,1.349e-05,0.40634,0.38473,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00063551,0.40634,0.33381,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0011199,0.40573,0.37036,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00012964,0.40505,0.40491,1,1
4,GO RESPONSE TO INTERFERON GAMMA,6.5149e-05,0.4038,0.34964,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,4.8379e-05,0.40314,0.34282,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.0018173,0.40298,0.38489,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,4.4712e-06,0.40206,0.36733,1,1
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0015653,0.40188,0.37773,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.5201e-05,0.40164,0.35429,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.9841e-06,0.4014,0.37898,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.1904e-06,0.40127,0.40675,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,1.0184e-05,0.39919,0.37903,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00018427,0.39914,0.48966,1,1
4,GO VITAMIN D BIOSYNTHETIC PROCESS,6.0504e-05,0.39883,0.39568,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0001547,0.39877,0.27787,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.001662,0.39844,0.41622,1,1
4,GO MUSCLE ATROPHY,0.0050528,0.39736,0.27454,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00034072,0.39693,0.29728,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,1.8251e-06,0.39654,0.34069,1,1
4,GO LUNG CELL DIFFERENTIATION,0.00054072,0.39634,0.44046,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0094949,0.39619,0.35561,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,7.8282e-05,0.39616,0.31521,1,1
4,GO STEROID ESTERIFICATION,0.00092958,0.39615,0.42252,1,1
4,GO RESPONSE TO THYROID HORMONE,0.00069957,0.39571,0.28531,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0010528,0.39436,0.31581,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00084609,0.39378,0.47931,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00012074,0.39346,0.32037,1,1
4,GO RESPONSE TO LITHIUM ION,1.9904e-06,0.39243,0.50975,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.3287e-06,0.39231,0.42557,1,1
4,GO DIGESTION,8.3127e-06,0.39193,0.34562,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,8.628e-07,0.39147,0.39109,1,1
4,GO DIGESTIVE SYSTEM PROCESS,4.2876e-06,0.39141,0.33044,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00037661,0.39117,0.4559,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00040247,0.39085,0.33217,1,1
4,GO RETINAL METABOLIC PROCESS,0.0010206,0.38968,0.51808,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00029782,0.38964,0.37405,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00029782,0.38794,0.4518,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.1831e-07,0.38702,0.3945,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0047853,0.3867,0.43582,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,4.3218e-05,0.38613,0.35081,1,1
4,GO DEFENSE RESPONSE TO VIRUS,5.0226e-05,0.38613,0.29726,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.0604e-05,0.38574,0.35787,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.00084609,0.38562,0.5548,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00036427,0.38505,0.38459,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.3654e-06,0.38489,0.47187,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,6.5149e-05,0.38464,0.33803,1,1
4,GO REGULATION OF VASCULOGENESIS,0.00038934,0.38453,0.3895,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,9.3916e-06,0.38441,0.31077,1,1
4,GO ANOIKIS,1.2454e-05,0.38393,0.39835,1,1
4,GO VASODILATION,0.00023468,0.38393,0.39145,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.0311e-06,0.38176,0.38607,1,1
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0013054,0.38156,0.39683,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00014935,0.38134,0.36415,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00026003,0.38092,0.34107,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.00069957,0.38088,0.30301,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0024367,0.38065,0.33265,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,8.3127e-06,0.37869,0.37577,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00059588,0.3757,0.31565,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00098941,0.3757,0.3139,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,8.7323e-05,0.37561,0.30787,1,1
4,GO ACUTE PHASE RESPONSE,9.7346e-05,0.37529,0.33656,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0036303,0.37501,0.25518,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,7.2754e-05,0.37436,0.35723,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,7.3528e-06,0.37397,0.34107,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,3.3132e-05,0.37312,0.32776,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,9.4334e-07,0.37261,0.36223,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0036303,0.37254,0.45187,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.0025817,0.37233,0.34201,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,7.8282e-05,0.37224,0.41592,1,1
4,GO SUPEROXIDE ANION GENERATION,0.00037661,0.3717,0.37257,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,1.7806e-05,0.37151,0.3237,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,7.3528e-06,0.37091,0.32279,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.2524e-05,0.37071,0.42794,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.6174e-05,0.37061,0.30989,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00019753,0.37054,0.30709,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.001662,0.37044,0.3639,1,1
4,GO NATURAL KILLER CELL PROLIFERATION,0.00037661,0.37032,0.36506,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,1.1493e-05,0.36967,0.34149,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,3.0689e-05,0.36938,0.37483,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.00019079,0.36893,0.38156,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0015189,0.36886,0.3108,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,3.0689e-05,0.36822,0.30423,1,1
4,GO LIPID TRANSLOCATION,1.104e-05,0.36796,0.31382,1,1
4,GO TISSUE REMODELING,1.349e-05,0.36757,0.32001,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.7801e-06,0.36748,0.35447,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.00036427,0.36725,0.24584,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0042883,0.36696,0.29366,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,9.8628e-07,0.36681,0.37114,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.00081984,0.36499,0.2548,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00013917,0.3645,0.35283,1,1
4,GO REGULATION OF ICOSANOID SECRETION,2.1831e-07,0.36362,0.43501,1,1
4,GO REGULATION OF COAGULATION,0.00029782,0.36332,0.31394,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0017641,0.36307,0.28233,1,1
4,GO RESPONSE TO COPPER ION,0.00050664,0.36221,0.44339,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00095906,0.36177,0.36331,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,3.7791e-06,0.36075,0.36888,1,1
4,GO RESPONSE TO MAGNESIUM ION,0.00036427,0.36047,0.41654,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00041602,0.36002,0.34203,1,1
4,GO RESPONSE TO INTERLEUKIN 2,5.0226e-05,0.35966,0.30468,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0013054,0.35917,0.26425,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00017796,0.35869,0.32287,1,1
4,GO VIRAL GENOME REPLICATION,8.7323e-05,0.35831,0.2824,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00042998,0.35821,0.3309,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0028141,0.35807,0.29904,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.00010462,0.3575,0.33007,1,1
4,GO B CELL MEDIATED IMMUNITY,0.00021167,0.35743,0.25433,1,1
4,GO RESPONSE TO WATER,0.0025083,0.35662,0.3051,1,1
4,GO ETHER METABOLIC PROCESS,0.00034072,0.35661,0.26781,1,1
4,GO REGULATION OF RESPIRATORY BURST,3.3132e-05,0.356,0.38076,1,1
4,GO EPITHELIAL CELL FATE COMMITMENT,0.0027346,0.3554,0.31398,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,6.0504e-05,0.35533,0.26571,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,3.1888e-05,0.3553,0.35632,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0011549,0.35463,0.30443,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00010845,0.35445,0.31047,1,1
4,GO BONE REMODELING,7.9801e-06,0.35442,0.36566,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0031536,0.35346,0.27811,1,1
4,GO STEROL HOMEOSTASIS,6.0504e-05,0.35303,0.34343,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00018427,0.35276,0.26052,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,3.0689e-05,0.35265,0.30819,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00049035,0.35203,0.28942,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2962e-05,0.35143,0.29013,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,8.6584e-06,0.35128,0.37601,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,2.6307e-05,0.35102,0.35317,1,1
4,GO MAGNESIUM ION TRANSPORT,2.5308e-05,0.34988,0.32443,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,3.3132e-05,0.34972,0.30194,1,1
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00026003,0.34961,0.32044,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,1.104e-05,0.3495,0.26845,1,1
4,GO ETHANOL OXIDATION,0.004408,0.34893,0.46405,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010462,0.34805,0.24813,1,1
4,GO N GLYCAN PROCESSING,0.001872,0.34777,0.29003,1,1
4,GO FUCOSE METABOLIC PROCESS,0.007729,0.34715,0.30927,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00044439,0.34708,0.25882,1,1
4,GO PHAGOSOME ACIDIFICATION,2.4692e-06,0.34703,0.36089,1,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0097392,0.34685,0.26685,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00017186,0.34617,0.27905,1,1
4,GO REGULATION OF FERTILIZATION,1.4609e-05,0.34615,0.36835,1,1
4,GO MYOBLAST FUSION,0.0001547,0.34615,0.28378,1,1
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.031748,0.34606,0.26756,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,4.1617e-05,0.34592,0.36154,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0015189,0.3452,0.31425,1,1
4,GO LYTIC VACUOLE ORGANIZATION,3.4772e-07,0.34517,0.35757,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0019282,0.34508,0.29177,1,1
4,GO DIET INDUCED THERMOGENESIS,8.7323e-05,0.34457,0.30979,1,1
4,GO LIPID DROPLET ORGANIZATION,1.0604e-05,0.34421,0.31514,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,5.2837e-06,0.34392,0.31161,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0006154,0.34369,0.23249,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00016595,0.34296,0.30869,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.0073e-05,0.34261,0.38845,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.019739,0.34213,0.26183,1,1
4,GO REGULATION OF B CELL PROLIFERATION,1.2862e-06,0.34144,0.36412,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.011326,0.34143,0.30452,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.0033369,0.3414,0.25962,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00054072,0.34124,0.40601,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00010092,0.34116,0.35083,1,1
4,GO ICOSANOID METABOLIC PROCESS,3.3132e-05,0.34061,0.35228,1,1
4,GO STEROL METABOLIC PROCESS,3.7791e-06,0.34058,0.30283,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00017796,0.34043,0.29595,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.3218e-05,0.33995,0.35442,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.2754e-05,0.33942,0.25357,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0015189,0.33912,0.36024,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,4.3218e-05,0.33857,0.33162,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,3.3132e-05,0.33837,0.30263,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.7413e-06,0.33803,0.30051,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,4.4878e-05,0.33768,0.38789,1,1
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.0031536,0.33756,0.23112,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,1.6455e-05,0.3371,0.32653,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,0.00012512,0.33626,0.3243,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,4.8612e-06,0.33605,0.35182,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,3.3287e-06,0.33602,0.3031,1,1
4,GO KERATINIZATION,5.508e-06,0.33601,0.3082,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0012662,0.33575,0.37527,1,1
4,GO REGULATION OF CELL KILLING,1.349e-05,0.33559,0.33695,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,4.8379e-05,0.33538,0.3513,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0014299,0.33504,0.29755,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,6.2367e-06,0.33476,0.30339,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.00028792,0.33443,0.28797,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.9263e-05,0.33402,0.28048,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.00019753,0.33363,0.28501,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,6.0504e-05,0.33252,0.25599,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00052342,0.33184,0.27697,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.7145e-05,0.33182,0.32765,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.00021909,0.3317,0.31222,1,1
4,GO CORNIFICATION,9.7801e-06,0.33161,0.34567,1,1
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00074557,0.33124,0.33284,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0001547,0.33118,0.24925,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001986,0.33058,0.24474,1,1
4,GO INNATE IMMUNE RESPONSE,1.1964e-05,0.3304,0.26438,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.6455e-05,0.33039,0.28847,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.01282,0.33015,0.26193,1,1
4,GO CELL KILLING,2.2658e-06,0.33,0.28553,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0050528,0.32937,0.2871,1,1
4,GO EPOXYGENASE P450 PATHWAY,0.025414,0.32925,0.2509,1,1
4,GO IMMUNE EFFECTOR PROCESS,2.1663e-05,0.3288,0.25556,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.2139e-05,0.32867,0.29293,1,1
4,GO TYPE I INTERFERON PRODUCTION,3.0689e-05,0.32848,0.26986,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011199,0.32792,0.25151,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012964,0.32754,0.41498,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.00074557,0.32713,0.29328,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.547e-05,0.32679,0.27114,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,1.349e-05,0.32667,0.31663,1,1
4,GO REGULATION OF WOUND HEALING,0.00014935,0.32558,0.2849,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,6.7596e-05,0.32528,0.26453,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00017796,0.32418,0.24075,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0014299,0.32376,0.25077,1,1
4,GO STEROID HORMONE SECRETION,0.0019282,0.32371,0.27158,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,3.8583e-05,0.32356,0.36298,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00036427,0.32348,0.30104,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00014935,0.32342,0.37151,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00040247,0.32336,0.25047,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00026903,0.3227,0.27687,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00024286,0.32219,0.34264,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,1.0184e-05,0.32218,0.25484,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0018173,0.32214,0.24781,1,1
4,GO APICAL JUNCTION ASSEMBLY,1.5201e-05,0.32178,0.37267,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,6.0504e-05,0.32177,0.36997,1,1
4,GO STEROID METABOLIC PROCESS,5.0683e-06,0.32163,0.31648,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.0032441,0.32057,0.26254,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0024367,0.31983,0.28751,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0001165,0.3198,0.36535,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.4994e-06,0.3197,0.29425,1,1
4,GO PLATELET DEGRANULATION,0.0015653,0.31951,0.22844,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.3418e-05,0.31941,0.33943,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00019079,0.31933,0.26434,1,1
4,GO MAST CELL ACTIVATION,2.2524e-05,0.31927,0.29247,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0001547,0.31916,0.22506,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.001872,0.31905,0.21453,1,1
4,GO RESPONSE TO VIRUS,4.8379e-05,0.31871,0.2558,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00063551,0.31817,0.37455,1,1
4,GO MAST CELL MEDIATED IMMUNITY,4.3218e-05,0.31812,0.28813,1,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,9.389e-05,0.31794,0.39664,1,1
4,GO PROTEIN DEGLYCOSYLATION,7.547e-05,0.31783,0.37401,1,1
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00095906,0.31774,0.27721,1,1
4,GO RETINOL METABOLIC PROCESS,0.00014935,0.31713,0.40854,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0085714,0.31679,0.22933,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,7.3528e-06,0.3166,0.37149,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0081404,0.31656,0.33268,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00054072,0.31651,0.32022,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,9.389e-05,0.31628,0.2762,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00016595,0.31617,0.28566,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.0179e-06,0.3159,0.2673,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0046564,0.31579,0.19076,1,1
4,GO ADRENAL GLAND DEVELOPMENT,0.00027832,0.31537,0.40509,1,1
4,GO B CELL PROLIFERATION,2.5774e-06,0.31511,0.29009,1,1
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0079323,0.31484,0.28989,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00031859,0.31456,0.22675,1,1
4,GO UBIQUINONE METABOLIC PROCESS,4.4878e-05,0.31423,0.30601,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,1.2962e-05,0.3137,0.33101,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.2139e-05,0.31355,0.25821,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.5816e-05,0.31267,0.26687,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.018398,0.31252,0.24132,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,2.4346e-05,0.31236,0.26496,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.00055855,0.31161,0.28225,1,1
4,GO REGULATION OF B CELL ACTIVATION,8.6584e-06,0.31129,0.26655,1,1
4,GO REGULATION OF ACTIN NUCLEATION,4.1617e-05,0.31106,0.33338,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.3528e-06,0.31085,0.3118,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.001872,0.31084,0.35213,1,1
4,GO TRNA CATABOLIC PROCESS,0.010245,0.31084,0.31856,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00019753,0.3103,0.22926,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00026003,0.31025,0.32115,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00024286,0.30929,0.39586,1,1
4,GO METHIONINE METABOLIC PROCESS,4.0073e-05,0.30855,0.31125,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.007729,0.30809,0.23987,1,1
4,GO GLYCOSYLATION,2.4692e-06,0.30808,0.31008,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.027188,0.3078,0.16338,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00063551,0.30776,0.28866,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.9301e-06,0.30749,0.27251,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.4772e-07,0.30715,0.31772,1,1
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.0056288,0.30709,0.23926,1,1
4,GO INTERLEUKIN 12 PRODUCTION,1.906e-06,0.30703,0.32707,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00055855,0.3069,0.3066,1,1
4,GO RESPONSE TO GROWTH HORMONE,3.4421e-05,0.3068,0.3439,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0025083,0.30662,0.21929,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.5308e-05,0.30658,0.27727,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,9.7346e-05,0.3065,0.25455,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,4.0073e-05,0.3064,0.25828,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0038387,0.30573,0.29832,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.7118e-05,0.30526,0.26739,1,1
4,GO LIPID LOCALIZATION,2.6902e-06,0.30521,0.27855,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.001872,0.30503,0.26916,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00013917,0.30487,0.24859,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00054072,0.30467,0.41358,1,1
4,GO T CELL CYTOKINE PRODUCTION,0.0022332,0.3045,0.22485,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.3127e-06,0.3044,0.34218,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.7343e-05,0.30427,0.24282,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00036427,0.30423,0.35831,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.015203,0.30417,0.2241,1,1
4,GO VACUOLAR ACIDIFICATION,4.2876e-06,0.30365,0.35869,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,9.0221e-07,0.30322,0.31866,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,6.5149e-05,0.30303,0.32751,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00081984,0.30301,0.26229,1,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.0037331,0.30299,0.20849,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,3.7145e-05,0.30295,0.34086,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.00030804,0.3027,0.25975,1,1
4,GO B CELL HOMEOSTASIS,5.2139e-05,0.3019,0.28619,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.00012512,0.30189,0.3765,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00055855,0.30165,0.25984,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0029794,0.30127,0.29574,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.019739,0.30123,0.1664,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.0010528,0.30108,0.37335,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.00025131,0.30104,0.21992,1,1
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.018836,0.30072,0.31608,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.3132e-05,0.30069,0.2587,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.0010528,0.30043,0.22486,1,1
4,GO WATER HOMEOSTASIS,2.3418e-05,0.30025,0.29538,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00019079,0.29997,0.26578,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00026903,0.29977,0.35713,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00042998,0.29966,0.33611,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,3.3132e-05,0.29962,0.25253,1,1
4,GO BILE ACID METABOLIC PROCESS,1.4039e-05,0.29912,0.36592,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.3218e-05,0.29856,0.26855,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,0.00021909,0.29816,0.27126,1,1
4,GO RESPIRATORY BURST,0.00018427,0.29796,0.27325,1,1
4,GO FUCOSYLATION,0.001228,0.29784,0.30757,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,7.8282e-05,0.29751,0.23322,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.2139e-05,0.29721,0.25951,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00038934,0.29671,0.21257,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0028141,0.29662,0.19925,1,1
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0099891,0.29632,0.24962,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,8.1192e-05,0.29631,0.29408,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,7.013e-05,0.29623,0.30572,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00016595,0.29608,0.28192,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.017549,0.29593,0.24531,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.00012512,0.29592,0.27583,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.9418e-06,0.29563,0.26017,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00010092,0.29548,0.34286,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.00052342,0.29529,0.2621,1,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.0037331,0.29524,0.2379,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,4.0073e-05,0.29522,0.32287,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,3.0689e-05,0.29516,0.25621,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.29439,0.2494,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00035231,0.29433,0.4784,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0015653,0.29414,0.30551,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.001191,0.2941,0.205,1,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.0010859,0.29326,0.41698,1,1
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.010245,0.29307,0.29476,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0028957,0.29286,0.27368,1,1
4,GO POLYOL TRANSPORT,0.00021909,0.29263,0.35115,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00054072,0.29231,0.26968,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00090094,0.29231,0.35256,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.6584e-06,0.29225,0.34003,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.00026003,0.29207,0.31375,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00047456,0.29205,0.22044,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00063551,0.2919,0.27052,1,1
4,GO INTERLEUKIN 6 PRODUCTION,1.8521e-05,0.29186,0.2442,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,9.0221e-07,0.29159,0.2816,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00028792,0.29157,0.21663,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00069957,0.2909,0.33681,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0015189,0.29082,0.20586,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00012964,0.29042,0.27546,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.033894,0.29027,0.26063,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.349e-05,0.29024,0.29436,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,1.7806e-05,0.28973,0.32206,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0011549,0.28949,0.35101,1,1
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00036427,0.28946,0.32826,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00016595,0.28939,0.32586,1,1
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.011047,0.28938,0.20778,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0037331,0.28853,0.19109,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00035231,0.2885,0.23464,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.001191,0.2885,0.26887,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00037661,0.28833,0.2303,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.0013054,0.28833,0.26493,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.0006154,0.28827,0.27805,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,5.2139e-05,0.28812,0.31145,1,1
4,GO INTEGRIN ACTIVATION,3.4421e-05,0.28796,0.30828,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,2.9301e-06,0.28746,0.2742,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0021689,0.2874,0.30855,1,1
4,GO DEFENSE RESPONSE,1.2962e-05,0.28718,0.23778,1,1
4,GO INTERLEUKIN 10 PRODUCTION,4.1617e-05,0.28714,0.27088,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00034072,0.28707,0.354,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0019282,0.28704,0.2878,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.00025131,0.2869,0.25205,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.00026903,0.28661,0.34518,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.00011241,0.28652,0.2542,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.0046564,0.28647,0.34279,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,2.7343e-05,0.28613,0.26675,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0025083,0.28607,0.24302,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0024367,0.28599,0.24969,1,1
4,GO TRANSPOSITION,0.0036303,0.28564,0.28204,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00055855,0.28559,0.23739,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00081984,0.2854,0.24341,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.9532e-05,0.28522,0.2433,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00035231,0.28508,0.23429,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00045924,0.28467,0.23168,1,1
4,GO INTERLEUKIN 13 PRODUCTION,0.022165,0.28458,0.21645,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00017796,0.28375,0.23379,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0034322,0.28358,0.19502,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00014418,0.28335,0.29875,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00087311,0.28297,0.27898,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0085714,0.28252,0.27975,1,1
4,GO LEUKOCYTE PROLIFERATION,5.0226e-05,0.28242,0.22742,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,4.1112e-06,0.28231,0.29704,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0017641,0.28216,0.29268,1,1
4,GO LUNG EPITHELIUM DEVELOPMENT,0.0097392,0.28193,0.24231,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.01282,0.28187,0.21448,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0023671,0.28153,0.23777,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.001228,0.28136,0.28771,1,1
4,GO PHOSPHOLIPID TRANSPORT,4.1112e-06,0.2811,0.25307,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00011241,0.28096,0.26843,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.3418e-05,0.28051,0.29963,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00050664,0.28048,0.25915,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00057693,0.28038,0.25409,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00090094,0.28036,0.18661,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,8.7323e-05,0.28,0.302,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00013917,0.27943,0.21233,1,1
4,GO CELLULAR RESPONSE TO STARVATION,3.1904e-06,0.27942,0.26212,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.1964e-05,0.27919,0.3123,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,3.4421e-05,0.27914,0.26247,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,7.2754e-05,0.27909,0.29487,1,1
4,GO HAIR CELL DIFFERENTIATION,0.00017186,0.27896,0.24362,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,6.7596e-05,0.2788,0.24827,1,1
4,GO VITAMIN CATABOLIC PROCESS,0.02268,0.27866,0.27482,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,5.9841e-06,0.27847,0.25704,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,1.5816e-05,0.27786,0.24752,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0011549,0.27785,0.35404,1,1
4,GO AMELOGENESIS,0.0046564,0.27758,0.23773,1,1
4,GO ENDOCRINE PROCESS,8.7323e-05,0.27722,0.26944,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.0604e-05,0.27721,0.27457,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.00052342,0.27702,0.26938,1,1
4,GO GDP METABOLIC PROCESS,0.012508,0.277,0.23624,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.27678,0.24348,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,2.9301e-06,0.27672,0.26106,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.013139,0.27629,0.31538,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,2.7343e-05,0.27626,0.21543,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.001986,0.27608,0.18042,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0007696,0.27607,0.26912,1,1
4,GO RESPONSE TO TUMOR CELL,0.00098941,0.27601,0.31161,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,4.6597e-05,0.27584,0.27707,1,1
4,GO RESPONSE TO ACIDIC PH,0.0099891,0.27562,0.24756,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.00021167,0.27537,0.23241,1,1
4,GO PHOSPHOLIPID EFFLUX,0.0019282,0.27536,0.33416,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00090094,0.27525,0.26344,1,1
4,GO AMINE METABOLIC PROCESS,1.3441e-06,0.27516,0.29274,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,1.4039e-05,0.27508,0.28113,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,4.4878e-05,0.27503,0.25818,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0033369,0.27499,0.2246,1,1
4,GO LIPID STORAGE,0.00012964,0.27492,0.26646,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00041602,0.2749,0.29293,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00040247,0.27478,0.20427,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00010845,0.27476,0.23944,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.0025083,0.27475,0.21567,1,1
4,GO OSTEOBLAST PROLIFERATION,0.0026572,0.2746,0.24783,1,1
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0059384,0.27447,0.30823,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.014486,0.2744,0.23082,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00026003,0.27416,0.22771,1,1
4,GO STEROL TRANSPORT,0.00012964,0.27395,0.2626,1,1
4,GO BONE CELL DEVELOPMENT,0.0036303,0.27388,0.19749,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.020205,0.27382,0.22038,1,1
4,GO DIOL METABOLIC PROCESS,4.8379e-05,0.2736,0.34422,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.011612,0.27353,0.2757,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00090094,0.27341,0.20629,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.017969,0.27305,0.20722,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00095906,0.27246,0.2379,1,1
4,GO RESPONSE TO FATTY ACID,0.0006154,0.27234,0.22108,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0013457,0.27219,0.24854,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.009256,0.27183,0.23134,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,5.0194e-07,0.27153,0.26761,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,0.00029782,0.27149,0.28674,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.00022676,0.2711,0.27008,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.0033e-05,0.27076,0.3063,1,1
4,GO ALANINE TRANSPORT,0.0029794,0.27024,0.28417,1,1
4,GO CHEMOKINE PRODUCTION,0.0012662,0.26967,0.20004,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0069616,0.2696,0.23345,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.906e-06,0.26941,0.32128,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0021062,0.26887,0.19688,1,1
4,GO TISSUE HOMEOSTASIS,2.7343e-05,0.26871,0.22388,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,1.7806e-05,0.26853,0.24922,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.036948,0.26832,0.23232,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0049174,0.26823,0.35057,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00079435,0.26765,0.28558,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,9.0179e-06,0.26765,0.26092,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.0030654,0.26757,0.21576,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00038934,0.26749,0.23776,1,1
4,GO RESPONSE TO NUTRIENT,0.0050528,0.26733,0.15964,1,1
4,GO INTERLEUKIN 4 PRODUCTION,0.007729,0.26702,0.19915,1,1
4,GO DRUG METABOLIC PROCESS,0.00042998,0.26696,0.32471,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,9.7801e-06,0.26685,0.26793,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,1.8521e-05,0.26674,0.34369,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0010859,0.26671,0.2481,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00036427,0.26636,0.23651,1,1
4,GO CYTOPLASM ORGANIZATION,0.00081984,0.26633,0.2819,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,9.389e-05,0.26624,0.26178,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,5.6174e-05,0.26612,0.29637,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.5308e-05,0.26603,0.24304,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0028141,0.26602,0.22801,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.1617e-05,0.26598,0.24522,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,1.6729e-06,0.26531,0.40306,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,2.4346e-05,0.26522,0.25772,1,1
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0079323,0.26484,0.25034,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.022165,0.26469,0.20987,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0090226,0.26432,0.23843,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00045924,0.26431,0.24221,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00013917,0.26415,0.248,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,3.6228e-06,0.2638,0.21733,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,2.8077e-06,0.2638,0.2774,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00069957,0.26376,0.20245,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,2.4346e-05,0.26335,0.23453,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0071468,0.26328,0.19235,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0022332,0.26327,0.19286,1,1
4,GO KERATINOCYTE DIFFERENTIATION,4.1617e-05,0.26325,0.25818,1,1
4,GO HORMONE METABOLIC PROCESS,0.00036427,0.26322,0.26822,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00092958,0.26286,0.3066,1,1
4,GO TRANSFERRIN TRANSPORT,2.8077e-06,0.26283,0.33209,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,9.389e-05,0.26277,0.30283,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00063551,0.26271,0.24005,1,1
4,GO RESPONSE TO CAFFEINE,0.0057817,0.26265,0.22279,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,2.2524e-05,0.26247,0.22718,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.00042998,0.26238,0.24248,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.00050664,0.26197,0.22905,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.00035231,0.26162,0.29265,1,1
4,GO INFLAMMATORY RESPONSE,4.8379e-05,0.26145,0.21426,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010462,0.26144,0.19679,1,1
4,GO DENDRITIC CELL MIGRATION,0.0050528,0.26118,0.18549,1,1
4,GO SECRETION BY TISSUE,0.00081984,0.26114,0.23218,1,1
4,GO ANDROGEN METABOLIC PROCESS,9.7346e-05,0.26105,0.39053,1,1
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.012508,0.26105,0.20901,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0014299,0.26101,0.23368,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.00010092,0.26086,0.28115,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,1.7806e-05,0.26066,0.2493,1,1
4,GO ORGANELLE MEMBRANE FUSION,9.0551e-05,0.25928,0.22533,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.0022992,0.25923,0.16875,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00030804,0.25919,0.25422,1,1
4,GO RESPONSE TO PROTOZOAN,0.001872,0.25893,0.18604,1,1
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.023205,0.25891,0.18398,1,1
4,GO LYMPHOCYTE MIGRATION,0.00026903,0.25889,0.2021,1,1
4,GO FATTY ACID CATABOLIC PROCESS,8.1192e-05,0.25881,0.25558,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00029782,0.25881,0.21296,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0007696,0.25864,0.1869,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00014935,0.25859,0.19844,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.7145e-05,0.25855,0.25349,1,1
4,GO LEUKOCYTE MIGRATION,4.1617e-05,0.25848,0.23181,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00036427,0.25826,0.29566,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,1.7474e-06,0.25752,0.28605,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00087311,0.25711,0.23071,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00029782,0.25693,0.2766,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.00017186,0.25681,0.21205,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0041716,0.25657,0.26391,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00054072,0.25654,0.2507,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0001547,0.25642,0.26558,1,1
4,GO RESPONSE TO GONADOTROPIN,0.00092958,0.25639,0.23103,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00063551,0.25623,0.21185,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00026003,0.25593,0.20409,1,1
4,GO RESPONSE TO CADMIUM ION,0.0039469,0.25583,0.21678,1,1
4,GO VASCULAR WOUND HEALING,0.0047853,0.25579,0.34509,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.1112e-06,0.25558,0.27044,1,1
4,GO EXOCYTOSIS,3.1888e-05,0.2547,0.20379,1,1
4,GO PIRNA METABOLIC PROCESS,0.0017123,0.25452,0.2943,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0016129,0.25408,0.18433,1,1
4,GO OXALATE TRANSPORT,0.0051916,0.25365,0.17519,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00019079,0.25351,0.26406,1,1
4,GO NOTCH SIGNALING PATHWAY,0.00016023,0.25332,0.202,1,1
4,GO RESPONSE TO CYTOKINE,6.7596e-05,0.25328,0.20643,1,1
4,GO MONOCYTE CHEMOTAXIS,0.0028957,0.25294,0.20085,1,1
4,GO RESPONSE TO BACTERIUM,8.4205e-05,0.25283,0.20618,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00016595,0.25267,0.23089,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,0.00019753,0.25262,0.23189,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00092958,0.25253,0.30543,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.6597e-05,0.25239,0.23901,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,4.6597e-05,0.25212,0.28025,1,1
4,GO CERAMIDE METABOLIC PROCESS,3.3287e-06,0.25149,0.27659,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,6.0504e-05,0.25134,0.24545,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,9.0551e-05,0.25107,0.33524,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.001228,0.25102,0.24654,1,1
4,GO MUSCLE HYPERTROPHY,0.00021167,0.25089,0.21239,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.0010206,0.25071,0.27105,1,1
4,GO T CELL PROLIFERATION,0.0001547,0.25037,0.21971,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0020453,0.25033,0.19401,1,1
4,GO REGULATION OF DEFENSE RESPONSE,1.7118e-05,0.24999,0.21797,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.00087311,0.24996,0.21792,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,1.8251e-06,0.24994,0.25414,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.0013457,0.24972,0.19693,1,1
4,GO CARBOHYDRATE TRANSPORT,8.3127e-06,0.24963,0.25733,1,1
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.010245,0.24943,0.23047,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,9.0179e-06,0.24917,0.23693,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0083534,0.24892,0.18916,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00025131,0.24889,0.26208,1,1
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.015203,0.24868,0.21873,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,2.9301e-06,0.24856,0.26048,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00037661,0.24843,0.24076,1,1
4,GO CYTOKINE PRODUCTION,4.8379e-05,0.24837,0.22345,1,1
4,GO MEMBRANE FISSION,0.024288,0.2483,0.19537,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0006154,0.24822,0.19389,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00026003,0.24803,0.23774,1,1
4,GO MEMBRANE FUSION,6.0504e-05,0.248,0.2102,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.2367e-06,0.24765,0.24306,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,9.0551e-05,0.24763,0.2257,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00022676,0.24742,0.19772,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,9.7346e-05,0.24719,0.21491,1,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.01282,0.2471,0.18961,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00069957,0.24708,0.25241,1,1
4,GO REGULATION OF T CELL MIGRATION,0.0073363,0.247,0.19739,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00026903,0.24687,0.23509,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.6307e-05,0.24686,0.24396,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.007729,0.24682,0.20868,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.6455e-05,0.2468,0.24456,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,5.4121e-05,0.24646,0.21725,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0050528,0.24639,0.2685,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.4039e-05,0.24634,0.26636,1,1
4,GO PANCREAS DEVELOPMENT,0.0023671,0.24608,0.1957,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,9.3916e-06,0.24575,0.24375,1,1
4,GO T CELL MIGRATION,0.0054795,0.2457,0.18398,1,1
4,GO SYNCYTIUM FORMATION,0.00087311,0.2457,0.19563,1,1
4,GO COAGULATION,0.001191,0.2457,0.16588,1,1
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.034637,0.24559,0.18283,1,1
4,GO HEART TRABECULA FORMATION,0.02166,0.24558,0.25232,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,4.6623e-06,0.24557,0.26643,1,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.050569,0.24551,0.18113,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,7.0571e-06,0.24505,0.26982,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.001872,0.24492,0.28237,1,1
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.019283,0.24488,0.15774,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.00012074,0.24479,0.36015,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.004408,0.24465,0.25035,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025083,0.24459,0.34244,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,6.2786e-05,0.24428,0.32674,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.8301e-05,0.24409,0.21722,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.00059588,0.24407,0.19209,1,1
4,GO ER OVERLOAD RESPONSE,0.0028957,0.24407,0.25128,1,1
4,GO NEUTROPHIL MIGRATION,1.104e-05,0.24393,0.22387,1,1
4,GO KERATINOCYTE DEVELOPMENT,0.024288,0.2438,0.26342,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,3.1904e-06,0.24374,0.22295,1,1
4,GO CAMP BIOSYNTHETIC PROCESS,0.014138,0.24342,0.22746,1,1
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.036164,0.24331,0.2085,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,4.2876e-06,0.24307,0.23679,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,5.8301e-05,0.24302,0.21548,1,1
4,GO PH REDUCTION,2.0033e-05,0.24288,0.24787,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.0041716,0.24255,0.20241,1,1
4,GO GRANULOCYTE MIGRATION,5.6174e-05,0.24249,0.21929,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00042998,0.24249,0.20857,1,1
4,GO RENAL SYSTEM PROCESS,0.00026003,0.2419,0.20784,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00072223,0.24151,0.18863,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.019283,0.24149,0.22718,1,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.034637,0.24127,0.2497,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.004408,0.2409,0.36918,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.00072223,0.2409,0.206,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0029794,0.24087,0.22417,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.0059384,0.24079,0.1728,1,1
4,GO POSITIVE CHEMOTAXIS,0.0014299,0.24075,0.17976,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.00032948,0.24068,0.33699,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.00054072,0.23984,0.31418,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.00092958,0.23977,0.22424,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,2.1663e-05,0.23969,0.23882,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.00026003,0.23941,0.20224,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0071468,0.23909,0.21961,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.00027832,0.239,0.1801,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,7.013e-05,0.23888,0.19569,1,1
4,GO PROTEIN PROCESSING,1.1493e-05,0.23882,0.26246,1,1
4,GO GLIAL CELL PROLIFERATION,0.0083534,0.23849,0.18914,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0015653,0.23843,0.24345,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00031859,0.23842,0.18585,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0007696,0.23833,0.22619,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00092958,0.23809,0.2135,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.027188,0.23788,0.18506,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.0060989,0.23755,0.21503,1,1
4,GO MUSCLE ADAPTATION,0.00052342,0.23754,0.18452,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00016595,0.23751,0.24717,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,2.2524e-05,0.23741,0.23551,1,1
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.049546,0.23701,0.16342,1,1
4,GO AMMONIUM TRANSPORT,0.011904,0.23701,0.17111,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,4.6597e-05,0.2369,0.22969,1,1
4,GO ALCOHOL METABOLIC PROCESS,2.0033e-05,0.23674,0.24663,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.001662,0.23667,0.22097,1,1
4,GO RESPONSE TO STARVATION,1.104e-05,0.23661,0.23933,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,8.4205e-05,0.23647,0.21784,1,1
4,GO PROTEIN KINASE C SIGNALING,0.031748,0.23646,0.18767,1,1
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.0028957,0.23645,0.2264,1,1
4,GO LEUKOCYTE CHEMOTAXIS,2.0833e-05,0.23632,0.22311,1,1
4,GO PIGMENTATION,0.00063551,0.23614,0.15838,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,9.0551e-05,0.2356,0.21506,1,1
4,GO REGULATION OF BLOOD PRESSURE,2.1663e-05,0.23545,0.20475,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.0001165,0.23535,0.18316,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.00010092,0.23526,0.18519,1,1
4,GO NADP METABOLIC PROCESS,0.0067808,0.23526,0.25391,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.00019753,0.23524,0.23374,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0047853,0.23523,0.23395,1,1
4,GO B CELL ACTIVATION,3.1888e-05,0.23521,0.20739,1,1
4,GO ALPHA BETA T CELL ACTIVATION,7.013e-05,0.23513,0.23178,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0011549,0.23511,0.23453,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0017123,0.23508,0.1841,1,1
4,GO CELL CHEMOTAXIS,3.7145e-05,0.23498,0.21897,1,1
4,GO CELL ACTIVATION,0.00010462,0.23495,0.19091,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0015189,0.2344,0.1941,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0045306,0.23438,0.25851,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00092958,0.2343,0.18281,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0045306,0.23425,0.17132,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,5.4121e-05,0.23406,0.19656,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0039469,0.23362,0.2509,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.00063551,0.23359,0.14791,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,0.00026903,0.23314,0.26301,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00069957,0.2331,0.23352,1,1
4,GO RESPONSE TO PROGESTERONE,0.0079323,0.2329,0.19459,1,1
4,GO SODIUM ION HOMEOSTASIS,0.00012512,0.23288,0.21413,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00010092,0.23282,0.19325,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,7.2754e-05,0.23254,0.2572,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00040247,0.23243,0.1786,1,1
4,GO EPIDERMIS DEVELOPMENT,0.00016023,0.23201,0.20037,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,9.389e-05,0.23199,0.23756,1,1
4,GO REGULATION OF HORMONE SECRETION,3.0689e-05,0.23197,0.20782,1,1
4,GO AMYLOID FIBRIL FORMATION,0.0069616,0.23181,0.21461,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0097392,0.23181,0.19832,1,1
4,GO PROTEIN AUTOPROCESSING,0.00041602,0.23172,0.31979,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00047456,0.23167,0.18836,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.024846,0.23166,0.16515,1,1
4,GO RESPONSE TO METAL ION,4.3218e-05,0.23158,0.21271,1,1
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.021165,0.2315,0.21665,1,1
4,GO PEPTIDE SECRETION,5.2837e-06,0.23147,0.21372,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00027832,0.23145,0.225,1,1
4,GO HORMONE TRANSPORT,8.6584e-06,0.23142,0.22906,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,5.6174e-05,0.23133,0.23777,1,1
4,GO VESICLE TARGETING,0.0014299,0.23129,0.2082,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,9.0551e-05,0.23117,0.195,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.6174e-05,0.23115,0.24072,1,1
4,GO RESPONSE TO PH,0.0040578,0.23109,0.17704,1,1
4,GO VITAMIN METABOLIC PROCESS,0.0033369,0.2309,0.20812,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0006154,0.2309,0.25084,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0017641,0.23074,0.24299,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,8.7323e-05,0.23047,0.2031,1,1
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.040234,0.23045,0.14057,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00052342,0.23034,0.17204,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00013433,0.23005,0.25135,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00013917,0.23002,0.21461,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00016023,0.23001,0.17676,1,1
4,GO REGULATION OF PEPTIDE SECRETION,2.4692e-06,0.22957,0.21601,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0050528,0.22947,0.24744,1,1
4,GO GOLGI VESICLE BUDDING,8.7323e-05,0.22943,0.22031,1,1
4,GO MANNOSYLATION,1.7118e-05,0.22889,0.26719,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.011326,0.22856,0.1518,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0085714,0.22847,0.16298,1,1
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0069616,0.22817,0.2495,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.0022992,0.22814,0.20019,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,2.2524e-05,0.22785,0.21256,1,1
4,GO CYTOKINE SECRETION,5.0226e-05,0.22741,0.22891,1,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.015953,0.22729,0.17336,1,1
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.023741,0.22705,0.22103,1,1
4,GO LIPID HOMEOSTASIS,0.00035231,0.22697,0.23198,1,1
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00019079,0.22695,0.26868,1,1
4,GO LINOLEIC ACID METABOLIC PROCESS,0.049546,0.22686,0.20247,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00013433,0.22676,0.22319,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0017641,0.22674,0.20301,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.00054072,0.22641,0.19783,1,1
4,GO REGULATION OF CELLULAR PH,5.7413e-06,0.22619,0.22284,1,1
4,GO SKIN DEVELOPMENT,0.00022676,0.22608,0.19576,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.013798,0.22601,0.16407,1,1
4,GO ARACHIDONIC ACID SECRETION,5.6174e-05,0.22593,0.26084,1,1
4,GO REGULATION OF RUFFLE ASSEMBLY,0.0020453,0.2258,0.21079,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.4346e-05,0.22545,0.21655,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.036948,0.22532,0.19231,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.3528e-06,0.22502,0.214,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.1964e-05,0.22495,0.20309,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.0020453,0.22467,0.21534,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0030654,0.22465,0.1641,1,1
4,GO INSULIN SECRETION,2.3418e-05,0.22428,0.21678,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,0.00013917,0.22424,0.21169,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0042883,0.22423,0.22443,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,3.1888e-05,0.22369,0.34264,1,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00038934,0.22365,0.18022,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0041716,0.22352,0.22487,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,4.6623e-06,0.22315,0.24846,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,2.8418e-05,0.22312,0.19361,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.013798,0.22304,0.16688,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0010528,0.22304,0.1834,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.0056288,0.22299,0.16033,1,1
4,GO RESPONSE TO CALCIUM ION,0.00052342,0.22276,0.19483,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00353,0.22274,0.15926,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.001872,0.22266,0.17672,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00018427,0.2226,0.24747,1,1
4,GO MUSCLE CELL MIGRATION,0.017137,0.22236,0.16004,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.031059,0.22234,0.13936,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.22231,0.2089,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00098941,0.22227,0.16291,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0025083,0.22209,0.20616,1,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.017549,0.22207,0.18257,1,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0016129,0.22181,0.17838,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,5.4121e-05,0.22157,0.22173,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0016129,0.22148,0.18156,1,1
4,GO RESPONSE TO ALCOHOL,0.00041602,0.22136,0.16428,1,1
4,GO PHAGOSOME MATURATION,0.00026003,0.22091,0.2666,1,1
4,GO NUCLEOTIDE TRANSPORT,3.7145e-05,0.22082,0.22928,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.2786e-05,0.22077,0.18926,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.0014299,0.22077,0.1906,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,2.6307e-05,0.22031,0.19281,1,1
4,GO RESPONSE TO KETONE,0.0017641,0.22018,0.16167,1,1
4,GO KERATINOCYTE PROLIFERATION,0.010245,0.21999,0.17005,1,1
4,GO REGULATION OF GLUCONEOGENESIS,6.5149e-05,0.21997,0.26122,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,2.0033e-05,0.21988,0.2412,1,1
4,GO PROTEIN HYDROXYLATION,0.025414,0.2198,0.18668,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001228,0.21963,0.16898,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00019753,0.21958,0.17307,1,1
4,GO ACTIN NUCLEATION,1.6455e-05,0.21947,0.23567,1,1
4,GO WOUND HEALING,0.004408,0.21933,0.14776,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0046564,0.21913,0.21081,1,1
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.02268,0.21911,0.22024,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.0021062,0.21908,0.20592,1,1
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.03245,0.21847,0.22899,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0011549,0.21847,0.16929,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00029782,0.21839,0.17395,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00042998,0.21835,0.21266,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00034072,0.2182,0.23178,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,5.8301e-05,0.21806,0.19086,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,2.0833e-05,0.21799,0.25942,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00042998,0.2178,0.1928,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0040578,0.21775,0.21193,1,1
4,GO REGULATION OF HORMONE LEVELS,7.9801e-06,0.21767,0.23473,1,1
4,GO COPULATION,0.013465,0.21722,0.17864,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.00034072,0.21705,0.23333,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.0024367,0.21649,0.25856,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.0037331,0.21597,0.23462,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0037331,0.21585,0.17541,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.00021909,0.21573,0.207,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00072223,0.21569,0.18009,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0012662,0.21541,0.23593,1,1
4,GO T CELL ACTIVATION,0.00016595,0.21531,0.18867,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0030654,0.21521,0.29284,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00087311,0.21506,0.15627,1,1
4,GO ORGANELLE FUSION,7.8282e-05,0.21503,0.18665,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,2.1663e-05,0.21503,0.17629,1,1
4,GO LIPID EXPORT FROM CELL,0.00353,0.21499,0.25144,1,1
4,GO LIPID OXIDATION,0.00065623,0.21492,0.1905,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00044439,0.21488,0.18329,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0006154,0.21486,0.26505,1,1
4,GO RESPONSE TO DSRNA,0.00026903,0.21471,0.1807,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00016595,0.21469,0.19916,1,1
4,GO PROSTAGLANDIN SECRETION,0.0022332,0.2146,0.25205,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0041716,0.21429,0.26271,1,1
4,GO B CELL DIFFERENTIATION,2.2524e-05,0.21419,0.2133,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.00019753,0.2139,0.18999,1,1
4,GO REGULATION OF CELL ACTIVATION,0.00067758,0.21375,0.15826,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0018173,0.21364,0.21534,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.00020448,0.21357,0.24599,1,1
4,GO PROTEIN ADP RIBOSYLATION,0.0050528,0.21353,0.17749,1,1
4,GO PLASMA MEMBRANE FUSION,0.014841,0.21266,0.20074,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00021909,0.21253,0.20842,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,1.349e-05,0.21241,0.20508,1,1
4,GO LAMELLIPODIUM MORPHOGENESIS,0.024288,0.21221,0.20442,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0094949,0.2122,0.12408,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.1493e-05,0.21204,0.25673,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0007696,0.21177,0.20039,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00057693,0.21153,0.16461,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00044439,0.21102,0.17195,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0010859,0.21072,0.15919,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,0.00010462,0.21065,0.1965,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0018173,0.21054,0.22764,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.015953,0.21043,0.16146,1,1
4,GO PEPTIDE HORMONE SECRETION,1.6455e-05,0.21025,0.21802,1,1
4,GO TERPENOID METABOLIC PROCESS,0.0059384,0.21002,0.19434,1,1
4,GO GOLGI RIBBON FORMATION,0.0040578,0.20998,0.19847,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.02268,0.2099,0.13692,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.0504e-05,0.20973,0.17375,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,2.2524e-05,0.2095,0.20628,1,1
4,GO LEUKOCYTE DIFFERENTIATION,7.2754e-05,0.20935,0.17176,1,1
4,GO WHITE FAT CELL DIFFERENTIATION,0.0010528,0.20931,0.21935,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0013872,0.20918,0.16184,1,1
4,GO NECROTIC CELL DEATH,0.00012074,0.20918,0.27978,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.00026903,0.20914,0.24484,1,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0012662,0.20909,0.19454,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0097392,0.20903,0.14963,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.00063551,0.20898,0.23208,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.013e-05,0.20893,0.18126,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.041093,0.20888,0.14863,1,1
4,GO CHOLESTEROL STORAGE,0.00036427,0.2086,0.27375,1,1
4,GO ADAPTIVE THERMOGENESIS,3.4728e-06,0.20858,0.22271,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.011047,0.20829,0.20863,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.043763,0.20829,0.10276,1,1
4,GO RESPONSE TO STEROL,0.0027346,0.20799,0.20739,1,1
4,GO REGULATION OF APPETITE,0.0013872,0.20791,0.15694,1,1
4,GO VACUOLE ORGANIZATION,7.6603e-06,0.20791,0.22962,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.01282,0.20779,0.39279,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0017123,0.20778,0.18892,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00032948,0.20773,0.18823,1,1
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.023205,0.20754,0.16854,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.0027346,0.20748,0.18469,1,1
4,GO REGULATION OF CELL ADHESION,0.0013054,0.20709,0.16506,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.0075304,0.20706,0.18527,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.00054072,0.2063,0.17602,1,1
4,GO PROTEIN MATURATION,3.7145e-05,0.2062,0.20794,1,1
4,GO FC RECEPTOR SIGNALING PATHWAY,0.00017186,0.20603,0.16297,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,4.8379e-05,0.206,0.21744,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,6.7728e-06,0.20567,0.24944,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.010506,0.20564,0.19299,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00049035,0.20545,0.16888,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.0504e-05,0.20542,0.19135,1,1
4,GO EATING BEHAVIOR,0.001872,0.20514,0.19322,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,8.4205e-05,0.2049,0.20353,1,1
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.0053338,0.20454,0.28873,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0033369,0.20415,0.191,1,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.004408,0.20405,0.16646,1,1
4,GO PLATELET ACTIVATION,0.00045924,0.20404,0.18562,1,1
4,GO CELL CELL ADHESION,0.0022992,0.20398,0.14603,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0011549,0.20395,0.20142,1,1
4,GO LYMPHOCYTE ACTIVATION,0.00032948,0.20383,0.15803,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.037747,0.20346,0.12504,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.2962e-05,0.20343,0.21494,1,1
4,GO REGULATION OF LIPID STORAGE,0.00067758,0.20338,0.20178,1,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.011612,0.20326,0.224,1,1
4,GO REGULATION OF INSULIN SECRETION,6.5149e-05,0.20308,0.19335,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.00014418,0.20271,0.20387,1,1
4,GO SECRETION,3.1888e-05,0.20263,0.18064,1,1
4,GO MEMBRANE DEPOLARIZATION,0.0031536,0.20259,0.19853,1,1
4,GO XENOBIOTIC TRANSPORT,0.004408,0.20258,0.26879,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.00050664,0.20257,0.24787,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0042883,0.20222,0.18775,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00040247,0.20211,0.19489,1,1
4,GO NEUTROPHIL CHEMOTAXIS,2.4346e-05,0.20199,0.18075,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.010506,0.20188,0.17054,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0069616,0.20182,0.1501,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0010528,0.20163,0.14405,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0021689,0.20158,0.16911,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00055855,0.20157,0.19451,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.025994,0.20154,0.18566,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.0066042,0.20098,0.17288,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.022165,0.20098,0.19439,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.00040247,0.20089,0.22709,1,1
4,GO REGULATION OF PH,7.6603e-06,0.20089,0.21831,1,1
4,GO COPII COATED VESICLE BUDDING,0.00021167,0.20059,0.20399,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0031536,0.20059,0.16249,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00095906,0.20035,0.15896,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00049035,0.20017,0.17495,1,1
4,GO AMYLOID BETA FORMATION,0.0064317,0.19963,0.18261,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.014841,0.19958,0.18838,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,7.013e-05,0.19939,0.18164,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.0006154,0.19853,0.16543,1,1
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0028957,0.19851,0.15235,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00010845,0.19806,0.2066,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0025817,0.19757,0.17673,1,1
4,GO ENDOCYTIC RECYCLING,0.0015653,0.19748,0.14843,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,0.19711,0.17067,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00035231,0.19699,0.25261,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0016129,0.19697,0.23274,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00047456,0.19687,0.18214,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00098941,0.19686,0.17308,1,1
4,GO TRANSCYTOSIS,0.009256,0.19667,0.21487,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0017641,0.19656,0.19454,1,1
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.011047,0.19654,0.29132,1,1
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.042857,0.19651,0.11462,1,1
4,GO REPLICATIVE SENESCENCE,0.0067808,0.19644,0.23158,1,1
4,GO RESPONSE TO MUSCLE INACTIVITY,0.02268,0.19634,0.22059,1,1
4,GO RESPONSE TO INSULIN,0.00016023,0.19606,0.17273,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,4.6597e-05,0.19601,0.19943,1,1
4,GO LIPID METABOLIC PROCESS,3.7145e-05,0.196,0.19635,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0041716,0.19581,0.15059,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.00052342,0.19577,0.20578,1,1
4,GO T CELL DIFFERENTIATION,0.00016595,0.19552,0.16296,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.033166,0.19543,0.14354,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0064317,0.1954,0.1926,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.00014418,0.19533,0.22228,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.01282,0.19515,0.16797,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.0066042,0.19491,0.15879,1,1
4,GO DENDRITIC CELL CHEMOTAXIS,0.014841,0.19486,0.15564,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00040247,0.19479,0.21735,1,1
4,GO EPITHELIUM DEVELOPMENT,0.00052342,0.19478,0.13875,1,1
4,GO VESICLE ORGANIZATION,0.00031859,0.1947,0.1696,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00090094,0.19459,0.18147,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,7.013e-05,0.1941,0.18923,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.00024286,0.19404,0.21549,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.014486,0.19404,0.19533,1,1
4,GO REGULATION OF TUBE SIZE,0.001662,0.19401,0.1669,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0034322,0.19398,0.16842,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0026572,0.19374,0.22287,1,1
4,GO CARNITINE METABOLIC PROCESS,0.036948,0.19344,0.19421,1,1
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00054072,0.19337,0.15967,1,1
4,GO HUMORAL IMMUNE RESPONSE,7.0571e-06,0.19299,0.22613,1,1
4,GO REGULATION OF DENDRITE EXTENSION,0.0054795,0.19293,0.32579,1,1
4,GO POSITIVE REGULATION OF SECRETION,1.4609e-05,0.19256,0.206,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00081984,0.19254,0.17065,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.001191,0.19223,0.16471,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.0007696,0.19218,0.14359,1,1
4,GO REGULATION OF HEMOPOIESIS,0.00022676,0.19211,0.15158,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.017549,0.19168,0.16754,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.00032948,0.19151,0.18783,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00021909,0.19138,0.15842,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0014299,0.19117,0.1624,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0045306,0.19116,0.202,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0010528,0.19109,0.20778,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.00055855,0.19049,0.19549,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,3.3132e-05,0.19022,0.19784,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00050664,0.19018,0.15896,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0017123,0.18998,0.15807,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00063551,0.18974,0.17256,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0022992,0.18966,0.16337,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0073363,0.18945,0.18835,1,1
4,GO RESPONSE TO IRON ION,0.011904,0.18932,0.17299,1,1
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.014138,0.18925,0.18699,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.0056288,0.18895,0.20412,1,1
4,GO PROTEIN KINASE B SIGNALING,0.011047,0.18885,0.11878,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00032948,0.18858,0.32325,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00049035,0.18847,0.16682,1,1
4,GO MYOTUBE DIFFERENTIATION,0.00041602,0.1883,0.18474,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.00016023,0.18795,0.17366,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0025083,0.18771,0.18168,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.0038387,0.18766,0.14734,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0039469,0.18759,0.17789,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.0075304,0.18754,0.13209,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.011904,0.18741,0.18279,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00042998,0.18737,0.20213,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.004408,0.18728,0.15764,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,1.1493e-05,0.18726,0.17791,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.00026903,0.18722,0.14618,1,1
4,GO GLUCOSE METABOLIC PROCESS,7.0571e-06,0.18714,0.22853,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00017186,0.18706,0.17353,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00017186,0.1869,0.16832,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.389e-05,0.18666,0.17149,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.0021062,0.18663,0.19564,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.0024367,0.18652,0.1498,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0021689,0.18632,0.14144,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0097392,0.18623,0.19386,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0049174,0.18606,0.13804,1,1
4,GO RENAL TUBULE DEVELOPMENT,0.015203,0.18606,0.1179,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.18602,0.23329,1,1
4,GO IRON ION TRANSPORT,7.8282e-05,0.18597,0.23853,1,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.040234,0.18593,0.11377,1,1
4,GO OXIDATION REDUCTION PROCESS,0.00010462,0.18558,0.19524,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00052342,0.18551,0.22367,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00095906,0.18503,0.27503,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00049035,0.18439,0.22314,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.4121e-05,0.18429,0.17888,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.0064317,0.18413,0.13226,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0012662,0.18413,0.21111,1,1
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0056288,0.18395,0.23512,1,1
4,GO ACID SECRETION,0.0067808,0.18391,0.14584,1,1
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.01282,0.18384,0.17251,1,1
4,GO CHLORIDE TRANSPORT,0.00023468,0.18369,0.16092,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0012662,0.18367,0.1592,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.010506,0.18354,0.14514,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00019753,0.18306,0.14259,1,1
4,GO FIBROBLAST PROLIFERATION,0.046579,0.18291,0.10955,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0010528,0.1829,0.18697,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00037661,0.18277,0.20048,1,1
4,GO RESPONSE TO WOUNDING,0.0067808,0.18272,0.12906,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.0001547,0.18254,0.18744,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.0036303,0.18232,0.16213,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,6.0504e-05,0.1823,0.17779,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.046579,0.18217,0.1559,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,3.6228e-06,0.18209,0.2187,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,4.8379e-05,0.18201,0.20383,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.001872,0.18165,0.24104,1,1
4,GO TEMPERATURE HOMEOSTASIS,5.6174e-05,0.18151,0.18218,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00087311,0.18149,0.27856,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00027832,0.18111,0.22319,1,1
4,GO RESPONSE TO LIPID,0.0017641,0.18072,0.13667,1,1
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0036303,0.17996,0.18947,1,1
4,GO RESPONSE TO CHEMOKINE,0.00040247,0.17992,0.15619,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0056288,0.17979,0.15963,1,1
4,GO LIPID CATABOLIC PROCESS,3.0689e-05,0.17976,0.22057,1,1
4,GO CHEMICAL HOMEOSTASIS,4.8379e-05,0.17955,0.16693,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.0073363,0.17947,0.14551,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.041967,0.17939,0.18135,1,1
4,GO MECHANORECEPTOR DIFFERENTIATION,0.00087311,0.17938,0.17232,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0016129,0.17866,0.16172,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00019079,0.1786,0.19514,1,1
4,GO PROTEIN DESTABILIZATION,0.00034072,0.17843,0.17308,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0038387,0.17829,0.2436,1,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.041093,0.17809,0.13412,1,1
4,GO ORGANELLE INHERITANCE,0.0030654,0.17796,0.146,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00047456,0.17788,0.15531,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.00041602,0.17776,0.14455,1,1
4,GO MANGANESE ION TRANSPORT,0.0040578,0.17775,0.17988,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0031536,0.17742,0.14841,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0099891,0.17736,0.19481,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0031536,0.17733,0.14137,1,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.0099891,0.17722,0.15489,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,3.8583e-05,0.1772,0.15986,1,1
4,GO GLOMERULUS DEVELOPMENT,0.0057817,0.17713,0.18073,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00019079,0.17712,0.16738,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,4.3218e-05,0.17709,0.2356,1,1
4,GO ORGANIC ANION TRANSPORT,1.9263e-05,0.17705,0.19793,1,1
4,GO INTERFERON GAMMA PRODUCTION,0.0051916,0.17698,0.13927,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,8.1192e-05,0.17687,0.15729,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.001191,0.17687,0.15558,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0075304,0.17668,0.26872,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.001191,0.17647,0.16741,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00098941,0.1759,0.12912,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.0036303,0.17574,0.15296,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,3.1904e-06,0.17553,0.20256,1,1
4,GO SPLEEN DEVELOPMENT,0.0049174,0.17525,0.17676,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0081404,0.17523,0.17215,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00017796,0.17522,0.15392,1,1
4,GO FATTY ACID TRANSPORT,0.00011241,0.17513,0.21913,1,1
4,GO PLATELET MORPHOGENESIS,0.011326,0.17486,0.16778,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00019079,0.17477,0.18368,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00052342,0.17468,0.15887,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.015203,0.1746,0.13731,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00021167,0.1744,0.18697,1,1
4,GO RESPONSE TO PROSTAGLANDIN,0.046579,0.17408,0.17283,1,1
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0062634,0.17389,0.1673,1,1
4,GO METAL ION HOMEOSTASIS,0.00036427,0.17349,0.13935,1,1
4,GO REGULATION OF ANION TRANSPORT,0.00045924,0.17344,0.22462,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.030383,0.17331,0.15711,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.0001547,0.17297,0.1685,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.00067758,0.17273,0.15077,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0028957,0.17236,0.17553,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.00016595,0.17198,0.13618,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.0056288,0.17189,0.24792,1,1
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.052669,0.17177,0.16694,1,1
4,GO RESPONSE TO ETHER,0.0030654,0.17168,0.17725,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.0023671,0.17164,0.18333,1,1
4,GO OOCYTE DIFFERENTIATION,0.00063551,0.1715,0.16157,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.00012964,0.17099,0.16362,1,1
4,GO T CELL HOMEOSTASIS,0.0036303,0.17089,0.14953,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.026586,0.17087,0.16879,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.01282,0.17083,0.13359,1,1
4,GO DETECTION OF STIMULUS,7.013e-05,0.17072,0.13871,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.04854,0.17046,0.18725,1,1
4,GO REGULATION OF SECRETION,7.2754e-05,0.17039,0.16527,1,1
4,GO REGULATION OF BONE DEVELOPMENT,0.025994,0.17017,0.12796,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0047853,0.16955,0.12166,1,1
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0073363,0.16952,0.14784,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0073363,0.16944,0.24566,1,1
4,GO CELLULAR PIGMENTATION,0.001662,0.16927,0.16752,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.033894,0.16925,0.13648,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,7.8282e-05,0.16914,0.22127,1,1
4,GO RESPONSE TO FUNGUS,0.00035231,0.16914,0.16824,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00087311,0.16913,0.18577,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,2.4346e-05,0.16865,0.16967,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0014299,0.16858,0.14295,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00032948,0.16835,0.14251,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0022332,0.16804,0.17417,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00081984,0.16743,0.23594,1,1
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.011326,0.16725,0.15329,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.010506,0.16722,0.13184,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.4346e-05,0.16716,0.18801,1,1
4,GO INORGANIC ANION TRANSPORT,0.00016595,0.16693,0.15229,1,1
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0059384,0.16693,0.13752,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.001872,0.16666,0.16397,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.00074557,0.16658,0.14345,1,1
4,GO REGULATION OF PROTEOLYSIS,0.00045924,0.16654,0.15361,1,1
4,GO ANION TRANSPORT,2.7343e-05,0.16632,0.18053,1,1
4,GO BIOLOGICAL ADHESION,0.011326,0.16627,0.11225,1,1
4,GO PROTEOLYSIS,0.00012964,0.16613,0.14203,1,1
4,GO AGING,0.00072223,0.16607,0.13025,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.00047456,0.166,0.13031,1,1
4,GO PEROXISOME ORGANIZATION,0.0021062,0.16595,0.18033,1,1
4,GO HEPATOCYTE DIFFERENTIATION,0.015203,0.16589,0.21894,1,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.021165,0.16557,0.10723,1,1
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.018398,0.16554,0.14435,1,1
4,GO RESPONSE TO DRUG,0.0022992,0.16528,0.1457,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0059384,0.16519,0.1656,1,1
4,GO FATTY ACID BETA OXIDATION,0.0049174,0.16475,0.18015,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.00057693,0.16462,0.13518,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0011199,0.16439,0.15122,1,1
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0013872,0.16412,0.14421,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.017969,0.16403,0.13882,1,1
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.016339,0.16373,0.13518,1,1
4,GO ION HOMEOSTASIS,0.00027832,0.16357,0.14329,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.0079323,0.16357,0.11845,1,1
4,GO ORGANELLE DISASSEMBLY,0.00014935,0.1634,0.16815,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00074557,0.16291,0.17709,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00098941,0.16257,0.13383,1,1
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.012203,0.16251,0.15827,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0087944,0.16244,0.12027,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.001662,0.16243,0.15881,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0028957,0.16241,0.12757,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.00087311,0.16228,0.1319,1,1
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.033894,0.16169,0.1344,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.0019282,0.16163,0.16874,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.0046564,0.16152,0.12294,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0007696,0.16143,0.1752,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0071468,0.16089,0.17689,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00047456,0.16057,0.17416,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00098941,0.16009,0.13218,1,1
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.012203,0.1598,0.203,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00036427,0.15968,0.18488,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.01282,0.15963,0.13141,1,1
4,GO EPITHELIAL CELL PROLIFERATION,0.0075304,0.15958,0.1206,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.0025083,0.15957,0.1394,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.010245,0.15935,0.22533,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0028957,0.15931,0.12724,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00034072,0.15916,0.1691,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00098941,0.15914,0.13549,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,4.1617e-05,0.15911,0.17371,1,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0016129,0.15898,0.18467,1,1
4,GO TRANSLESION SYNTHESIS,0.0037331,0.15881,0.12379,1,1
4,GO RUFFLE ORGANIZATION,0.0022992,0.15837,0.17999,1,1
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.030383,0.15792,0.13009,1,1
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.038561,0.15789,0.19461,1,1
4,GO PEROXISOMAL TRANSPORT,0.0021689,0.1578,0.18827,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.027803,0.15779,0.1235,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.011326,0.15748,0.16793,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,1.2454e-05,0.15728,0.15572,1,1
4,GO RRNA CATABOLIC PROCESS,0.0066042,0.1569,0.17175,1,1
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.033894,0.1565,0.20335,1,1
4,GO BIOMINERALIZATION,0.0050528,0.15626,0.13833,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0064317,0.15607,0.12711,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00034072,0.15591,0.1335,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.022165,0.15589,0.14861,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0050528,0.15571,0.11877,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00011241,0.15567,0.21073,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.0013054,0.15556,0.13198,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0033369,0.15555,0.18605,1,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015574,0.15551,0.12864,1,1
4,GO LYSOSOME LOCALIZATION,0.00057693,0.1555,0.16348,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.0079323,0.15536,0.17033,1,1
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0029794,0.15522,0.15349,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.0090226,0.15503,0.11856,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.022165,0.15459,0.1312,1,1
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0015189,0.15452,0.15531,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00017186,0.1544,0.17394,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0021062,0.15419,0.11602,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.00067758,0.15403,0.159,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.001662,0.15368,0.14149,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.031059,0.15358,0.16064,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00030804,0.15324,0.16604,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0010859,0.15295,0.13813,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00012512,0.15287,0.16437,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.012508,0.15252,0.14565,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.014486,0.15249,0.13522,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0027346,0.15248,0.20895,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,7.8282e-05,0.15195,0.19485,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.001662,0.15177,0.13779,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.040234,0.15173,0.1496,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.0011199,0.15156,0.1475,1,1
4,GO GLAND DEVELOPMENT,0.001228,0.15138,0.12976,1,1
4,GO MYELOID CELL DEVELOPMENT,0.0046564,0.15135,0.1259,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0020453,0.15123,0.1505,1,1
4,GO CALCIUM ION IMPORT,0.0094949,0.15116,0.12242,1,1
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.027188,0.1511,0.1437,1,1
4,GO HOMEOSTATIC PROCESS,5.6174e-05,0.15108,0.13752,1,1
4,GO SIGNAL RELEASE,0.00055855,0.15085,0.14969,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.041093,0.15082,0.26953,1,1
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0037331,0.15068,0.13823,1,1
4,GO CARDIAC CELL DEVELOPMENT,0.013465,0.15054,0.11914,1,1
4,GO NCRNA CATABOLIC PROCESS,0.015574,0.1505,0.12696,1,1
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.027188,0.15047,0.13135,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0010206,0.15039,0.16637,1,1
4,GO SODIUM ION TRANSPORT,0.0015189,0.15033,0.14993,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,2.9532e-05,0.15032,0.17114,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.0030654,0.15028,0.17705,1,1
4,GO ZINC ION TRANSPORT,0.019283,0.15,0.16104,1,1
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.040234,0.14991,0.088987,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0015189,0.14964,0.12721,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.02166,0.14955,0.13525,1,1
4,GO ENDOSOME ORGANIZATION,0.0010859,0.14931,0.16385,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00098941,0.14924,0.1416,1,1
4,GO ACROSOME REACTION,0.02068,0.14917,0.18018,1,1
4,GO RESPONSE TO ALKALOID,0.0081404,0.14861,0.13472,1,1
4,GO CELL MOTILITY,0.014486,0.1486,0.095819,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.001986,0.14831,0.11549,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0018173,0.14815,0.11821,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0022332,0.1481,0.11734,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.0046564,0.14808,0.15306,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0017641,0.14803,0.16847,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0047853,0.14802,0.1146,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0097392,0.14791,0.10796,1,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.02268,0.14777,0.10983,1,1
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.011326,0.14763,0.10271,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0017123,0.14747,0.12176,1,1
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.023205,0.14696,0.11916,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0073363,0.14657,0.11211,1,1
4,GO RESPONSE TO HORMONE,0.00084609,0.14653,0.13942,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0011549,0.14623,0.17739,1,1
4,GO PROTEIN MANNOSYLATION,0.012203,0.1462,0.16025,1,1
4,GO REGULATION OF ION TRANSPORT,0.0049174,0.14615,0.11345,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0013054,0.14599,0.12646,1,1
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.012508,0.14566,0.077985,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00090094,0.14559,0.12816,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.0014299,0.14545,0.16352,1,1
4,GO GLUCOSE IMPORT,0.0046564,0.14521,0.16207,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.001191,0.145,0.18409,1,1
4,GO ORGANIC ACID TRANSPORT,8.4205e-05,0.14499,0.19492,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0010206,0.14489,0.12635,1,1
4,GO MEMBRANE ORGANIZATION,0.0028957,0.14444,0.10388,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.049546,0.14435,0.13914,1,1
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.011904,0.14413,0.36147,1,1
4,GO REGULATION OF PROTEIN BINDING,0.0050528,0.1438,0.12555,1,1
4,GO POLYOL CATABOLIC PROCESS,0.0050528,0.14372,0.14923,1,1
4,GO CELL MATURATION,0.00038934,0.14327,0.14324,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00095906,0.14306,0.15968,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.00092958,0.14263,0.1652,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0053338,0.14239,0.11726,1,1
4,GO RESPONSE TO ISCHEMIA,0.0029794,0.14219,0.19935,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00044439,0.14183,0.15848,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0097392,0.14179,0.18579,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.00052342,0.14169,0.134,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.0011549,0.14155,0.12857,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.050569,0.14145,0.16262,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0051916,0.14132,0.1368,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00023468,0.14125,0.13609,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00029782,0.14119,0.18242,1,1
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.045624,0.1411,0.074441,1,1
4,GO REGULATION OF MAPK CASCADE,0.0060989,0.14108,0.11356,1,1
4,GO REGULATION OF TOR SIGNALING,4.6597e-05,0.141,0.14146,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.00090094,0.14078,0.20088,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0010206,0.14075,0.12733,1,1
4,GO RETINA HOMEOSTASIS,0.02166,0.14015,0.07609,1,1
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.049546,0.13974,0.15827,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00054072,0.13962,0.12852,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.0010859,0.13958,0.12403,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0011199,0.13952,0.118,1,1
4,GO RESPONSE TO ETHANOL,0.015203,0.13943,0.11012,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0036303,0.13934,0.11473,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.045624,0.13919,0.10344,1,1
4,GO TISSUE MIGRATION,0.0051916,0.13913,0.14639,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0015653,0.13887,0.15455,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,0.0057817,0.13886,0.1686,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0015653,0.13879,0.12562,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00016023,0.13835,0.16499,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.00014418,0.13819,0.14607,1,1
4,GO REGULATION OF CHEMOTAXIS,0.0056288,0.13767,0.11095,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.012203,0.13767,0.1072,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00098941,0.13766,0.13584,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.012203,0.13759,0.116,1,1
4,GO FEEDING BEHAVIOR,0.019283,0.13754,0.11937,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.00014418,0.13753,0.12872,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.022165,0.13684,0.22154,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0020453,0.13658,0.13859,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.016734,0.13627,0.1037,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00018427,0.13624,0.14761,1,1
4,GO ENDOCYTOSIS,0.044685,0.13586,0.080089,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.0006154,0.13562,0.11485,1,1
4,GO ION TRANSPORT,0.00017796,0.13539,0.14793,1,1
4,GO EXOCYTIC PROCESS,0.0085714,0.13513,0.16195,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.014486,0.13422,0.14971,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.001662,0.13415,0.15018,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.011612,0.13404,0.14548,1,1
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.023741,0.13399,0.089883,1,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.045624,0.13394,0.10398,1,1
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.023741,0.13372,0.15911,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.0027346,0.1336,0.10804,1,1
4,GO LIPID MODIFICATION,0.00065623,0.13355,0.15319,1,1
4,GO EXCRETION,0.0090226,0.13355,0.13096,1,1
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.02268,0.13343,0.12479,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0064317,0.13332,0.10869,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0034322,0.13197,0.11975,1,1
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.050569,0.13174,0.11412,1,1
4,GO RESPONSE TO ESTRADIOL,0.052669,0.13157,0.073558,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0071468,0.13131,0.11434,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0018173,0.13121,0.10968,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.0014738,0.13104,0.13329,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.00074557,0.13079,0.12514,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.009256,0.13064,0.15908,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0029794,0.13062,0.11694,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.0031536,0.13023,0.12284,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.011612,0.13017,0.13795,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0014299,0.13014,0.14924,1,1
4,GO T CELL SELECTION,0.001662,0.13011,0.13446,1,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0062634,0.13004,0.13106,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.015203,0.12975,0.1582,1,1
4,GO NEPHRON DEVELOPMENT,0.030383,0.12958,0.092296,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0059384,0.12957,0.13673,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.0039469,0.12942,0.11991,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.019283,0.12917,0.10106,1,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.018836,0.12908,0.090674,1,1
4,GO SOMITOGENESIS,0.0033369,0.12902,0.11899,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.012203,0.12883,0.097762,1,1
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.03245,0.12878,0.13428,1,1
4,GO RESPONSE TO PEPTIDE,0.00095906,0.12876,0.12127,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00018427,0.12873,0.20866,1,1
4,GO REGULATION OF TRANSPORT,0.001228,0.12863,0.10351,1,1
4,GO RESPONSE TO ACTIVITY,0.0050528,0.12851,0.15561,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.0011199,0.1285,0.12545,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00069957,0.12839,0.15977,1,1
4,GO ESTROGEN METABOLIC PROCESS,0.045624,0.12837,0.16554,1,1
4,GO METAL ION TRANSPORT,0.0024367,0.12836,0.11686,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0050528,0.12836,0.15598,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.017969,0.12827,0.11286,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.0057817,0.12816,0.14797,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.00054072,0.12745,0.11098,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0099891,0.12725,0.15469,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0075304,0.12725,0.16769,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.00067758,0.12719,0.10153,1,1
4,GO DRUG CATABOLIC PROCESS,0.02843,0.127,0.20738,1,1
4,GO REGULATION OF CELL DEATH,0.0013872,0.12694,0.10994,1,1
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.017137,0.12688,0.13586,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.012203,0.12678,0.17486,1,1
4,GO GOLGI ORGANIZATION,0.00018427,0.12648,0.16125,1,1
4,GO SINGLE FERTILIZATION,0.0083534,0.12646,0.094825,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0049174,0.12641,0.10353,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.00029782,0.12628,0.12366,1,1
4,GO POLYOL METABOLIC PROCESS,0.0025817,0.12612,0.13641,1,1
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0064317,0.126,0.13128,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.012203,0.12599,0.10701,1,1
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.03939,0.12597,0.081892,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0025817,0.12596,0.10325,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0051916,0.12552,0.11694,1,1
4,GO THYMIC T CELL SELECTION,0.05161,0.12519,0.075973,1,1
4,GO TOR SIGNALING,1.349e-05,0.12502,0.12472,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0028957,0.12491,0.11274,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.024846,0.12464,0.10816,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.026586,0.12459,0.10972,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.017549,0.12395,0.10335,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0020453,0.12391,0.10467,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.023741,0.12388,0.16086,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0097392,0.12341,0.12799,1,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.024288,0.12285,0.088271,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0054795,0.12226,0.12197,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0013872,0.12195,0.11338,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00084609,0.12185,0.11681,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0015653,0.12145,0.13928,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.00090094,0.12096,0.1779,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00095906,0.12069,0.11158,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.033166,0.11995,0.07992,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,0.01282,0.11954,0.10757,1,1
4,GO MESONEPHROS DEVELOPMENT,0.023741,0.11934,0.10811,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.0081404,0.11934,0.099329,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.0054795,0.11927,0.099949,1,1
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011047,0.11859,0.12227,1,1
4,GO OOGENESIS,0.043763,0.11829,0.076635,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00012512,0.11756,0.13384,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0028141,0.1171,0.10186,1,1
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0051916,0.11709,0.13999,1,1
4,GO NEGATIVE REGULATION OF SECRETION,0.0073363,0.11689,0.10029,1,1
4,GO FAT CELL DIFFERENTIATION,0.0049174,0.11682,0.13891,1,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0073363,0.11678,0.092905,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0060989,0.11669,0.10921,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0014299,0.11647,0.12311,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0050528,0.11614,0.12265,1,1
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0020453,0.11591,0.11772,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0022992,0.11581,0.1319,1,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.031748,0.11556,0.16145,1,1
4,GO LYMPH NODE DEVELOPMENT,0.019739,0.11534,0.16031,1,1
4,GO VIRAL BUDDING,0.0073363,0.11466,0.14008,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.033894,0.11429,0.075888,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00018427,0.11425,0.13908,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.0081404,0.11408,0.095618,1,1
4,GO APOPTOTIC PROCESS,0.00098941,0.11407,0.11337,1,1
4,GO DNA CATABOLIC PROCESS,0.0010859,0.11396,0.12276,1,1
4,GO CATION TRANSPORT,0.0018173,0.11393,0.12239,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0060989,0.11383,0.17934,1,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.049546,0.11373,0.078177,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.031748,0.11371,0.091483,1,1
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.0066042,0.11341,0.10107,1,1
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.030383,0.1133,0.090855,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0075304,0.11326,0.10481,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.0028957,0.11296,0.097182,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.035393,0.11268,0.12838,1,1
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.031059,0.11236,0.09876,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.0034322,0.11234,0.10583,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0025817,0.1121,0.10091,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.014138,0.11186,0.10184,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.03245,0.11169,0.14992,1,1
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.033894,0.11142,0.096887,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0081404,0.11117,0.096041,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.007729,0.10983,0.093005,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.0013872,0.10978,0.11056,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.013465,0.10952,0.15356,1,1
4,GO T CELL LINEAGE COMMITMENT,0.0045306,0.10749,0.15195,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.019739,0.10748,0.11539,1,1
4,GO CELLULAR HOMEOSTASIS,0.0013457,0.10737,0.11462,1,1
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.029068,0.10723,0.080471,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00012512,0.10672,0.13638,1,1
4,GO BODY FLUID SECRETION,0.018836,0.10641,0.093733,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.013139,0.10609,0.09621,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.01282,0.10525,0.13106,1,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02068,0.105,0.07846,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00025131,0.10491,0.15378,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0054795,0.10449,0.091499,1,1
4,GO LEUKOCYTE TETHERING OR ROLLING,0.045624,0.10447,0.07899,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.018398,0.10425,0.082554,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.011326,0.10391,0.10017,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0010859,0.10374,0.11856,1,1
4,GO MULTI ORGANISM PROCESS,0.026586,0.10252,0.067993,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.043763,0.10223,0.065161,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.004408,0.10176,0.10161,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.014486,0.1013,0.084424,1,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.02166,0.10115,0.095596,1,1
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.03245,0.10039,0.12949,1,1
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.049546,0.10027,0.11035,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0071468,0.09916,0.10434,1,1
4,GO POSITIVE REGULATION OF NEURON DEATH,0.016339,0.099057,0.1158,1,1
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.018836,0.09896,0.089565,1,1
4,GO JNK CASCADE,0.0075304,0.098803,0.10945,1,1
4,GO POSITIVE T CELL SELECTION,0.012203,0.097813,0.10902,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.0036303,0.097367,0.10347,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.050569,0.09721,0.1312,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.009256,0.097043,0.11938,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.014486,0.097021,0.083444,1,1
4,GO FERTILIZATION,0.012203,0.096811,0.081027,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0067808,0.09659,0.094272,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.019739,0.096461,0.091748,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.014486,0.094521,0.12501,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.013465,0.094026,0.091287,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.0036303,0.093668,0.09398,1,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.03245,0.092942,0.072541,1,1
4,GO BONE MINERALIZATION,0.036164,0.092232,0.104,1,1
4,GO CYTOSOLIC TRANSPORT,0.0059384,0.091387,0.093335,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0087944,0.091238,0.083,1,1
4,GO REPRODUCTION,0.014486,0.091163,0.076131,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.013465,0.090848,0.096384,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.009256,0.090784,0.097367,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.013465,0.090584,0.12861,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0038387,0.089947,0.11037,1,1
4,GO REGULATION OF AUTOPHAGY,0.00063551,0.08954,0.12164,1,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.012508,0.089413,0.07812,1,1
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.01282,0.088373,0.082007,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0017123,0.088291,0.096355,1,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.021165,0.088254,0.073995,1,1
4,GO REGULATION OF OSSIFICATION,0.024288,0.088222,0.097624,1,1
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.022165,0.087474,0.072842,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0057817,0.08744,0.15075,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0054795,0.087366,0.085868,1,1
4,GO COBALAMIN METABOLIC PROCESS,0.050569,0.087316,0.20758,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.042857,0.087265,0.077405,1,1
4,GO REGULATION OF EXOCYTOSIS,0.011326,0.086981,0.12042,1,1
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.041967,0.086767,0.058141,1,1
4,GO SENSORY PERCEPTION,0.01282,0.086766,0.073341,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0097392,0.086719,0.10177,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0054795,0.086554,0.092326,1,1
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.011612,0.085515,0.10152,1,1
4,GO BLASTOCYST DEVELOPMENT,0.0059384,0.085403,0.094573,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.01282,0.08523,0.072842,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0066042,0.085158,0.10615,1,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.009256,0.084985,0.088634,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.019283,0.084624,0.078478,1,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.015574,0.084275,0.080821,1,1
4,GO MALE SEX DIFFERENTIATION,0.025414,0.083363,0.09639,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.025994,0.083273,0.1489,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.031748,0.08318,0.091249,1,1
4,GO TUBE DEVELOPMENT,0.045624,0.082063,0.072007,1,1
4,GO NEGATIVE REGULATION OF TRANSPORT,0.030383,0.079597,0.076876,1,1
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.011612,0.079462,0.07978,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0025817,0.078131,0.096229,1,1
4,GO VESICLE LOCALIZATION,0.024846,0.077178,0.090455,1,1
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.024846,0.076268,0.13779,1,1
4,GO DNA MODIFICATION,0.041967,0.075823,0.054613,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.0057817,0.075283,0.083422,1,1
4,GO REGULATION OF CELLULAR LOCALIZATION,0.049546,0.075227,0.050553,1,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0062634,0.073097,0.089844,1,1
4,GO NEURON DEATH,0.041967,0.072877,0.057891,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.0030654,0.072863,0.11058,1,1
4,GO RHYTHMIC PROCESS,0.031059,0.071908,0.065535,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.014486,0.071852,0.064571,1,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.037747,0.071651,0.078548,1,1
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.046579,0.071169,0.056288,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0097392,0.070833,0.086487,1,1
4,GO INTRACELLULAR TRANSPORT,0.0045306,0.069899,0.068765,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.020205,0.0685,0.07448,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE,0.049546,0.065903,0.052451,1,1
4,GO REGULATION OF BINDING,0.042857,0.063386,0.071169,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0028141,0.062937,0.068006,1,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.022165,0.062551,0.053457,1,1
4,GO SEXUAL REPRODUCTION,0.033894,0.061944,0.058399,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.033166,0.058467,0.070369,1,1
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.031059,0.056636,0.048113,1,1
4,GO REGULATION OF GTPASE ACTIVITY,0.036164,0.056291,0.07071,1,1
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.036164,0.052483,0.070694,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0064317,0.051948,0.083208,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.049546,0.050642,0.052383,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.031748,0.05034,0.050652,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.010773,0.049143,0.056701,1,1
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.037747,0.036413,0.07211,1,1
5,GO FOREBRAIN NEURON FATE COMMITMENT,9.389e-05,0.71711,0.80186,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.6623e-06,0.55173,0.51129,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0064317,0.52017,0.4028,1,1
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,5.7413e-06,0.42961,0.43401,1,1
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.001662,0.40189,0.43636,1,1
5,GO THALAMUS DEVELOPMENT,0.0030654,0.34803,0.3007,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0056288,0.34268,0.38809,1,1
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.00069957,0.33994,0.32635,1,1
5,GO NOSE DEVELOPMENT,0.00069957,0.31685,0.49465,1,1
5,GO ESTROUS CYCLE,0.052669,0.28315,0.1734,1,1
5,GO KINETOCHORE ORGANIZATION,0.0011199,0.25095,0.21623,1,1
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.02843,0.24932,0.2353,1,1
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00057693,0.24842,0.22834,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0056288,0.24639,0.32097,1,1
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0045306,0.23628,0.22267,1,1
5,GO MRNA SPLICE SITE SELECTION,9.7346e-05,0.23498,0.25837,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.021165,0.22443,0.16205,1,1
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.004408,0.22431,0.18055,1,1
5,GO REGULATION OF SISTER CHROMATID COHESION,0.001662,0.21515,0.17146,1,1
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.03245,0.21131,0.16347,1,1
5,GO KINETOCHORE ASSEMBLY,0.0037331,0.20983,0.18191,1,1
5,GO HISTONE H4 K16 ACETYLATION,6.7596e-05,0.20893,0.21464,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.019283,0.20669,0.16686,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.02268,0.20268,0.14706,1,1
5,GO APICAL PROTEIN LOCALIZATION,0.0014738,0.20132,0.19976,1,1
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0023671,0.1997,0.16584,1,1
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.02268,0.19484,0.16869,1,1
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.011612,0.1918,0.157,1,1
5,GO HISTONE H3 K9 TRIMETHYLATION,0.0013457,0.19125,0.16551,1,1
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.014841,0.18427,0.13251,1,1
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0087944,0.18181,0.14668,1,1
5,GO DENDRITIC TRANSPORT,0.036164,0.1809,0.16379,1,1
5,GO INTRACILIARY TRANSPORT,0.004408,0.17781,0.20037,1,1
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00017796,0.17735,0.19303,1,1
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0062634,0.17377,0.18316,1,1
5,GO HISTONE H4 K5 ACETYLATION,7.8282e-05,0.17219,0.23057,1,1
5,GO CHROMATIN REMODELING AT CENTROMERE,0.0023671,0.1689,0.18077,1,1
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.009256,0.16873,0.14068,1,1
5,GO POST ANAL TAIL MORPHOGENESIS,0.020205,0.168,0.12913,1,1
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00016595,0.16518,0.17921,1,1
5,GO HISTONE H3 K9 METHYLATION,0.001662,0.16495,0.15188,1,1
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0030654,0.16183,0.15187,1,1
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0018173,0.1616,0.19978,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.001228,0.15959,0.14229,1,1
5,GO MITOTIC SISTER CHROMATID COHESION,0.00074557,0.15708,0.2021,1,1
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.014841,0.15605,0.14197,1,1
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0053338,0.15466,0.13805,1,1
5,GO VIRAL LATENCY,0.018398,0.15335,0.15821,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0075304,0.15066,0.16181,1,1
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.017969,0.14957,0.16419,1,1
5,GO MITOTIC CHROMOSOME CONDENSATION,0.00049035,0.14904,0.19246,1,1
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.0099891,0.14669,0.13357,1,1
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0090226,0.14631,0.18841,1,1
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.027803,0.14457,0.086262,1,1
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.011047,0.14377,0.15009,1,1
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0060989,0.14327,0.12321,1,1
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00098941,0.14262,0.14932,1,1
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0049174,0.14194,0.114,1,1
5,GO CENTROSOME DUPLICATION,0.0014738,0.14193,0.13551,1,1
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.014138,0.14171,0.13144,1,1
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.024288,0.14085,0.08773,1,1
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.018836,0.13876,0.15832,1,1
5,GO POSITIVE REGULATION OF DNA REPAIR,0.0028957,0.13856,0.11061,1,1
5,GO DOSAGE COMPENSATION,0.0036303,0.13802,0.11567,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.035393,0.13456,0.13946,1,1
5,GO HISTONE H2A ACETYLATION,0.0029794,0.1334,0.15648,1,1
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.00055855,0.13302,0.13964,1,1
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0010859,0.12899,0.12425,1,1
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00025131,0.12819,0.14341,1,1
5,GO CENTRIOLE ASSEMBLY,0.0067808,0.12724,0.10893,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.024846,0.12086,0.12242,1,1
5,GO HISTONE H4 ACETYLATION,0.0010528,0.11655,0.11425,1,1
5,GO DNA STRAND ELONGATION,0.012203,0.11409,0.11334,1,1
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0059384,0.11377,0.098808,1,1
5,GO HISTONE H2A UBIQUITINATION,0.0051916,0.11361,0.12739,1,1
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0031536,0.11323,0.1096,1,1
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.010773,0.11285,0.12603,1,1
5,GO HISTONE MONOUBIQUITINATION,0.00081984,0.11174,0.11912,1,1
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.0029794,0.11102,0.12406,1,1
5,GO G0 TO G1 TRANSITION,0.0021689,0.11076,0.13728,1,1
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0062634,0.10927,0.12693,1,1
5,GO PEPTIDYL LYSINE ACETYLATION,0.00063551,0.10704,0.0901,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.024846,0.10679,0.13066,1,1
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.001228,0.10592,0.10112,1,1
5,GO NUCLEOSOME ASSEMBLY,0.010245,0.10483,0.12713,1,1
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.030383,0.10204,0.12581,1,1
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00047456,0.10158,0.12537,1,1
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.01282,0.10152,0.14671,1,1
5,GO HISTONE H3 K4 METHYLATION,0.0042883,0.097565,0.13621,1,1
5,GO SISTER CHROMATID COHESION,0.0046564,0.095238,0.12185,1,1
5,GO CELL CYCLE DNA REPLICATION,0.036164,0.094995,0.077081,1,1
5,GO CHROMOSOME LOCALIZATION,0.012508,0.092369,0.075688,1,1
5,GO PROTEIN ACETYLATION,0.0034322,0.091896,0.065752,1,1
5,GO NUCLEOSOME ORGANIZATION,0.0081404,0.09049,0.09764,1,1
5,GO HISTONE UBIQUITINATION,0.016734,0.087846,0.075099,1,1
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.0062634,0.086238,0.12136,1,1
5,GO REGULATION OF PROTEIN ACETYLATION,0.049546,0.080845,0.059045,1,1
5,GO RECOMBINATIONAL REPAIR,0.035393,0.077267,0.058113,1,1
5,GO HISTONE EXCHANGE,0.019739,0.076629,0.10184,1,1
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.018398,0.076167,0.12658,1,1
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0045306,0.07494,0.09936,1,1
5,GO CHROMOSOME SEGREGATION,0.022165,0.073868,0.056315,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.050569,0.073369,0.091951,1,1
5,GO CHROMATIN REMODELING,0.0071468,0.072561,0.081955,1,1
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0034322,0.071547,0.095989,1,1
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.02843,0.067949,0.072722,1,1
5,GO CHROMOSOME CONDENSATION,0.038561,0.067571,0.085457,1,1
5,GO SISTER CHROMATID SEGREGATION,0.01282,0.066281,0.073421,1,1
5,GO CELL CYCLE CHECKPOINT,0.0097392,0.066261,0.0593,1,1
5,GO PEPTIDYL LYSINE MODIFICATION,0.040234,0.066025,0.042966,1,1
5,GO DNA INTEGRITY CHECKPOINT,0.024288,0.064855,0.051358,1,1
5,GO REGULATION OF DNA REPAIR,0.050569,0.063867,0.053422,1,1
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.052669,0.060045,0.073759,1,1
5,GO DEMETHYLATION,0.019739,0.058928,0.067902,1,1
5,GO DNA PACKAGING,0.0066042,0.057153,0.089103,1,1
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.037747,0.054907,0.049116,1,1
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.027803,0.053652,0.051478,1,1
5,GO DNA CONFORMATION CHANGE,0.044685,0.053238,0.053727,1,1
5,GO CHROMATIN ORGANIZATION,0.0094949,0.052844,0.053259,1,1
